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ABSTRACT 
 
Alcohol is a commonly consumed beverage, a drug of abuse and an important 
molecule affecting nearly every organ-system in the body. This project seeks to 
investigate the interplay between alcohol’s effects on critical organ-systems making up 
gut-liver-brain axis. 
Alcohol initially interacts with the gastrointestinal tract. Our research describes 
the alterations seen in intestinal microbiota following alcohol consumption in an acute-
on-chronic model of alcoholic hepatitis and indicates that reducing intestinal bacteria 
using antibiotics protects from alcohol-induced intestinal cytokine expression, alcoholic 
liver disease and from inflammation in the brain. Alcohol-induced liver injury can occur 
due to direct hepatocyte metabolic dysregulation and from leakage of bacterial products 
from the intestine that initiates an immune response. Here, we will highlight the 
importance of this immune response, focusing on the role of infiltrating immune cells in 
human patients with alcoholic hepatitis and alcoholic cirrhosis. Using a small molecule 
inhibitor of CCR2/CCR5 chemokine receptor signaling in mice, we can protect the liver 
from damage and alcohol-induced inflammation. In the brain, we observe that chronic 
alcohol leads to the infiltration of macrophages in a region-specific manner. CCR2/CCR5 
inhibition reduced macrophage infiltration, alcohol-induced inflammation and microglial 
changes. We also report that chronic alcohol shifts excitatory/inhibitory synapses in the 
hippocampus, possibly through complement-mediated remodeling. Finally, we show that 
anti-inflammasome inhibitors altered behavior by reducing alcohol consumption in 
female mice. 
 
 
 
 
  v 
Together, these data advance our understanding of the gut-liver-brain axis in 
alcoholism and suggest novel avenues of therapeutic intervention to inhibit organ 
pathology associated with alcohol consumption and reduce drinking. 
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CHAPTER I  
Introduction 
 
Introduction 
Alcohol has saturated human society for millennia. Ancient Greeks and Romans 
worshiped gods such as Dionysus and Bacchus who were celebrated as patrons of the 
vine, of a good harvest and of winemaking. Alcohol, and wine in particular, are important 
features in many modern religions, including the Judeo-Christian tradition: in the Torah, 
Noah is credited with planting the first vineyard (Genesis 9:20) and in the Gospels, Jesus’ 
first public miracle was to turn water into wine during the Wedding at Cana (John 2:1-
11). Indeed, alcohol permeates even our modern-day pop-culture, so much so that the 
British Medical Journal recently published a retrospective study of Commander James 
Bond (code name: 007) that assesses the likelihood for adverse medical outcomes 
associated with his high alcohol intake1. 
Despite the prominence of alcohol throughout ancient and modern human history, 
alcohol consumption has significant influence on health and disease. Upon introduction 
of alcohol into the body, its interaction with multiple organs can induce both anxiolytic 
and euphoric sensations as well as dangerously adverse effects. Beginning with the 
intestinal lumen and the gastrointestinal parenchyma, systemic interactions with the 
immune system, metabolism in the liver and then systemic circulation, critical contact 
points exist throughout the body where alcohol can influence our physiology. Given the 
near ubiquitous interactions alcohol has with the organs of the body, we propose that the 
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study of alcohol physiology and pathology requires a holistic approach, encompassing 
organs throughout the body. Previous research highlighting various mechanisms in the 
study of alcohol often emphasize contributions from the intestine, the liver, the immune 
system and the brain.  Here, we will explore the hypothesis that immune activation and 
organ-specific pathology induced by alcohol consumption is dependent on cross-talk 
between the intestine, liver, peripheral immune system and the brain. 
 
Clinical manifestations of alcohol use disorder 
Alcohol use and abuse results in significant disease burden worldwide. In the 
United States, according to the National Institute on Alcohol Abuse and Alcoholism of 
the National Institutes of Health, 17 million adults and half a million adolescents have an 
alcohol use disorder2. In 2016, the Centers for Disease Control and Prevention reported 
42,000 Americans died due to opioid overdose3 while more than 80,000 patients die of 
alcohol related causes each year2. Behind only tobacco and poor diet/physical activity, 
alcohol use disorder (AUD) is the third leading cause of preventable death2 and a 
majority of patients with clinically diagnosed AUD do not receive treatment2,4,5. These 
data provide compelling evidence of the need for better understanding of alcohol use and 
related diseases, as well as the critical need for interventions to both reduce organ-
specific disease and mitigate alcohol addiction. 
Alcohol use disorder is described in the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-5) as problem drinking that leads to either clinically relevant or 
psychosocial functional impairment6. DSM-5 diagnosis of AUD is dependent on having 
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two or more of eleven symptoms. These symptoms include: being unable to cut back 
drinking despite a desire to do so, having memory blackouts due to excessive drinking, 
experiencing withdrawal symptoms when not drinking and drinking despite it causing 
troubles with family, friends or work. Severity of the disorder is defined by increasing 
symptom number6.  
AUD has multiple pathologic medical sequelae in organs throughout the body. 
Common pathophysiologic manifestations of AUD, discussed in brief below, include 
disease of the gastrointestinal tract, alcoholic liver disease, cardiomyopathy, bleeding 
disorders, peripheral neuropathy, brain alterations and addiction7. 
Alcoholic liver disease (ALD) is a prominent clinical concern because of the near 
ubiquitous nature of alcohol exposure in cultures across the globe8. ALD 
pathophysiology falls on a progressive spectrum of disease often related to the amount 
and duration of alcohol consumption. This spectrum includes liver steatosis, 
steatohepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma9. Some stages of disease 
are reversible, such as fatty liver, which can be corrected with abstinence. However, more 
severe forms of ALD develop in 35% of heavy alcohol drinkers and may be 
irreversible10. Hallmarks of ALD include hepatocyte injury (indicated by systemic release 
of liver enzymes such as alanine and aspartate transaminase (ALT/AST)), lipid 
accumulation, and immune cell infiltration. 
Historically, AUD has been thought of as a psychiatric disorder that leads to 
organ disease. However, our scientific understanding of addiction has evolved and it is 
now recognized as a disease of the brain11. The underlying neurobiological mechanisms 
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of AUD included dysregulated neuronal activity and excitability, reward pathway 
activation and neurotoxicity in various brain regions. Neurologic and psychologic 
symptoms of AUD include intoxication (dyscoordination, dizziness, blackout, etc.), 
alcohol dependence and craving, memory deficits and withdrawal symptoms (including 
seizure, tremor, agitation, psychosis, etc.). Immune signaling has emerged as an 
important component underpinning many of these changes12-17 and will be explored 
further below. 
AUD is associated with various other health problems and diseases beyond the 
liver and brain18. In the gastrointestinal (GI) tract, gastritis, ulcers and pancreatitis are 
common. Cardiovascular diseases include cardiomyopathy and increased risk for 
bleeding. Peripheral neuropathy, sexual dysfunction, osteoporosis and increased risk of 
breast and GI cancers are just some of the remaining diseases associated with chronic 
alcohol abuse.   
Current therapies to treat AUD vary in their therapeutic mechanism and include 
naltrexone (an opioid antagonist), acomporosate (a modulator of neurotransmitter 
signaling) and disulfuram (an inhibitor of acetaldehyde dehydrogenase)19. However, 
millions of patients continue to suffer with AUD and methods to reduce alcohol 
consumption, whether through changes in behavior or pharmacologic therapies, can have 
a significant impact on relieving a preventable, but often untreated, health burden. For 
some of the sequelae of AUD, such as progressive alcoholic liver disease, there are no 
definitive therapies except abstinence, and current standards of care (with corticosteroids 
such as prednisolone) have limited efficacy, multiple contraindications and significant 
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side effects20. These limited options make discovery of new treatments for AUD and the 
associated clinical diseases of great importance for both improved patient outcomes and 
reduced burden on healthcare systems and society at large. 
Decades of research into AUD have pointed toward an axis of organs critical in 
the pathomechanisms of AUD-associated diseases. Based on the sequence of exposure to 
alcohol once it is consumed, these organs include the intestinal microbiome and the GI 
tract, the liver, the peripheral immune system and the central nervous system (CNS). The 
impact of alcohol on each of these organs in the development of disease is discussed 
below. 
 
Influence of alcohol on gut microbiome 
While the first organs that come to mind when thinking about AUD-associated 
disease may be the liver or the brain, the first organ that alcohol actually encounters after 
consumption is the GI tract. Consumed orally, alcohol is treated as much of all oral intake 
is treated: it is passed through the esophagus to the stomach and eventually to the 
intestines. Along the way, alcohol encounters the microbiome of the GI tract as well as 
the cells that make up the gut barrier. These interactions are critical first steps in our 
physiologic interaction with alcohol and varying degrees of homeostatic disruption 
contribute to the ensuing intoxication, dysfunction and ultimately, pathology21,22. 
For decades, researchers have observed an increase in endotoxin in the circulation 
of patients with alcoholic liver disease, a phenomenon referred to as alcohol-induced 
“leaky gut”23-27. Endotoxin is a component of the gram-negative bacterial cell wall and is 
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also known as lipopolysaccharide (LPS). However, it was not immediately apparent how 
bacterial products (also referred to as pathogen-associated molecular patterns or PAMPs), 
such as LPS, could end up increased in the circulation. In 2000, Parlesak et al.27 in 
Germany reported that patients with alcoholic liver disease have increased permeability 
in the intestine to large molecular weight molecules of polyethylene glycol compared to 
control human subjects. Additionally, they reported 5-fold increases in plasma endotoxin 
in patients27. This important demonstration of the loss of intestinal barrier integrity 
corroborates the phenomenon observed by others in both human disease28-30 and in 
animal models of AUD31-34. Our lab recently showed that leaky gut is not restricted to 
patients with chronic alcohol use disorder, but can also be observed with a single alcohol 
binge in otherwise healthy control subjects26. 
The exact mechanisms involved in the breakdown of the intestinal barrier remain 
unclear, although multiple possible pathways have been proposed. Bacteria are capable of 
metabolizing alcohol35,36 and the alcohol metabolite acetaldehyde as well as production 
of reactive oxygen species cause disassociation of intestinal tight junction proteins37,38. 
Multiple cytokines, including IL-1b, TNFa and IL-6, have been shown to reduce key 
proteins for tight junction integrity through activation of various intracellular signaling 
pathways and these cytokines, coming from peripheral immune cell activation, liver 
immune cells or from intestinal cells, are increased in the circulation of patients with 
AUD39-42. NFkB, an important proinflammatory transcription factor, induces 
rearrangement of cellular cytoskeletal proteins43. Trophic signaling as well as luminal 
microenvironment homeostasis involving mucins and lectins are also important in the 
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intestinal pathogenesis of alcohol use32,44,45 and changes in intestinal metabolites such as 
phenols and indole compounds have been reported after alcohol exposure30. Given these 
various lines of evidence, it is likely that alcohol acts through a variety of mechanisms to 
induce cellular stress and barrier dysfunction that culminates in the leakage of bacteria 
and microbiome products from the lumen of the intestine through the intestinal lamina 
propria and into the circulation. 
In addition to gut barrier breakdown, alcohol consumption induces dysbiosis of 
the gut microbiome and bacterial overgrowth in humans30,46-48 and rodents32,33,49,50. 
Dysbiosis refers to alterations from the normal intestinal microbiome composition and is 
likely caused by some direct effect of alcohol, such as changes in gastric acid secretion 
leading to a shift in pH, or by the introduction of a new energy source, ethanol, which can 
be metabolized by some bacteria35,36. A decrease in the rate of intestinal flow in AUD 
patients could also contribute to a microenvironment that favors some bacterial species 
over others51. Dysbiosis is not limited to bacterial species content, however, as intestinal 
metabolites and metabolism of bile acids are also affected by chronic alcohol 
consumption52,53. Some have suggested that it is the microbiome dysbiosis, or perhaps the 
associated shifts in gut lumen content (bile acids, metabolites, etc.), that primarily drives 
gut barrier leakage because enteric microbes can provide positive trophic signals to the 
barrier54,55. However, studies have shown that after three weeks of alcohol detoxification, 
intestinal permeability is normalized despite the persistence of shifts in the microbiome 
content29,47, suggesting that if the microbiome content does play a role in leaky gut 
formation, it is likely secondary to other causes. 
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The composition of the gut microbiome has a significant causative role in some 
diseases, such as inflammatory bowel disease56, and dysbiosis is particularly prominent in 
ulcerative disease associated with Helicobacter pylori and Clostridium difficile-
associated colitis. Similar to the influence of stomach acid on Helicobacter pylori 
infection, the microbiome composition may change secondary to environmental factors, 
such as the diet that intestinal bacteria are exposed to. One particular study in AUD 
patients highlights the important effects of diet, and in particular drink choice, on the 
microbiome composition30. Researchers studying the intestinal bacterial content of AUD 
patients noted that only a subset of patients had altered bacterial composition and that this 
group of patients tended to consume more liquor compared to wine or beer.  
To what degree the microbiome affects other organs leading to AUD pathology is 
an active area of research with recent findings that suggest that the microbiome has 
significant influence on the peripheral immune system, liver and the brain. 
 
The effect of the microbiome on peripheral immune cells, the liver and the brain 
The presence of a microbiome contributes critically to host immune development 
and defense. Germ-free mice have impaired peripheral and organ-specific immune 
development at the cellular and molecular levels57,58. Importantly, it has been suggested 
that antibiotic treatment in human patients early in life, which can cause changes in the 
intestinal microbiome, may contribute to autoimmune and inflammatory diseases such as 
allergic asthma, multiple sclerosis and inflammatory bowel disease59-61. 
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Leakage of bacteria or their cellular components and products can occur in cases 
of intestinal barrier integrity loss and breakdown of natural lamina propria defense 
mechanisms. When this occurs, the leaked components enter circulation and can 
encounter immune cells in circulation or in organs throughout the body. This leakage has 
been implicated in numerous peripheral diseases, such as metabolic syndrome and 
diabetes62,63, as well as psychiatric diseases including autism spectrum disorder, anxiety 
and depression64,65. 
The liver is the first organ to be encountered by blood flowing through the portal 
circulation from the intestine and therefore serves to remove or neutralize any bacteria, 
bacterial products and absorbed toxins that may have translocated across the intestinal 
barrier66,67. Interestingly, bacterial contents within the intestine have a significant impact 
on alcohol-related liver function. The degree of cirrhosis in human AUD patients has 
been correlated with increasing bacterial overgrowth68. Additionally, fecal transplantation 
from human patients with AUD to previously healthy germ-free mice resulted in the 
development of alcoholic liver disease69.  
Intestinal-derived bacterial products, not necessarily dependent on the makeup of 
intestinal bacteria, also play a critical role in the liver pathology associated with alcohol 
consumption and compound the alcohol-induced cell stress, hepatocyte death and release 
of multiple sterile danger signals that occurs independently from the influence of the 
microbiome70,71. Bacterial LPS, leaking from inside the intestinal lumen into the portal 
circulation and traveling to the liver, signals through pattern recognition receptors such as 
Toll-like receptor 4 (TLR4). TLR4 activation leads to intracellular signaling and an 
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inflammatory response that can amplify ongoing hepatocyte stress and damage caused by 
alcohol metabolism. 
We and others have shown the importance of intestinal-derived bacterial signaling 
for the induction of liver inflammation. Antibiotic treatment in certain mouse models of 
AUD reduces the bacterial load in the GI tract as well as circulating PAMPs such as LPS, 
thereby attenuating liver inflammation and steatosis after alcohol use50,72,73. Treatment 
with antibiotics54,73, dietary fiber34 and probiotics48,49,74, each of which impact gut 
microbiome composition, can protect from some of the hallmark features of alcoholic 
liver disease in animal models 
While previous studies have described the role of gut-derived bacteria in the liver, 
and others have studied how alcohol impacts the brain directly75-77, the literature on what 
role the gut microbiota has regarding alcohol-induced CNS neuroinflammation is lacking. 
However, there is evidence from other disorders to suggest that the microbiome has 
effects on both addiction and neuroinflammation. Antibiotic treatment of mice, which 
dramatically reduced the total gut microbiome load, abrogated conditioned place 
preference for animals provided cocaine, suggesting a link between the gut microbiome 
and addiction78. Additionally, recent evidence suggests that metabolites from the intestine 
can significantly affect microglia and alter neuroinflammatory signaling in mouse models 
of multiple sclerosis79. Based on evidence from the gut-liver axis in AUD as well as from 
other disease models, we hypothesize that the intestinal microbiome may contribute to 
alcohol-induced neuroinflammation. 
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Alcohol’s effect on peripheral macrophages 
Gut barrier breakdown and leakage of bacteria and PAMPs from the intestinal 
lumen is an important feature of alcohol-induced pathology24,26,27. Circulating peripheral 
blood mononuclear cells (PBMCs), which include lymphocytes as well as 
monocyte/macrophages, respond to PAMPs by becoming activated and secreting 
cytokines. PBMCs taken from patients with alcoholism have an altered response to TLR 
ligands, exhibiting a blunted NFkB response, but an increased NLRP3 inflammasome 
response and increased production of IL-1b80. In fact, patients in the first day or two of 
alcohol detoxification were shown to have elevated circulating IL-1b and IL-8, 
proinflammatory cytokines that positively correlated with symptoms of depression, 
anxiety and alcohol craving during the detox period. In the same patients, the anti-
inflammatory cytokine IL-10 negatively correlated with these clinical scores80. Patients 
with AUD also have elevated serum levels of TNFa and IL-6 that persists even after 
weeks of abstinence and these cytokines correlate with craving, depression and anxiety81. 
The response of alcohol-naïve human PBMCs to alcohol exposure reveals 
important insight into how immune signaling is affected by the duration of alcohol 
exposure. For example, acute alcohol decreases signaling through NFkB in human blood 
mononuclear cells as well as production of proinflammatory cytokines, such as TNFa 
and IL-682-84. However, chronic alcohol treatment of PBMCs increases signaling and 
cytokine production84,85. Interestingly, while PBMCs from AUD patients have increased 
NLPR3 inflammasome response80, PBMCs from healthy donors exhibit a blunted 
inflammasome response when exposed to alcohol86,87. Upon alcohol consumption, 
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circulating PBMCs are therefore exposed to concentrations of alcohol that can directly 
influence their immune signaling in addition to any immune-activating gut-derived 
PAMPs or proinflammatory cytokines released from organs, such as the liver. Indeed, our 
lab has previously shown that exposure to acute alcohol and TLR ligands, such as LPS, 
can also increase proinflammatory cytokine production88. 
Alcohol itself and other microenvironmental factors significantly alter the 
immune response of circulating monocytes, which may influence their behavior once 
recruited to tissues to respond to a pathologic insult. This recruitment process typically 
occurs via release of chemokines, such as C-C chemokine ligand types 2 (CCL2; also 
known as monocyte chemoattractant protein-1 [MCP-1]) and CCL5 (also known as 
regulated on activation, normal T cell expressed and secreted [RANTES]), from tissues 
that attracts circulating monocytes via chemokine receptors, such as CC receptor type 2 
(CCR2)89-91. Within the liver, alcohol activates inflammatory signaling that includes 
upregulation of various cytokines and chemokines, including CCL2 and CCL5, leading to 
monocyte recruitment92. Infiltration of peripheral monocytes has been shown to be a 
critical component of disease development as targeting CCL2/5 signaling (genetically or 
pharmacologically) in mouse models of ALD has shown protection from disease93-95. 
 
Alcoholic liver disease 
Alcoholic liver disease (ALD) is a chronic progressive disorder associated with 
prolonged alcohol consumption in some patients with AUD. The progression of disease 
includes liver steatosis, steatohepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma9. 
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Some of its features are irreversible at the more severe ends of the spectrum while early 
stage pathology, such as lipid accumulation, are reversible with even short-term 
abstinence10. However, a portion of patients with AUD develop alcoholic hepatitis which 
can be rapid in onset and is associated with significant mortality and persistent 
inflammatory lesions10,96. 
Primary damage in the liver is due to alcohol and alcohol metabolism itself, which 
induces mitochondrial and endoplasmic reticulum stress and the release of reactive 
species damaging to hepatocytes, the main parenchymal liver cell70,71,97-99. Alcohol-
induced reactive oxygen species and shifts in NAD+/NADH balance can be toxic and 
lead to hepatocyte cell death100-102. Hepatocytes can also be stimulated by gut-derived 
LPS to produce and release acute phase reactants such as C-reactive protein (CRP), 
ceruloplasm, serum amyloid A and even proinflammatory cytokines103,104. 
A secondary insult that contributes significantly to ALD involves immune 
signaling. Immune activation is likely due to multiple factors, including hepatocyte stress 
and damage, changes in the gut microbiome and leakage of bacterial products, systemic 
cytokines and peripheral blood immune cell activation and other yet unknown signals105-
107. Many studies have described the variety of proinflammatory cytokines induced by 
alcohol in the liver as well as chemokines that attract monocytes, neutrophils and 
lymphocytes108. Prominent among these chemokine molecules are CCL2, which attracts 
monocytes, and IL-8, a neutrophil chemoattractant, among others. Neutrophils are a 
classic component of acute alcoholic hepatitis observed in liver histology96. Although the 
role of neutrophils is not fully determined, neutrophils in the liver negatively correlate 
 
 
 
 
  14 
with clinical outcomes in patients with alcoholic hepatitis109 and animal models that 
reduce neutrophils have shown some protection from alcoholic liver disease110. 
Kupffer cells are the resident macrophages of the liver and serve a critical role in 
ALD. Both Kupffer cells and macrophages that infiltrate from circulation express TLR4, 
the major receptor for bacterial LPS. After leaking through the gut barrier and entering 
the portal circulation, LPS stimulates TLR4 on hepatic macrophages leading to NFkB 
activation and the production of proinflammatory cytokines70,71. Kupffer cells also 
contribute to alcohol-induced liver steatosis through signaling dependent on CCL2 
expression93 and CCL2 inhibition has been shown to protect from macrophage 
infiltration, proinflammatory cytokine expression and steatosis in models of chronic liver 
injury94. 
As resident immune cells, Kupffer cells express proteins involved in 
inflammasome signaling. The inflammasome is a protein assembly that senses molecular 
patterns through a receptor (for example, via the Nod-like receptor NLRP3), an adaptor 
(such as Apoptosis-associated speck-like protein containing a CARD, ASC) and an 
effector (such as the enzyme caspase-1). Inflammasome activation eventually leads to the 
cleavage and activation of IL-1b which may be released to spread a proinflammatory 
signal. Multiple studies have examined the role of inflammasome-related proteins and 
have shown that deficiencies in ASC, caspase-1 and IL-1 receptor ameliorate hallmarks 
of alcoholic liver disease in rodents70,111-113. Treatment with a recombinant IL-1 receptor 
antagonist, thus blocking IL-1b signaling, also protects from key features of ALD112. 
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Liver fibrosis is a hallmark of end-stage ALD114. In addition to Kupffer cells and 
other macrophages, the liver contains stellate cells which are responsible for the 
establishment of fibrosis by laying down scar tissue and increasing myofibroblast 
activity. Stellate cells become activated by LPS signaling, reactive oxygen species, 
cytokines from the circulation and Kupffer cells (particularly TGFb) and other 
mechanisms115. Some studies suggest that the microbiome has influence over the 
progression of liver fibrosis and cirrhosis because bacterial overgrowth correlates with 
cirrhosis severity in AUD patients68,116.  
Through a combination of hepatocyte damage, immune cell activation and 
fibrosis, alcohol induces significant pathology in the liver that can lead to the 
development of steatosis, fibrosis and ultimately cirrhosis or hepatocellular carcinoma. 
Many pathways are involved in each of these pathophysiological processes, providing 
researchers many targets for the development of ALD therapeutics. 
 
Alcohol’s effect in the CNS 
For some, alcohol is a casual component of social and culinary life. However, for 
others, it is a drug of abuse and a substance of addiction. As proposed by Ron and 
Barak117, the neural circuitry involved in alcohol addiction can be generally divided into 
two categories: go pathways and stop pathways. Go pathways promote alcohol 
consumption based on activation in the mesocorticolimbic system reinforcing learning, 
memory and reward118-120. Stop pathways limit alcohol consumption and can be thought 
of as the negative aspects of alcohol intake. Stop pathway components contribute to the 
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aversive neurobiology of withdrawal and the physiological symptoms of a hangover. In 
some patients, an aversion to stop pathways and the rewarding benefits of go pathways 
lead to the development of alcohol use disorder117,121.  
The convergent roles of these seemingly divergent go/stop pathways in AUD are 
best exemplified in two pharmacological treatments. Targeting the go pathway, the 
opioid antagonist naltrexone reduces dopamine release and thus reduces the reward 
associated with alcohol consumption122. Alcohol has been shown to activate components 
of the mesolimbic dopamine circuit which can be activated by µ-opioid receptor 
activation that removes GABAergic inhibitory interneuron tone and allows ventral 
tegmental area (VTA) dopamine signaling119,120,123. A recent study revealed that 
activation of dopamine signaling in regions such as the VTA influences the amount of 
alcohol consumed124. VTA activation resulted in less alcohol consumption while high-
consuming mice displayed VTA activation comparable to alcohol-naïve mice, suggesting 
underactive reward response may be, at least in part, responsible for alcohol seeking 
behavior. Some patients may be predisposed to benefit from opioid inhibition using the 
drug naltrexone, while others may be resistant to treatment. Genetic analysis of treatment 
susceptible/resistant patients reveals that mutations in the µ-opioid receptor determine 
patient response to naltrexone125,126. These clinical observations have been confirmed in 
nonhuman primates with comparable polymorphisms127, highlighting the important 
variation of µ-opioid receptor signaling and its effects on the mesolimbic dopamine 
reward circuitry in alcohol addiction within the population128. 
 
 
 
 
  17 
Approved AUD therapies also target the stop pathway. Acomprosate is a partial 
agonist of the glutamate NMDA receptor that can serve to reduce receptor excitability 
and glutamate hyperactivity that occurs after alcohol cessation and is associated with 
withdrawal dysphoria, including in regions of mesolimbic reward circuit such as the 
nucleus accumbens129,130. Disulfiram therapy may serve to augment the stop pathway, so 
much so that disulfiram-induced dysphoria associated with alcohol consumption (i.e. 
severe symptoms of a hangover) is better dealt with by alcohol cessation rather than 
repeated cycles of over intoxication and hangover131. Disulfiram works by inhibiting 
complete alcohol metabolism, leading to a buildup of acetaldehyde and inducing the 
physiological symptoms of a hangover. 
The effects of alcohol on the hippocampus and in particular on learning and 
memory have been studied for decades. A recent publication spanning 30 years showed 
that alcohol consumption led to increased odds of hippocampal atrophy in a dose-
dependent manner13 and recent meta-analysis comparing alcohol consumption and 
hippocampal volume reveals a similar finding132. The hippocampus is critical in the 
formation of memories and these findings of alcohol-associated decreased hippocampal 
volume manifest in memory dysfunction among alcohol consumers. Korsakoff’s 
syndrome is a well-described amnesic disorder in patients with AUD who have profound 
confabulatory speech and behavior associated with severe anterograde and retrograde 
memory dysfunction133. Memory loss can also occur acutely and the age of onset of 
drinking correlates with an increase in acute-memory loss incidents (“blackouts”) even 
with reduced frequency in alcohol binge episodes134. 
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How alcohol can influence the hippocampus and memory formation is also an 
area of active research. Multiple studies have demonstrated that alcohol suppresses long-
term potentiation (LTP) of synapses135-137, a process associated with synaptic learning 
and memory formation, and some have suggested that this LTP inhibition is dependent on 
age with younger age associated with more inhibition137. Alcohol consumption also 
significantly affects dendritic processes and synapses. For example, recent studies using 
mice that were pretreated with alcohol in adolescence revealed an increase in dendritic 
spines and a decrease in synapses in adulthood, suggesting dysregulation of dendrites and 
synapses within the hippocampus following alcohol exposure138,139. 
In addition to alterations in neurotransmission and reward pathways, alcohol has 
profound effects on immune signaling in the brain. Neuroimmune activation has been 
noted in post-mortem CNS tissue of patients with AUD140-143. Various mechanisms are 
involved and likely act in concert to induce neuroimmune signaling in the setting of 
alcohol consumption. Alcohol induces oxidative stress by disrupting mitochondrial 
function in the brain which leads to the release of reactive species144. Alcohol, along with 
neuroimmune activation, has also been demonstrated to induce neurodegeneration and 
reduce neurogenesis145-147. Alcohol upregulates CNS expression of important 
neuroimmune receptors including TLR2, TLR4 and RAGE141,148 making the CNS primed 
for pattern recognition and immune activation. Alcohol-induced neuroinflammation and 
its role in pathology and behavior are emerging areas of intense study and represent 
important avenues for the development of novel therapeutics to assist in addiction 
therapy. 
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Microglia, neuroinflammation and peripheral macrophages 
Microglia are derived from the hematopoietic lineage from the yolk sac and enter 
the brain during development around embryonic day 9.5-10.5 in mice149-151. As the 
resident macrophages of the CNS, microglia serve multiple physiological functions 
including CNS surveillance152-154, neuroimmune protection155 and synaptic 
maintenance156-159. However, in a disease state or following a CNS insult, microglia can 
become activated, much like other tissue resident macrophages, with characteristic 
morphologic changes160 and the production and release of inflammatory signals such as 
cytokines142,161-163. During homeostatic development as well as during a 
neuroinflammatory response, microglia express multiple phagocytic receptors164. 
Microglia also express pathogen and danger signal receptors, such as TLRs that are 
critical in alcohol-induced neuroinflammation14,165,166 as well as NOD-like receptors such 
as NLRP3162.  
TLR4 is the major receptor recognizing bacteria-derived LPS167 as well as various 
endogenous danger signals including HMGB1168,169. Mice deficient in TLR4 exhibit less 
microglia activation and lower expression of proinflammatory cytokines when treated 
with alcohol than TLR4 proficient animals170-172. LPS does not significantly cross the 
blood-brain barrier under healthy conditions173, however alcohol can cause a breakdown 
in blood-brain barrier integrity174. Regardless of whether LPS crosses into the brain 
following alcohol exposure, data from TLR4 knockout mice certainly highlight the 
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importance of signaling through this LPS-recognition receptor in the induction of 
neuroinflammation after alcohol exposure. 
In addition to signaling through TLR4, alcohol induces a substantial inflammatory 
response through the NLRP3 inflammasome. Inflammasome activation requires multiple 
signaling steps beginning with activation of intracellular NLRP3 by danger associated 
molecular patterns (DAMPs) such as uric acid, ATP and reactive oxygen species175,176. 
NLRP3 then forms a multiprotein complex with the adaptor molecule ASC which leads 
to the cleavage of pro-caspase-1 to active caspase-1. Active caspase-1 is an enzyme 
capable of cleaving pro forms of the cytokines IL-1b and IL-18. Upon cleavage, IL-1b 
can be released from the cell and serve as a cytokine signal to surrounding tissue177,178. 
IL-1b expression and release has been identified as a hallmark of alcohol-induced 
neuroinflammation170,179,180 and blockade of IL-1b signaling ameliorates alcohol-induced 
neuroinflammation162. 
Astrocytes are another important glial cell type in the CNS. Astrocytes serve 
multiple functions in the brain including neurotransmitter uptake, ion buffering, structural 
support and even serving immune functions. They produce and release inflammatory 
cytokines and become activated, similar to microglia, with altered morphology and 
characteristic protein expression changes181-183. Postmortem human CNS tissue from 
patients with AUD reveal increased staining of astrocyte markers174. 
Various studies have looked at the effects of alcohol on cell models and have 
shown that alcohol exposure can induce an inflammatory response in rodent brain 
slices184-186 and in primary glial cells162,170,171,187,188. Two recent publications explore the 
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transcriptional changes caused by in vivo alcohol in specific glial cells and reveal 
important and distinct roles for each cell type. In the study, mice were provided a two-
bottle choice of alcohol every other day for sixty days. Microglia and astrocytes were 
isolated from the total brain and the cell-specific RNA was sequenced. Interestingly, 
while shifts in expression were noteworthy in both cell types, network analysis in the 
astrocyte transcriptome revealed an upregulation in genes related to extracellular matrix 
formation and maintenance as well as calcium signaling and homeostasis189. Conversely, 
biological network analysis revealed microglial gene expression upregulation in multiple 
immune networks related to “innate immune signaling,” “toll-like receptor signaling,” 
“positive regulation of NFkB” and “regulation of TGFb signaling”190. Although this 
study uses only one model of AUD in mice, it reveals that between two glial cell-types, 
both of which can be involved in immune signaling, microglia predominate as the 
immune responders in the setting of chronic alcohol. 
Microglia also serve as critical players in the maintenance and maturation of 
neuronal connectivity in the CNS. Throughout development, microglia participate in 
engulfing inactive and unnecessary synapses throughout the brain154,191. This process of 
synaptic pruning uses the complement pathway, classically described in the context of 
inflammation and immune signaling. Complement proteins tag synapses for engulfment 
and microglia, expressing various complement receptors and other surface phagocytic 
proteins, respond by pruning unwanted synapse structures157,159. 
Disruption of homeostatic microglia behavior, for example by disturbing the 
microenvironment in the CNS, can have significant impact on neurodevelopment and 
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result in significantly dysfunctional behavioral outcomes191-193. Very recently, acute 
alcohol binge administration in animals has been shown to activate microglia from their 
resting, homeostatic state and induce neuroinflammation. Interestingly, associated with 
this immune activation is altered synaptic development and pruning in the prefrontal 
cortex194,195. Indeed, in vitro assays exposing organotypic brain slices to a 
proinflammatory milieu with various cytokines affects both excitatory and inhibitory 
synapse density196 and alcohol induction of cytokine expression in the CNS is a well-
documented phenomenon170,179,180,187,188. 
Another cell type important during neuroinflammatory processes are recruited 
peripheral macrophages. Systemic inflammation leads to microglial recruitment of 
peripheral macrophages to the CNS197 and subsequent upregulation of innate immune 
signals198. The effects of peripheral macrophage infiltration on CNS inflammation are 
seen both in models of systemic infection (LPS injection) as well as systemic sterile 
inflammation (circulating cytokines such as TNFa, IL-1b and IL-6)199. Infiltrating 
macrophages may be targeted to an area of tissue damage or respond to sights of ongoing 
neuroinflammation200.  
Macrophage infiltration normally occurs sparingly if at all in the healthy brain, 
but a recent study from researchers in Spain has revealed an important mechanism by 
which peripheral immune cells may be able to enter into the typically immune-protected 
CNS. Rubio-Araiz et al.174 showed reduced levels of key blood-brain barrier (BBB) 
proteins, including basal lamina protein, collagen-IV and claudin-5 in human post-
mortem tissue from patients with AUD. They also describe an increase in the number of 
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CD45+ cells in the dorsolateral prefrontal cortex in these patients. To date, this report 
provides the most comprehensive evidence of BBB breakdown in human alcoholic 
patients. The authors also show that the pattern of decreased barrier integrity is also 
present in mouse models of alcohol consumption where they observed reduced 
hippocampal expression of laminin and collagen-IV along with increased IgG 
extravasation. Interestingly, these BBB changes, along with increased MMP9 activity and 
ERK1/2 activation, were abrogated in TLR4 knockout mice, suggesting an important 
component in this process is inflammation- and immune cell-related. 
Reduced BBB integrity could allow for the infiltration of peripheral immune cells, 
such as monocytes, as well as the leakage into the CNS of proinflammatory molecules 
such as LPS or circulating cytokines. Mice lacking TLR4, which is expressed on both 
microglia and peripheral monocytes among other cells, are protected from the decreased 
expression of BBB junctional proteins and show less IgG extravasation from the 
circulation into the brain parenchyma174, suggesting a causative role of TLR4-dependent 
inflammation in BBB breakdown201. Additionally, cellular stress in brain endothelial 
cells, perhaps related to immune signaling or as a primary response to alcohol-induced 
oxidative stress, has been shown to alter tight junction proteins and allows for immune 
cell infiltration202-204. Indeed, both alcohol and its metabolite acetaldehyde decreased 
collagen expression and increased expression of matrix metalloproteinases at endothelial 
cells associated with the neurovascular space204. 
 
CCR2 axis and alcohol 
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Breakdown in endovascular barriers may be an important step to allow for 
infiltration of circulating monocytes into tissue such as the brain, but a chemoattractant 
signaling process is also critical for attracting peripheral immune cells to the site of organ 
damage. Signaling through the chemokine receptors CCR2 and CCR5 has been shown to 
be important in the development of multiple liver diseases including non-alcoholic 
steatohepatitis94, fibrosis91,95 and hepatocellular carcinoma205. Previously, our laboratory 
has shown the critical role of CCL2 signaling in alcoholic liver disease. Mice deficient in 
CCL2 were protected from liver damage, steatosis and inflammation. Interestingly, 
CCR2-/- mice were not protected from liver injury and steatosis, suggesting that at least 
some components of alcoholic liver disease may be influenced by CCL2 signaling in a 
CCR2-independent manner93. 
CCR2/CCL2 axis signaling is also a common component of many CNS 
pathologies including hemorrhagic and ischemic stroke206,207, epilepsy208 and ALS209 and 
rodents treated with CCL2 blocking antibody are protected from excitotoxic injury210,211. 
Patients with AUD have significantly elevated levels of CCL2 protein in blood and 
cerebral spinal fluid, which persists for weeks following alcohol cessation and positively 
correlates with circulating liver enzymes212. He and Crews have shown that CCL2 
increases in limbic regions of the postmortem human brain, including VTA, SN, 
hippocampus and amygdala142 and rodent studies have described upregulation of CCL2 
in various brain regions after alcohol administration142,162,170. Indeed, 
intracerebroventricular administration of CCL2 in rats increased voluntary alcohol 
consumption213 and prenatal maternal alcohol consumption led to an increase in CCR2+ 
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neurons in the lateral hypothalamus of offspring and also led to increased alcohol 
consumption in adolescence214 suggesting CCL2/CCR2 signaling may be related to 
addiction. 
Researchers at the Scripps Institute have investigated the role of alcohol and 
CCL2 signaling. Using hippocampal slice cultures from transgenic mice that chronically 
overexpress astrocyte-produced CCL2, they show that elevated CCL2 did not affect 
baseline or alcohol-related synaptic transmission patterns. However, long-term 
potentiation, which is normally depressed under alcohol exposure, was restored in 
hippocampi with CCL2 overexpression215. Interestingly, behavioral studies show that 
chronic CCL2 overexpression protects from alcohol-impaired cue and contextual fear 
conditioning and has effects on alcohol consumption, spatial learning and associative 
learning215,216. These effects may be mediated by alterations in hippocampal synapses as 
CCL2 overexpression had modest effects on synapse protein expression in two-bottle 
choice alcohol feeding models217.  
CCL2/CCR2 signaling plays a critical role in regulating blood-brain barrier 
integrity and breakdown218. In primary mouse endothelial cells, CCL2 treatment 
effectively reduced the integrity of an in vitro BBB model by reorganizing tight junction 
proteins such as ZO-1, ZO-2, occludin and claudin-5 leading to reduced transendothelial 
electrical resistance and increased permeability. Barrier integrity was not affected in 
endothelial cells from CCR2-/- mice219,220. Additional research has shown that CCL2 
cell-specific expression has important influence on the degree and time course of BBB 
breakdown during neuroinflammation221. CCL2/CCR2 has been shown to be critical to 
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development of CNS neuroinflammatory disease in mouse models222 and in human 
patients223. 
While genetic manipulation of CCL2 and CCR2 is useful for studying 
mechanisms of peripheral monocyte recruitment to tissues, pharmacologic inhibition of 
this signaling axis provides a novel approach for mitigating disease progression. 
Cenicriviroc (CVC) is a small molecule inhibitor that blocks signaling through both the 
CCL2/CCR2 and CCL5/CCR5 signaling. These chemokine axes are involved in 
recruitment of monocytes and T cells224. Accordingly, CVC has been shown to inhibit 
macrophage recruitment and activation in liver disease225. A Phase 3 clinical trial 
(NCT03028740) exploring the efficacy and safety of CVC for the treatment of non-
alcoholic steatohepatitis, a disease that involves significant inflammation178, is currently 
underway. Testing CVC in a preclinical model of chronic alcohol consumption will aid in 
understanding the importance of peripheral monocyte recruitment and CCL2/CCR2 
signaling in both alcoholic liver disease and neuroinflammation associated with chronic 
alcohol use. 
 
Evidence of cytokines influencing behavior 
Systemic inflammation outside of the CNS can be caused by viral or bacterial 
stimulation of the immune system or by sterile organ damage leading to the release of 
endogenous danger signals and immune activation. In either case, proinflammatory 
cytokines, chemokines and other inflammatory signaling molecules may be released into 
circulation and can affect the brain and behavior226. Circulating cytokines can signal to 
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the CNS by crossing the BBB227,228, signaling through neurovascular cells such as 
endothelial cells and pericytes229, or even through the vagus nerve afferents that are 
disbursed throughout multiple peripheral organs, including the GI tract230,231.  
In the setting of alcohol consumption, gut barrier leakage of bacterial products 
coupled with hepatocyte metabolic stress in the liver lead to systemic release of 
inflammatory molecules, including cytokines, which can reach and influence the CNS232. 
Cytokines in the CNS are broadly believed to induce a phenomenon known as sickness 
behavior which includes fever, behavioral changes (such as fatigue and social 
withdrawal) and an endocrine stress response233. Indeed, inducing systemic inflammation 
can have significant behavioral outcomes as shown in studies in which human subjects 
were given an intravenous injection of LPS which induced circulating TNFa, IL-6 and 
the neuroendocrine stress hormone cortisol. LPS-exposed subjects had more depressed 
mood, worse memory and increased anxiety234. Although this study does not test the 
specific roles of each cytokine, it does highlight the important effect of LPS-induced 
immune activation. In patients suffering from depression associated with high circulating 
levels of proinflammatory cytokines233, treatment with anti-inflammatory drugs (such as 
anti-TNFa therapy) improved symptoms235. 
Systemic cytokines have also been shown to correlate with psycho-behavioral 
symptoms associated with alcohol. Patients with alcoholism reported significant craving, 
depression and anxiety236 that correlated with circulating levels of proinflammatory 
cytokines80. During alcohol detoxification, decreased craving symptoms correlated with 
decreasing expression of these same systemic inflammation markers29. Glucocorticoid 
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therapy is often used clinically for its anti-inflammatory potential and a recent study in 
human patients with AUD showed that glucocorticoid treatment could reduce alcohol 
seeking behavior and consumption237. Multiple anti-inflammatory agents, some of which 
are also antibiotics, influence alcohol consumption in mouse models. These include 
doxycycline and minocycline, which have been used to reduce alcohol-induced 
neuroinflammation and shown to reduce alcohol consumption in animal models238,239. 
Naltrexone therapy, which has both opioid antagonistic as well as anti-inflammatory 
effects, also reduces alcohol consumption in human patients with AUD240. The anti-
inflammatory effects of naltrexone were demonstrated in studies using human peripheral 
blood cells and cell lines (including microglia) where naltrexone treatment inhibited IL-6 
and TNFa production following stimulation of TLRs and inhibited microglial 
activation241,242. Collectively, these studies reveal the important connection between the 
immune response and cytokine production caused by alcohol and the behavior symptoms 
seen in patients with AUD. 
Addiction is now recognized as a disease of the brain with a cycle of intoxication, 
withdrawal and anticipation that has various neurobiological underpinnings, some of 
which are specific to the relevant drug of abuse11. Based on gene expression studies of 
postmortem CNS tissue from patients with AUD, researchers identified immune 
pathways as neurobiological underpinnings of AUD and as potential targets for 
therapeutic intervention243.  
Animal studies can provide additional mechanistic evidence of the role of the 
immune system influencing alcohol-related behavior. Gene expression studies have 
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identified neuroimmune signaling as an important alteration in the CNS of mice after 
alcohol exposure244,245 as well as in alcohol-preferring mice compared to non-preferring 
mice246,247. Interestingly, because some neuroimmune genes were found to be upregulated 
in mice selectively bred based on alcohol preference in previous generations, but not in 
response to any alcohol exposure in the tested mice themselves, these studies suggest that 
neuroimmune signaling may be involved in a predisposition to alcohol addiction rather 
than only a byproduct of chronic intoxication. Among these genes were members of the 
IL-1 family, components of NFkB signaling and IL-6 signaling pathways. Subsequent 
studies with animal models and knockouts for various immune-related genes, such as 
CD14 and  IL-6, showed that indeed immune signaling influences alcohol-related 
behavior as knockout mice consumed less alcohol in a voluntary consumption assay16 
whereas overexpression of cytokines, such as IL-6, increases alcohol preference248. 
Interestingly, related to observations from human patients with AUD that 
correlated alcohol-related symptoms with elevations in systemic inflammatory 
markers29,249, researchers tested whether peripheral LPS exposure induced any changes in 
alcohol consumption in rodents. Peripheral LPS challenge has been shown in 
humans234,250 and in animal models251,252 to induce both systemic inflammation and CNS 
neuroinflammation. LPS-injected mice who were given free access to a choice of alcohol 
or alcohol-free drinking water consumed more alcohol than untreated mice253. Unlike 
wild-type mice, mice deficient in CD14, which serves as a co-receptor molecule 
alongside TLR4 to recognize LPS, did not consume more alcohol than untreated CD14 
KO mice, thereby emphasizing a connection between LPS-induced systemic 
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inflammation and alcohol drinking behavior254. Interestingly, while TLR4 KO mice 
exhibit reduced sedation and motor function loss after alcohol exposure255, multiple 
studies on the effect of TLR4 on alcohol consumption have revealed mixed results, 
suggesting that involvement of TLR4 immune signaling in alcohol seeking behavior may 
be more complicated than other immune signaling pathways174,254,255. 
To investigate a neural mechanism that could be manipulated by immune 
signaling and have an impact on behavioral response, researchers measured the firing rate 
of dopaminergic neurons in the VTA, a key reward center that has been implicated in 
alcohol and other drug addiction. Interestingly, they found that peripheral LPS treatment 
reduced dopaminergic neuronal firing253. Activation of the VTA can also have a feed-
forward effect and influence peripheral innate and adaptive immunity. Activation of 
dopaminergic neurons in the VTA was shown to enhance antibacterial activity in 
monocytes, macrophages and T cells following peripheral exposure to E. coli256. Chronic 
dysregulation of peripheral inflammation by alcohol as well as signaling in the VTA and 
elsewhere in the CNS due to the rewarding effects of alcohol likely induces critical 
adaptations over time. These studies provide insight into how systemic inflammation 
leads to changes in alcohol drinking behavior and how reward signaling connects with 
immune activation, emphasizing the importance of immune crosstalk between systemic 
organs, the peripheral immune system and the CNS. 
 
Conclusion 
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Here, we have explored evidence that support the hypothesis that organ-specific 
immune activation and pathology induced by alcohol consumption is dependent on cross-
talk between the intestine, liver, peripheral immune system and the central nervous 
system. The following chapters will provide additional data in support of this hypothesis 
and provide new insight into potential therapeutic targets. 
The study in Chapter II describes the effect of alcohol on the gut microbiome 
composition in a new model of alcoholic hepatitis and neuroinflammation and how the 
use of antibiotics to reduce the gut bacterial load protects from inflammation in the small 
intestine, liver and brain and from features of alcoholic hepatitis in the liver.  
Chapter III will explore how pharmacologic blockade of CCR2/5 signaling and 
inhibition of macrophage infiltration into the liver alleviates alcoholic liver disease in a 
mouse model of chronic alcohol. 
Chapter IV presents new evidence of infiltrating peripheral macrophages into the 
CNS following chronic alcohol consumption in mice and the associated 
neuroinflammatory state induced by alcohol. Changes in excitatory and inhibitory 
synaptic densities are also described after alcohol consumption that are associated with 
increased expression of complement proteins and activated microglia. 
Finally, Chapter V provides interesting insight into the behavioral effect of 
immune signaling on alcohol consumption from a study that reveals that inhibition of 
multiple steps in NLRP3 inflammasome activation reduces alcohol consumption in 
female, but not in male, mice. 
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Collectively, these data provide new insight into the complicated interactions 
between the gut, liver, peripheral immune system and the brain in the setting of alcohol 
and test multiple potential therapeutic approaches to protect from organ pathology and 
behavioral changes caused by alcohol consumption.  
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Alcohol-related changes in the intestinal microbiome contribute to small intestinal, 
hepatic and CNS inflammation 
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Abstract 
Alcohol-induced intestinal dysbiosis disrupts homeostatic gut-liver axis function 
and is essential in the development of alcoholic liver disease. However, the role of the 
intestinal microbiome in alcohol-induced neuroinflammation has yet to be defined. Here, 
we investigate changes in enteric microbiome composition in a model of early alcoholic 
steatohepatitis and dissect the pathogenic role of intestinal microbes in alcohol-induced 
intestinal inflammation, liver pathology and neuroinflammation. Wild type mice received 
a ten-day diet that was either 5% alcohol-containing or an isocaloric control diet plus a 
single binge. 16S rDNA sequencing defined the bacterial communities in the cecum of 
alcohol- and pair-fed animals. Some mice were treated with an antibiotic cocktail prior to 
and throughout alcohol feeding. Small intestine (SI) cytokines and inflammasome 
expression, liver neutrophils, cytokines and steatosis and neuroinflammation were 
evaluated. Acute-on-chronic alcohol administration induced shifts in various bacterial 
phyla in the cecum, including increased Actinobacteria and a reduction in 
Verrucomicrobia driven entirely by a reduction in the genus Akkermansia. Antibiotic 
treatment reduced the gut bacterial load and circulating bacterial wall component 
lipopolysaccharide (LPS) in alcohol- and pair-fed mice. Reduction in the gut bacterial 
load attenuated expression of alcohol-induced proinflammatory cytokines and increased 
inflammasome expression in the SI. Bacterial load suppression prevented alcohol-related 
increases in the number of myeloperoxidase- (MPO) positive infiltrating neutrophils in 
the liver. Expression of liver and circulating cytokines was also reduced in antibiotic-
treated alcohol-fed mice. Alcohol-induced hepatic steatosis measured by Oil Red O 
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staining was significantly reduced in antibiotic-treated mice. Genes regulating lipid 
production and storage were also altered by alcohol and antibiotic treatment. 
Interestingly, antibiotic treatment did not protect from alcohol-induced increases in serum 
aminotransferases (ALT/AST). Alcohol feeding significantly increased expression of 
proinflammatory cytokines such as Tnfa, Ccl2, Hmgb1, Il-17 and Il-23 in the brain and 
antibiotic treatment attenuated expression. Alcohol feeding resulted in microglia 
activation and morphologic changes in the cortex and hippocampus characterized by a 
reactive phenotype. These alcohol-induced changes were abrogated following antibiotic-
induced reduction in the gut microbiome. Unexpectedly, antibiotic treatment increased 
the mRNA expression of some inflammasome components in the brain. Our data indicate 
that acute-on-chronic alcohol feeding alters the microflora at multiple taxonomic levels 
and identifies loss of Akkermansia as an early marker of alcohol-induced gut dysbiosis. 
We conclude that gut microbes influence intestinal and liver inflammation, neutrophil 
infiltration, liver steatosis and neuroinflammation following alcohol consumption and 
these data further emphasize the role of the gut-liver-brain axis after alcohol 
consumption. 
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Introduction 
The National Institute on Alcohol Abuse and Alcoholism reports that 17 million 
adults in the US have an alcohol use disorder (AUD), approximately 1.4 million adults 
receive treatment for this disorder, and close to 88,000 people die each year from alcohol 
related causes257,258. Chronic excessive alcohol use can lead to alcoholic hepatitis, a 
condition with high mortality, as well as neuroinflammation. The trigger(s) for acute 
alcoholic hepatitis and neuroinflammation are yet to be defined; however, the importance 
of the gut-liver-brain axis is increasingly recognized in AUD. 
Animal and human studies have shown that alcohol consumption causes “leaky 
gut,” translocation of bacteria and microbial compounds such as lipopolysaccharide 
(LPS; also known as endotoxin), across the intestinal basement membrane into the portal 
and systemic circulations24,26,27. Recently, we have shown that an acute dose of alcohol 
increases circulating markers of bacterial-product translocation across the gut barrier 
even in healthy individuals26. Additionally, alcohol consumption leads to intestinal 
bacterial dysbiosis and bacterial overgrowth in the small intestine in humans as well as in 
mouse models of alcohol consumption30,46. Once absorbed, alcohol along with gut-
derived LPS are delivered via the portal circulation to the liver.  
The liver is a primary site for alcohol metabolism and removal of bacteria and 
bacterial products that translocate across the intestinal barrier and into the portal 
circulation66,67. Once in the liver, bacterial products (also known as pathogen associated 
molecular patterns or PAMPs) such as LPS activate Toll-like receptor 4 (TLR4) signaling 
pathways and initiate an innate immune response, thereby augmenting the damage caused 
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by alcohol’s primary insult on hepatocytes70,71. The characteristic histological feature of 
inflammation in acute alcoholic hepatitis is the presence of neutrophils96. While the exact 
role of neutrophils is yet to be defined in alcoholic liver disease (ALD), the clinical 
outcome in patients correlates with the presence of neutrophils in the liver in alcoholic 
hepatitis109. 
Various models replicate aspects of human ALD in mice. Among them, the acute-
on-chronic feeding model utilizes a liquid diet containing 5% alcohol by volume for ten 
days followed by an acute binge259. This model is emphasized for its replication of 
neutrophil infiltration in the liver, mimicking acute steatohepatitis in human patients110. 
However, it is unknown if alcohol-related changes in the intestine, such as dysbiosis, are 
replicated in this new model. 
LPS, unmetabolized alcohol and alcohol metabolites also travel beyond the liver 
and reach the systemic circulation and other organs, such as the central nervous system 
(CNS). While previous studies have investigated the direct effects of alcohol on the 
brain75-77, little is known about the role of gut-derived microbial products and their 
impact on the nervous system and neuroinflammation. 
Microglia play a critical role in sensing and responding to alcohol consumption 
and are involved in multiple immune signaling pathways142,161-163. Microglia express 
TLR4, a pattern recognition receptor critical in alcohol-induced 
neuroinflammation14,165,166 as well as the NLR family pyrin domain containing 3 
(NLRP3) inflammasome162. Previous studies showed that TLR4 knockout mice are 
protected from increased cytokine expression in various regions of the brain and from 
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increased activation of microglia170-172. TLR4 recognizes endogenous danger signals such 
as HMGB1168,169 and is the major pattern recognition receptor of bacterial LPS167. 
Although LPS is not generally believed to cross the blood-brain barrier173, data from 
TLR4 knockout mice suggests that signaling through TLR4 is an important component 
influencing alcohol-induced neuroinflammation. Neuroinflammation is mediated by the 
inflammasome complex, a multiprotein complex that senses pathogens and danger 
signals leading to cleavage and release of pro-inflammatory IL-1b and IL-18162. 
Interestingly, antibiotic treatment in mice has previously been shown to reduce 
the bacterial load in the gastrointestinal tract (and thereby reducing LPS levels) 
coinciding with attenuation of liver inflammation and steatosis after alcohol use50,73. This 
reduction in gut bacterial load could ameliorate the alcohol-induced changes in the brain. 
Antibiotic therapy is common for decompensated patients with alcoholic cirrhosis or 
hepatitis in order to treat infection in these immunocompromised patients. Minocycline 
and other derivatives, which act both as tetracycline antibiotics and as anti-inflammatory 
agents, have been used in preclinical studies and can reduce alcohol consumption239,260. 
However, the use of broad-spectrum antibiotics to reduce the host microbiome and 
prevent the development of ALD has not been previously studied. 
Therefore, we hypothesized that enteric bacterial products play an important role 
in acute alcoholic hepatitis and alcohol-induced neuroinflammation in the acute-on-
chronic alcohol model in mice. Sequencing of enteric bacteria revealed modest shifts in 
composition after this short feeding model and identified changes in the genus 
Akkermansia as an early indicator of alcohol-induced dysbiosis. We further postulated 
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that the gut-liver axis particularly affects the infiltration of neutrophils. We show that 
suppression of intestinal bacterial load with antibiotics reduced neutrophil infiltration and 
the inflammatory response in the liver. Following acute-on-chronic alcohol consumption 
in mice, we show that alcohol induces neuroinflammation in the CNS that is attenuated 
by antibiotic treatment. Interestingly, although cytokine expression was reduced, 
antibiotic treatment induced the mRNA expression of inflammasome components and 
cytokines processed by the inflammasome in the CNS. Together, these data offer critical 
information regarding the gut-liver-brain axis and its role in alcoholic liver disease in a 
newly described alcohol feeding model. 
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Methods 
Mice and Alcohol Feeding 
All animals were cared for in strict accordance with the approved Institutional 
Animal Care and Use Committee protocol specific to the procedures described in this 
study at the University of Massachusetts Medical School (Protocol #A-1154-14; G.S.). 
Wild-type C57BL/6J six- to eight-weeks-old female mice were purchased from Jackson 
Laboratories and were cohoused in the University of Massachusetts Medical School 
Animal Medicine Facility for one week prior to the start of the experiment at which time 
they were doubly housed. Mice were treated with an alcohol feeding model described by 
Bertola et al.259. Briefly, all mice were fed the Lieber-DeCarli pair-fed diet for five days 
to become acclimated to a liquid diet. Some mice were then switched to the Lieber-
DeCarli alcohol diet containing 5% ethanol and maltose dextrin (to control for caloric 
intake). Pair-fed mice were calorie-matched with the ethanol-fed mice. On the tenth day, 
mice were gavaged between 12:00 AM and 2:00 AM with either ethanol (5g/kg body 
weight (BW)) or isocaloric maltose dextrin. Mice were cheek bled, anesthetized under 
ketamine (100mg/kg BW) and xylazine (10mg/kg BW) and then euthanized by 
exsanguination and bilateral pneumothorax at 9h post-gavage (9:00-11:00 AM). 
Throughout the experiments, animals were monitored at least twice daily (in the morning 
and the evening) by our laboratory as well as regular wellness checks by University of 
Massachusetts Medical School veterinary technicians and all efforts were made to 
minimize suffering. Following oral gavage, animals were monitored for respiratory 
distress, evidence of an accidental airway gavage. Four animals out of 50 exhibited 
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respiratory distress following an oral gavage (of either antibiotics or ethanol) and were 
euthanized according to our protocol. 
 
16S rDNA Sequencing 
Cecal contents were collected from some animals and frozen at -80°C. DNA was 
extracted using Stool DNA Extraction Kit (Qiagen) according to the manufacturer’s 
instructions. To check DNA quality and 16S content prior to sequencing, universal 
primers were used for SYBR Green quantitative polymerase chain reaction (qPCR; 
BioRad) with the following extended cycling protocol: 95°C 10min; 95°C 15sec, 60°C 
30sec, 72°C 30sec for 40 cycles. Sequencing was completed at the Cincinnati University 
Children’s Hospital Medical Center’s DNA Sequencing and Genotyping Facility Core 
(Cincinnati, OH) as described261. All antibiotic-treated samples failed to yield 16S rDNA 
sequence data; one sample each from the ethanol- and pair-fed groups was excluded 
based on insufficient sequence data. 
UPARSE262 and UTAX (http://www.drive5.com/usearch/manual/cmd_utax.html) 
were used to generate operational taxonomic unit (OTU) tables from 16S rDNA read data 
and to make taxonomic assignments. QIIME package scripts were used for calculations 
of α- (PD_whole_tree, chao1, observed_otus and shannon) and β- (Bray-Curtis, Un-
Weighted UniFrac, and Weighted UniFrac) diversity263. 
16S rDNA Sequencing data can be found in the NCBI GenBank repository with 
Accession Numbers: KY571432-KY572675.  
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Antibiotic Treatment and Bacterial Colony Count 
Some mice were treated twice daily orally with an antibiotic cocktail containing 
ampicillin (100mg/kg BW; Sigma), neomycin (100mg/kg BW; Gibco), metronidazole 
(100mg/kg BW; Sigma) and vancomycin (50mg/kg BW; Sigma) beginning at the 
initiation of liquid diet and continuing until the oral ethanol or maltose dextrin gavage on 
the final feeding day. Non-antibiotic-treated mice received an equivalent volume of 
water. Gavage needles were rinsed with acid-treated water and sterilized in a hot-bead 
sterilizer between each mouse treatment to minimize transfer of microbes between 
animals. 
Feces were collected directly from the anus prior to euthanization and frozen at -
20°C until plating. Upon thawing, stool was immediately weighed, dissociated in liquid 
thioglycolate media (Sigma) and diluted 1:1000 prior to plating on non-selective agar 
plates (EMD Millipore). Plates were incubated at 37°C for 48h. Colonies were quantified 
using OpenCFU264 and were normalized to the mass of stool. 
 
Histology 
Oil Red O tissue staining on OCT-embedded frozen liver sections was completed 
and quantification was performed using ImageJ to assess hepatic steatosis. Formalin-
fixed paraffin-embedded liver sections were stained at the University of Massachusetts 
Medical School Morphology Core with anti-mouse myeloperoxidase (MPO) antibody 
(Abcam) and subsequently labeled with streptavidin-biotin immunoenzymatic antigen for 
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detection with 3,3’-diaminobenzidine (DAB) (UltraVision Mouse Tissue Detection 
System Anti-Mouse HRP/DAB; Lab Vision). 
Following sacrifice, brain tissue was dissected and fixed in 10% formalin 
overnight before paraffin embedding. Immunohistochemical staining was completed at 
the University of Massachusetts Medical School Morphology Core using anti-ionized 
calcium binding adapter molecule (IBA1) antibody (Wako; 1:1000) and subsequently 
labeled with streptavidin-biotin immunoenzymatic antigen for detection with 3,3’-
diaminobenzidine (DAB) (UltraVision Mouse Tissue Detection System Anti-Mouse 
HRP/DAB; Lab Vision). Images were acquired from the described CNS areas by light 
microscopy (cortex; CA1, CA3 and dentate gyrus of the hippocampus) at 40X 
magnification for process length and cell body size measurements of microglia using 
ImageJ. IBA1 positivity was measured using the Color Deconvolution plug-in in ImageJ. 
The investigator was blinded to the sample groups during staining, image acquisition and 
ImageJ analysis. 
 
Biochemical Assays 
Serum was isolated from whole blood and frozen at -80°C until use. Serum 
alanine (ALT) and aspartate (AST) aminotransferases were measured using a kinetic 
method112. Serum LPS was quantified using Pierce LAL Chromogenic assay 
(ThermoFisher). Serum CCL2 level was determined by enzyme-linked immunosorbent 
assay (ELISA; BioLegend). 
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Real-Time qPCR Analysis 
RNA was extracted from liver tissue using RNeasy (Qiagen) according to the 
manufacturer’s instructions, including on-column DNase digestion (Zymo Research). 
cDNA was reverse transcribed from 1µg of RNA and then diluted 1:5 in nuclease-free 
water. SYBR Green (BioRad) real-time qPCR was performed according to the 
manufacturer’s instructions. The primers used are listed in Table 2.1 and 18S was used as 
a housekeeping gene for 2-DDCt method of RNA expression analysis. For 16S comparison 
between antibiotic-treated and non-treated animals, stool bacterial DNA was extracted 
using QIAamp DNA Stool Mini Kit (Qiagen) according to manufacturer’s protocol. After 
running a qPCR reaction using 16S primers similar to described above, a DCt was 
calculated using the average Ct value of each sample duplicate and subtracting the 
average DCt of untreated pair-fed mice. The bacterial 16S PCR product was run on a 1% 
agarose gel to visualize the relative reduction in bacterial load. 
 
Table 2.1 Real-time PCR primers. 
Primer Forward (5’>3’) Reverse (5’>3’) 
18S GTA ACC CGT TGA ACC CCA TT CCA TCC AAT CGG TAG TAG CG 
16S TCCTACGGGAGGCAGCAGT GGACTACCAGGGTATCTAATCCTGTT 
E-selectin ATG CCT CGC GCT TTC TCT C GTA GTC CCG CTG ACA GTA TGC 
Ly6g TGC GTT GCT CTG GAG ATA GA CAG AGT AGT GGG GCA GAT GG 
Mpo CAT CCA ACC CTT CAT GTT CC CTG GCG ATT CAG TTT GG 
Tnfα GAA GTT CCC AAA TGG CCT CC GTG AGG GTC TGG GCC ATA GA 
Cxcl1 ACT GCA CCC AAA CCG AAG TC TGG GGA CAC CTT TTA GCA TCT T 
Ccl2 CAG GTC CCT GTC ATG CTT CT TCT GGA CCC ATT CCT TCT TG 
Il-1b TCTTTGAAGTTGACGGACCC TGAGTGATACTGCCTGCCTG 
Il-17 CAGGGAGAGCTTCATCTGTGT GCTGAGCTTTGAGGGATGAT 
Il-23 AAGTTCTCTCCTCTTCCCTGTCGC TCTTGTGGAGCAGCAGATGTGAG 
Hmgb1 CGCGGAGGAAAATCAACTAA TCATAACGAGCCTTGTCAGC 
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Nlrp3 AGCCTTCCAGGATCCTCTTC CTTGGGCAGCAGTTTCTTTC 
Asc GAAGCTGCTGACAGTGCAAC GCCACAGCTCCAGACTCTTC 
Casp1 AGATGGCACATTTCCAGGAC GATCCTCCAGCAGCAACTTC 
Il-18 CAGGCCTGACATCTTCTGCAA TCTGACATGGCAGCCATTGT 
Fasn GAG GTG GTG ATA GCC GGT AT TGG GTA ATC CAT AGA GCC CAG 
Ucp1 AGG CTT CCA GTA CCA TTA GGT CTG AGT GAG GCA AAG CTG ATT T 
Prdm16 CCC CAC ATT CCG CTG TGA T CTC GCA ATC CTT GCA CTC A 
Scd2 TAC TAC AAG CCC GGC CTC C CAG CAG TAC CAG GGC ACC A 
Adrp CTG TCT ACC AAG CTC TGC TC CGA TGC TTC TCT TCC ACT CC 
Lcn2 CCC CAT CTC TGC TCA CTG TC  TTT TTC TGG ACC GCA TTG 
The above forward and reverse sequences of primers were used in real-time PCR. Ly6g, 
Lymphocyte antigen 6 complex locus G6D; Mpo, myeloperoxidase; Tnfα,  tumor necrosis 
factor-α; Cxcl1, C-X-C motif chemokine ligand 1; Ccl2, C-C motif chemokine ligand 2; 
Il-1b, interleukin-1b; Il-17, interleukin-17; Il-23, interleukin-23; Hmgb1, high-mobility 
group box 1; Nlrp3, NLR family pyrin domain containing 3; Asc apoptosis-associated 
speck-like protein; Casp1, caspase-1; Il-18, interleukin-18; Fasn, fatty acid synthase; 
Ucp1, uncoupling protein 1; Prdm16, PR-domain zinc finger protein 16; Scd2, stearoyl-
CoA desaturase 2; Adrp, adipose differentiation-related protein; Lcn2, Lipocalin-2. 
 
Statistical Analysis 
Statistical analysis was carried out using GraphPad Prism Version 7.0 using 
Mann-Whitney test. p < 0.05 was considered statistically significant. Outlier exclusion 
was calculated using Grubbs’ outlier test with alpha set to 0.05. 
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Results 
Alpha- and beta-diversity of cecal microbiome are unaltered by acute-on-chronic 
alcohol feeding 
We applied 16S rDNA sequencing to define and to assess the changes in the cecal 
microbiota induced by the acute-on-chronic alcohol feeding in mice (Fig 2.1A). The 
bacterial load was substantially reduced in antibiotic-treated mice and 16S rDNA 
sequence was not obtained for that cohort. Of the non-antibiotic-treated mice, samples 
from 7/8 pair-fed (PF) and 9/10 alcohol-fed (EtOH) mice were available for analysis. We 
observed no significant differences (p>0.05) in α-diversity between pair-fed and alcohol-
fed groups (Table 2.2), indicating that the mean species diversity was not affected by 
acute-on-chronic alcohol. 
 
Table 2.2 α-diversity of cecal bacterial content. 
  
PD_whole_tree chao1 observed_otus shannon 
Average Error Average Error Average Error Average Error 
Pair-fed 6.76 2.35 82.38 36.25 63.86 30.42 2.85 0.69 
EtOH-fed 7.37 2.07 87.86 31.59 69.37 25.33 2.62 0.56 
Single rarefaction at a depth of 10,000 sequences indicated no significant difference in α-
diversity between pair- and ethanol-fed cecal bacterial communities by four different 
metrics. 
 
Next, we examined β-diversity to assess the degree of dissimilarity of bacterial 
communities between samples. These analyses determined no significant differences 
between pair-fed and alcohol-fed mice. Additionally, comparisons within pair-fed and 
within alcohol-fed conditions revealed that the β-diversity within each group (intra-group 
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diversity) was not statistically different from diversity between the groups (inter-group 
diversity). 
 
Alcohol induces taxonomic shifts in bacterial communities 
Although α- and β-diversity were not significantly changed, we hypothesized that 
there may be specific taxonomic shifts after acute-on-chronic alcohol administration 
between alcohol-fed and pair-fed mice and 16S sequencing indeed revealed multiple 
taxonomic changes (Fig 2.1B-C). Compared to pair-fed mice, the phylum Actinobacteria 
was significantly enriched (Fig 2.1D; d_Bacteria;p_Actinobacteria, PF: 0.29% vs EtOH: 
1.43%), while the phylum Tenericutes was reduced in relative abundance in alcohol-fed 
mice (Fig 2.1D; d_Bacteria;p_Tenericutes, PF: 0.14% vs EtOH: 0.00%). The most 
abundant phylum, Verrucomicrobia (Fig 2.1D; d_Bacteria;p_Verrucomicrobia) showed 
the greatest reduction in alcohol-fed mice (PF: 39.54% vs EtOH: 20.64%). 
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Figure 2.1 Alcohol induces shifts in gut bacterial content at various taxonomic 
levels. A) Mice were provided a liquid diet for five days to acclimate to the new diet. 
Some mice were then provided 5% ethanol in the liquid diet or provided a calorie-
matched pair-fed diet for ten days. Nine hours before sacrifice, mice were orally gavaged 
with either ethanol (5g/kg BW) or a calorie-matched gavage of maltose dextrin. B) Cecal 
stool content was obtained from pair-fed (PF) or alcohol-fed (EtOH) mice and DNA was 
isolated for 16S bacterial sequencing. Following alignment and clustering of sequences, a 
cladogram was generated to show the bacterial taxa that are enriched in PF (green) or 
EtOH (red) mice. C) Proportional contributions of various bacterial phyla to the overall 
gut microbiome in PF and EtOH mice. D) The average percent of total bacteria measured 
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for each phylum reveals enrichment in Actinobacteria (navy blue) in the microbiome of 
alcohol-fed mice. Phylum Tenericutes (beige) was reduced in relative abundance in 
alcohol-fed mice. The phylum Verrucomicrobia (light blue), which represented the 
majority of bacteria in PF mice, was reduced in the acute-on-chronic alcohol model. The 
prefix letter followed by an underscore represents the taxonomic level (e.g. “d_” for 
domain, “p_” for phylum, etc.). Data are mean +/- SEM, n=8-9 mice/group. *p < 0.05 by 
Mann-Whitney test. 
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An examination of the nine most abundant families represented in our sample set 
(Fig 2.2A) revealed that the most abundant family in cecal content was 
Verrucomicrobiaceae, which was significantly reduced in alcohol-fed animals when 
compared to the pair-fed group. Other families with reduced abundance in alcohol-fed 
mice included Lachnospiraceae and Moraxellaceae (green asterisk), while 
Eubacteriaceae was enriched in alcohol-fed mice (red asterisk). Examination of the 
genus composition of the Verrucomicrobiaceae family revealed only one genus, 
Akkermansia which accounted for the reduction observed in alcohol-fed mice from the 
phylum (Verrucomicrobia) to the genus level (Fig 2.2B). This analysis identifies 
reduction of Akkermansia as an early marker of alcohol-induced changes in the gut 
microbiome. 
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Figure 2.2 Alcohol alters family-level community representation in some of the nine 
most abundant bacterial families. A) To represent a subset of the bacterial composition 
in cecal content of pair- (PF) and alcohol-fed (EtOH) mice, we chose the nine most 
abundant families, each comprising >0.5% of all families. Those differentially enriched 
in pair-fed mice are indicated by a green asterisk; red asterisk denotes families enriched 
in alcohol-fed mice. B) The genus Akkermansia represented 100% of the family 
Verrucomicrobiacea, the most abundant family found in pair-fed mice and was 
significantly reduced by alcohol administration. The prefix letter followed by an 
underscore represents the taxonomic level (e.g. “p_” for phylum, “c_” for class, etc.). 
Data are mean +/- SEM, n=8-9 mice/group. *p < 0.05 by Mann-Whitney test.  
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Antibiotic treatment dramatically decontaminates gut bacterial load 
While the modulating effects of chronic alcohol administration have been studied 
in the gut microbiome, alcoholic liver disease and neuroinflammation, it is unclear how 
shorter alcohol use and/or alcohol binge affect inflammation signaling and what role the 
gut microbiome plays in this process. In this study, mice received 5% alcohol (EtOH) in a 
liquid diet for ten days (after a five-day liquid diet acclimation period), followed by a 
one-time alcohol binge or a calorie-matched pair-fed (PF) diet259. To directly test the 
impact of gut bacterial load on alcohol-induced inflammation, we first used an antibiotic 
cocktail (ampicillin, neomycin, vancomycin and metronidazole) to drastically reduce the 
intestinal bacterial flora (Fig 2.3A). In a preliminary study, we found that mice became 
averse to drinking water containing the dissolved antibiotic cocktail, which has also been 
observed by others265. We therefore switched to a twice-daily oral gavage regimen to 
ensure adequate bacterial clearing.  
Oral antibiotic treatment (Abx) caused a significant reduction in LPS in the 
circulation at the time of sacrifice both in pair-fed and alcohol-fed mice (Fig 2.3B). The 
expression of 16S bacterial DNA, measured from mice stools collected immediately prior 
to sacrifice, was dramatically reduced by antibiotic treatment (Fig 2.3C-D). Stool 
bacteria cultured on non-selective agar plates also revealed almost complete elimination 
of culturable colonies after five days of antibiotic treatment (Fig 2.3E). Some recovery of 
bacteria in the stool was observed by the conclusion of the fifteen-day study, likely due to 
the development of antibiotic resistance (Fig 2.3E). However, bacterial colony forming 
units (CFUs) were dramatically reduced in the stool obtained on the day of sacrifice in 
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antibiotic-treated animals compared with untreated mice (Fig 2.3F). Importantly, 
antibiotic treatment did not affect daily alcohol diet intake (EtOH-fed: 9.1 ± 0.6 
mL/day/mouse; EtOH-fed plus antibiotics: 8.7 ± 0.2 mL/day/mouse; p=0.14). Together, 
these data indicate that antibiotic treatment successfully suppressed gut bacterial load and 
reduced circulating endotoxin in both pair- and alcohol-fed mice. 
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Figure 2.3 Oral antibiotics significantly reduce the gut bacterial load. A) Four groups 
of wild-type C57BL/6J female mice were treated with: pair-fed diet (PF; n=5); 5% 
alcohol diet (EtOH; n=10); oral antibiotics (Abx) with PF (n=6); or Abx with EtOH 
(n=9). An acute sugar or alcohol binge was given 9h before sacrifice. B) Serum 
endotoxin was measured at sacrifice to determine translocation of gut bacterial products 
into systemic circulation. C) DNA was isolated from the stool of PF and EtOH mice 
before sacrifice and 16S DNA was measured by qPCR using universal 16S primers. D) 
The PCR products from C) were run on an agarose gel for a general comparison of the 
four groups. E) Stools were resuspended in thioglycolate and plated on non-selective agar 
to measure gut bacterial load prior to antibiotic treatment (Untreated), after 5 days of Abx 
treatment (Abx Day 5) and at the end of the experiment (Abx Day 15). F) Colony 
forming units (CFUs) were quantified from stool extracted at sacrifice on Day 15. Data 
are mean +/- SEM, n=5-10 mice/group. *p < 0.05; n.s., not significant by Mann-Whitney 
test. 
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Alcohol-induced cytokine expression in the small intestine is attenuated by 
antibiotic administration 
 Previous studies have shown that intestinal cytokine expression can reduce gut 
barrier integrity and may allow leakage of pathogen-associated molecules from the 
intestinal lumen into the systemic circulation266. Therefore, we measured the intestinal 
expression of various proinflammatory cytokines and found that they were increased after 
acute-on-chronic alcohol administration compared to calorie-matched pair-fed mice (Fig 
2.4). The expression of Tnfa, Ccl2 and Hmgb1 mRNA was significantly increased 
following alcohol consumption and Il-17 and Il-23 expression also showed an increasing 
trend in alcohol-fed mice. Treatment with the antibiotic cocktail reduced the bacterial 
load in the intestine (Fig 2.3) and led to significantly attenuated alcohol-induced Ccl2 and 
Hmgb1 mRNA levels. Antibiotic treatment reduced the baseline expression of the 
inflammatory cytokines including Tnfa, Il-17 and Il-23 in PF mice compared to untreated 
pair-fed mice (Fig 2.4). Interestingly, even with antibiotic treatment, alcohol feeding still 
increased expression of Tnfa, Il-17 and Il-23 in the small intestine of antibiotic-treated 
mice compared to antibiotic-treated pair-fed mice (Fig 2.4). 
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Figure 2.4 Alcohol-induced small intestinal inflammation is reduced with gut 
bacterial load reduction. Expression of proinflammatory cytokines Tnfa, Ccl2, Hmgb1, 
Il-17 and Il-23 was measured from the small intestine of pair-fed (PF) or alcohol-fed 
(EtOH) mice with or without daily antibiotic treatment (Abx). Data are mean +/- SEM, 
n=4-10 mice/group. *p < 0.05 by Mann-Whitney test. 
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Antibiotic treatment increases the mRNA expression of the inflammasome in the 
small intestine 
 Recent research has highlighted an important connection between the intestinal 
microbiome and inflammasomes267, particularly the NLRP3 inflammasome268. Therefore, 
we investigated whether antibiotic decontamination of the gut impacted expression of 
inflammasome components in the small intestine. Expression of Il-1b, Il-18, Asc and 
Casp1 mRNA was elevated in antibiotic-treated, alcohol-fed mice compared to untreated 
pair-fed mice (Fig 2.5). Alcohol consumption increased Nlrp3, Asc and Casp1 expression 
in the small intestine. Although antibiotic treatment in alcohol-fed mice significantly 
inhibited Il-18 mRNA levels and increased Asc expression compared to untreated 
alcohol-fed mice, the expression levels of Il-1b, Casp1 and Nlrp3 were not significantly 
affected (Fig 2.5). 
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Figure 2.5 Antibiotic treatment increases expression of inflammasome components 
and inflammasome-processed cytokines in the small intestine. Expression of 
inflammasome components Nlrp3, Asc and Casp1 as well as the cytokines Il-1b and Il-18 
were measured from the small intestine of pair-fed (PF) or alcohol-fed (EtOH) mice with 
or without daily antibiotic treatment (Abx). Data are mean +/- SEM, n=4-10 mice/group. 
*p < 0.05 by Mann-Whitney test. 
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Neutrophil infiltration to the liver is attenuated in mice with reduced gut bacterial 
load 
Having established a reduction in bacterial load and circulating LPS with 
antibiotic treatment, we hypothesized that this might reduce hepatic inflammation. To test 
this, we measured liver mRNA expression of the neutrophil-associated genes including 
E-selectin (associated with neutrophil attraction), Ly6g (a neutrophil-specific marker) and 
Mpo (an enzyme involved in processing phagocytic material in neutrophils). E-selectin 
was not significantly increased by alcohol, although antibiotics reduced its expression 
and alcohol-fed antibiotic-treated mice did display an increase when compared to pair-fed 
plus antibiotics (Fig 2.6A). The trend toward increased Ly6g expression following 
alcohol administration (p=0.052) was not abrogated after gut decontamination by 
antibiotics in alcohol-fed mice (Fig 2.6B). Liver Mpo mRNA expression was reduced by 
antibiotics in both control and alcohol-fed mice (Fig 2.6C). The increased involvement of 
neutrophils in the liver following alcohol consumption was confirmed by anti-MPO 
immunohistochemical staining. Pair-fed mice treated with antibiotics had fewer MPO+ 
neutrophils at baseline (p=0.10) and antibiotic-treated mice were protected from alcohol-
induced increase in infiltrating neutrophils in the liver (Fig 2.6D-E). 
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Figure 2.6 Alcohol-induced hepatic inflammation and neutrophil infiltration is 
attenuated in mice with reduced gut-bacterial load. A-C) Liver expression of 
neutrophil associated genes E-selectin, Ly6g and Mpo were measured by qPCR and 
normalized to 18S. E) MPO immunohistochemical staining to detect neutrophils in the 
liver parenchyma revealed an increased number of neutrophils/area in alcohol-fed mice 
compared to pair-feds and reduced gut bacterial load led to fewer infiltrating neutrophils. 
Interestingly, antibiotics also cause a decreased trend in hepatic neutrophils at baseline in 
pair-fed mice (quantified in D)). Data are mean +/- SEM, n=4-10 mice/group. *p < 0.05; 
n.s., not significant by Mann-Whitney test.  
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Gut decontamination reduces alcohol-induced inflammatory mediators in the liver 
and circulation  
Liver inflammation is a major component of the pathomechanism of alcoholic 
hepatitis in humans and in animal models. To test if liver inflammation is mediated by 
bacterial load, we measured transcripts of key cytokines and chemokines from liver 
tissues by qPCR. Expression of Tnfα, Cxcl1 and Ccl2 mRNA was elevated in alcohol-fed 
mice compared to pair-fed controls (p<0.05 for Tnfα, Ccl2; p<0.1 for Cxcl1). 
Importantly, increases in Tnfα and Cxcl1 were eliminated by antibiotic treatment in 
alcohol-fed mice (Fig 2.7A-C). Circulating CCL2 protein in the serum showed an 
alcohol-induced increase that was mitigated by antibiotic reduction of intestinal bacteria 
suggesting that gut decontamination has an important effect on liver inflammation in 
alcoholic hepatitis (Fig 2.7D). Together, this data showed that treatment with antibiotics 
reduced circulation of CCL2 and expression of inflammatory markers. 
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Figure 2.7 Antibiotic treatment reduces expression of inflammatory mediators in 
the liver and circulation. A-B) Liver expression of the cytokine Tnfα and the chemokine 
Cxcl1 is increased by alcohol and antibiotics eliminate these increases. C) Although 
mRNA levels of Ccl2 are not different between the antibiotic-treated/untreated alcohol-
fed groups, D) circulating CCL2 protein is reduced in alcohol-fed antibiotic-treated mice. 
Data are mean +/- SEM, n=4-10 mice/group. *p < 0.05; n.s., not significant by Mann-
Whitney test. 
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Suppressed bacterial load reduces alcohol-induced liver steatosis but not serum 
transaminases 
Antibiotic treatment resulted in proinflammatory signal reduction, suggesting that 
perhaps other aspects of alcoholic liver disease, such as hepatic steatosis, may also be 
impacted. To test this, we used Oil Red O staining and observed that alcohol-fed mice 
had increased hepatic steatosis compared to pair-fed mice. However antibiotic treatment 
reduced the alcohol-related increase in steatosis (Fig 2.8A-B). To investigate the effect of 
alcohol and antibiotic treatment on lipid regulation and synthesis, we measured mRNA 
levels of various liver genes involved in lipid metabolism (Fig 2.8C). Alcohol feeding 
reduced expression of fatty acid synthase (Fasn), uncoupling protein-1 (Ucp1), PR-
domain zinc finger protein 16 (Prdm16), stearoyl-CoA desaturase 2 (Scd2). Antibiotic 
treatment, irrespective of alcohol feeding, also reduced expression of Fasn, Ucp1, and 
Prdm16 while antibiotics plus alcohol further reduced Scd2 compared to antibiotics plus 
pair-fed. Adipose differentiation-related protein (Ardp) is a molecule that coats 
intracellular stores of lipid and lipocalin-2 (Lcn2) is involved in intracellular lipid 
transport. Adrp expression was elevated in alcohol-fed animals regardless of antibiotic 
treatment and Lcn2 trended toward an increase (p=0.10) in alcohol-fed animals and was 
significantly increased in alcohol plus antibiotic mice, reflecting the increase in liver Oil 
Red-O in alcohol-fed animals. Serum ALT (Fig 2.8D) and AST (Fig 2.8E) were elevated 
in mice fed alcohol compared to those receiving control diet, indicating hepatocyte 
injury. Interestingly, serum ALT and AST levels remained elevated in ten-days plus 
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binge alcohol-fed mice receiving antibiotic treatment, suggesting the presence of 
microbe-independent mechanisms of alcohol-induced hepatocyte injury. 
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Figure 2.8 Steatosis but not serum transaminase increase from alcohol consumption 
is reduced by gut sterilization. A-B) Oil Red O staining on liver sections reveals that 
alcohol causes a dramatic increase in hepatic steatosis. C) Liver mRNA expression of 
various genes involved in lipid metabolism, including fatty acid synthase (Fasn), 
uncoupling protein-1 (Ucp1), PR-domain zinc finger protein 16 (Prdm16), stearoyl-CoA 
desaturase 2 (Scd2), adipose differentiation-related protein (Ardp) and lipocalin-2 (Lcn2) 
were measured by qPCR. D-E) Serum alanine (ALT) and aspartate (AST) transaminases, 
which are increased by acute-on-chronic alcohol, are unchanged by antibiotic treatment. 
Data are mean +/- SEM, n=4-10 mice/group. *p < 0.05. For C), groups that do not share a 
letter are significantly different by Mann-Whitney test. 
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Antibiotic treatment abrogates alcohol-induced proinflammatory cytokine 
expression in the cerebral cortex 
Chronic alcohol use results in neuroinflammation both in humans and in 
mice142,165. We found that the ten days of chronic alcohol feeding followed by a one-time 
binge in mice, a model of acute-on-chronic alcohol consumption not previously used to 
study neuroinflammation, induced expression of multiple proinflammatory cytokine 
genes including Tnfa, Ccl2, Hmgb1, Il-17 and Il-23 in the brain cortex (Fig 2.9).  
Previous studies indicate that antibiotic treatment that reduces intestinal bacterial 
load also reduces alcohol-induced inflammation in the liver72. Here, we hypothesized that 
translocation of gut bacterial products to the CNS contributes to alcohol-induced 
neuroinflammation and that this process is regulated by the gut microbial load. Therefore, 
we sought to investigate whether gut decontamination using antibiotics could protect 
from neuroinflammation associated with alcohol consumption. We observed that 
proinflammatory cytokine expression was significantly increased in the cortex in alcohol-
fed mice compared to pair-fed controls; however, this was markedly reduced in mice 
treated with antibiotics (Fig 2.9). The cerebral cortex has previously been identified as a 
site of alcohol-induced microglial activation, astrogliosis and proinflammatory cytokine 
increases269. Antibiotic treatment fully prevented alcohol-related induction of Ccl2, Il-17 
and Il-23 mRNA expression in the cortex. Tnfa was induced in antibiotic-treated, 
alcohol-fed mice compared to antibiotic-treated pair-fed mice but its expression was still 
significantly lower compared to alcohol-fed mice without antibiotic treatment. 
Expression of Tnfa, Ccl2, Il-17 and Il-23 was also reduced in the cortex of antibiotic-
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treated pair-fed mice compared to those without antibiotic treatment. These results 
indicate that acute-on-chronic alcohol feeding in mice increases proinflammatory 
cytokine induction that is prevented by antibiotic treatment and reduced gut microbiome. 
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Figure 2.9 Antibiotic treatment protects from alcohol-induced inflammatory 
cytokine expression in the cortex. Expression levels of proinflammatory cytokines 
Tnfa, Ccl2, Hmgb1, Il-17 and Il-23 were measured from the cortex of pair-fed (PF) or 
alcohol-fed (EtOH) mice with or without daily antibiotic treatment (Abx). Data are mean 
+/- SEM, n=5-10 mice/group. *p < 0.05; n.s., not significant by Mann-Whitney test. 
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Cortical expression of inflammasome components increases with bacterial 
decontamination 
Because we found that multiple proinflammatory cytokines were reduced in the 
cortex of antibiotic-treated mice (Fig 2.9), we next measured inflammasome-related 
transcripts to elucidate if alcohol or antibiotics influenced CNS inflammasome-mediated 
cytokine expression. The inflammasome is a multiprotein complex containing: NOD-like 
receptors (NLRs, including NLRP3) that can sense pathogens and danger signals; an 
adaptor molecule, ASC; and an effector molecule, caspase-1. Inflammasome activation 
leads to cleavage of pro-IL-1b and pro-IL-18 to their respective bioactive forms, IL-1b 
and IL-18162. Interestingly, although chronic alcohol consumption models have led to 
increased expression of inflammasome components and Il-1b162, we found no significant 
increase in Il-1b  mRNA expression in this acute-on-chronic alcohol model (Fig 2.10). 
However, expression of Il-18 was induced in alcohol-fed mice in the cortex. While we 
did not observe an increase in Il-1b between PF and EtOH-fed mice without antibiotics, 
we did observe significantly elevated cortical Il-1b mRNA expression in antibiotic-
treated pair-fed mice and an increasing trend in Il-1b in antibiotic-treated alcohol-fed 
mice. Interestingly, in antibiotic-treated mice, alcohol administration significantly 
increased Il-1b mRNA expression compared to pair-fed mice. Similar to the increase in 
pair-fed Il-1b, we also found that Il-18 and Asc were elevated in antibiotic-treated, pair-
fed mice compared to untreated pair-fed mice. Acute-on-chronic alcohol administration 
reduced the expression of Nlrp3 and Asc and increased the expression of Il-18 in 
untreated alcohol-fed mice compared to untreated pair-fed controls. Asc and Il-18 mRNA 
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expression were reduced in antibiotic-treated compared to untreated alcohol-fed mice. 
Caspase-1 mRNA levels did not change significantly in any of the treatment groups (Fig 
2.10). These observations suggest that regulation of the inflammasome and IL-1b 
depends on the gut microbiome and is minimally influenced in the acute-on-chronic 
alcohol model in mice. 
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Figure 2.10. The expression levels of inflammasome components, Il-1b and Il-18 are 
increased in the cortex after antibiotic decontamination. Cortical expression of the 
inflammasome components Nlrp3, Asc and Casp1 as well as the cytokines Il-1b and Il-
18, were measured from the brains of pair-fed (PF) or alcohol-fed (EtOH) mice with or 
without daily antibiotic treatment (Abx). Data are mean +/- SEM, n=5-10 mice/group. *p 
< 0.05; n.s., not significant by Mann-Whitney test. 
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Antibiotic treatment alters the morphology and IBA1 positivity of cortical microglia 
 To characterize the effects of the acute-on-chronic alcohol model in the CNS, we 
next examined microglia activation. Microglia are the resident macrophages of the CNS 
capable of expressing proinflammatory cytokines in response to an insult, such as 
alcohol188. Activated microglia are characterized by altered cell morphology, taking on an 
amoeboid shape with enlarged cell bodies (soma) and shortened peripheral processes270. 
We used immunohistochemistry to identify IBA1-positive microglia (Fig 2.11A-B). The 
soma size was measured in these cortical microglia in all treatment groups and 
normalized to PF mice. No significant differences in soma size were observed between 
groups (Fig 2.11C). Next, we measured the lengths of cell extensions coming off the 
soma and summed those measurements for a total cell process length (Fig 2.11D). We 
found that alcohol reduced the total process length compared to pair-fed mice, consistent 
with the condensed cell morphology characteristic of microglial activation270. Antibiotic 
treatment eliminated this alcohol-induced reduction in process length in the microglia. 
We measured total cortex IBA1 positivity and observed no difference between pair-fed 
and alcohol-fed mice. In contrast, IBA1 expression was markedly reduced in the cortex 
of antibiotic-treated mice in the presence and absence of alcohol administration (Fig 
2.11E). These results suggested that acute-on-chronic alcohol feeding results in 
morphologic changes in microglia that are prevented by the antibiotic-induced reduction 
in the gut microbiome. 
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Figure 2.11 Antibiotic treatment prevents alcohol-induced morphological changes in 
cortical microglia. A) Microglia were immunohistochemically stained for IBA1 and 
visualized at 40X magnification in the cortex of pair-fed (PF) or alcohol-fed (EtOH) 
mice. Representative microglia from the insets are shown in (B). C-D) Soma area (C) and 
cell process length (D) were measured in cortical microglia and normalized to the 
respective PF controls. E) Quantification of overall IBA1-positive staining area. Data are 
mean +/- SEM, n=3 mice/group and 5-9 images/region. *p < 0.05; n.s., not significant by 
Mann-Whitney test. 
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Alcohol-induced microglia changes in the hippocampus are normalized by antibiotic 
treatment 
 The hippocampus is a critical area of the brain associated with memory formation 
as well as addiction271. Previous research has indicated that this brain region plays an 
important role in alcohol-associated pathology and is the site of significant 
neuroinflammation after alcohol consumption142. Some patients with AUD suffer from 
Korsakoff syndrome, a significant memory disorder caused by alcohol-induced 
neurotoxicity and vitamin deficiency133 and various studies have identified the 
hippocampus, critical for learning and memory, as a key brain region impacted by 
alcohol exposure132,135. Therefore, we sought to investigate the morphology of microglia 
in the hippocampus after acute-on-chronic alcohol feeding as morphological changes 
have previously been associated with neuroinflammation252,270. IBA1-positive microglia 
were observed throughout the hippocampus (with representative dentate gyrus microglia 
displayed) (Fig 2.12A-B). Investigation of the sub-regions of the hippocampus, such as 
the CA1, CA3 and dentate gyrus (DG) areas, revealed that alcohol increased the soma 
area only in microglia of the CA3 region. There was no change in the soma area for CA3 
microglia in alcohol-fed mice compared to pair-fed controls when treated with antibiotics 
(Fig 2.12C). The length of processes on the hippocampal microglia from alcohol-fed 
mice were significantly reduced compared to pair-fed controls in all regions investigated 
and, as in the cortex, antibiotic treatment eliminated this morphological change (Fig 
2.12D). Alcohol increased the IBA1-positive area in the hippocampus and this was 
prevented by antibiotic treatment (Fig 2.12E). Similar to our observations in the cortex, 
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the total IBA1-positive area was decreased in the hippocampus by antibiotic treatment in 
both pair-fed and alcohol-fed mice (Fig 2.12E). 
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Figure 2.12 Hippocampal microglia morphology in CA1, CA3 and dentate gyrus is 
restored in antibiotic-treated alcohol-fed mice. A-B) Hippocampal microglia were 
immunohistochemically stained for IBA1 in pair-fed (PF) or alcohol-fed (EtOH) mice 
and visualized at 40X magnification with representative microglia from the insets in (B). 
C-D) Microglia soma area (C) and cell process length (D) in the CA1, CA3 and dentate 
gyrus (DG) of the hippocampus (HIPP). Data from alcohol-fed mice were normalized to 
the respective PF control. E) Quantification of overall IBA1-positive staining. Data are 
mean +/- SEM, n=3 mice/group and 5-9 images/region. *p < 0.05; n.s., not significant by 
Mann-Whitney test. 
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Discussion 
This study provides, for the first time, insight into the microbiome changes that 
occur in a mouse model of early acute alcoholic steatohepatitis and neuroinflammation. 
The model does not induce differences in the α-diversity or the β-diversity between 
intestinal bacterial communities in alcohol and pair-fed mice. However specific 
taxonomic shifts did reflect important changes in the makeup of the bacterial community 
in alcohol-fed mice and represent early indicators of developing alcoholic liver disease. 
Specifically, we identify Akkermansia decrease as an early change in alcohol-induced 
intestinal dysbiosis. 
Our study utilized the acute-on-chronic feeding in which alcohol exposure spans a 
total of ten days. Others have investigated microbiome shifts in long-term alcohol feeding 
paradigms and observed α- and β-diversity changes at later time points. In one such 
study49, diversity measurements were increased in alcohol-fed mice after six-weeks of 
alcohol, while earlier time points were not investigated. That same study also showed 
trends in stool samples similar to ours, including a modest increase in the phylum 
Actinobacteria after alcohol administration. These similarities are particularly interesting 
because that study analyzed bacterial content of the stool while we examined bacteria 
from cecal content. In a short alcohol exposure model using seven-day intragastric 
alcohol infusion, Wang et al. described an increase in β-diversity between alcohol-
infused and control mice45. However, the intragastric infusion model varies significantly 
from the orally consumed Lieber-DeCarli liquid diet used in our study and the 
consumption method alone could explain the discrepant diversity findings. 
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In analysis of cecal content, we observed various taxonomic changes between 
alcohol- and pair-fed mice. Among these changes, phylum Verrucomicrobia was 
dominated by Akkermansia and its abundance was dramatically reduced by alcohol 
consumption. This finding is corroborated by careful investigation of other studies45 and 
offers a promising look into the potential importance of this genus in gut barrier 
maintenance disrupted by alcohol. Indeed, Akkermansia has been found to be decreased 
in mouse models of obesity and type-2 diabetes, while supplementation with the bacteria 
alleviated the burden of metabolic dysfunction272. 
Our data support previous studies showing that alcohol can induce inflammatory 
signaling in the intestine. This inflammation may be a key factor in the breakdown of the 
intestinal barrier integrity and ensuing leakage of bacterial products into the circulation 
associated with alcohol. Using both in vitro and in vivo models, Al-Sadi et al. have shown 
that proinflammatory cytokines are capable of reducing tight junctions and gut barrier 
integrity, leading to breakdown and molecule translocation across the gastrointestinal 
tract39-41. Other mechanisms of alcohol-induced loss of intestinal barrier integrity have 
been explored and include bacterial dysbiosis45, luminal homeostasis32,44 and enterocyte 
cellular stress and dysregulation of structural proteins37. Furthermore, the relationship 
between proinflammatory gene expression and gut barrier dysfunction appears to be 
critical43,266, and our data further emphasize the role of alcohol and intestinal bacteria in 
regulating intestinal cytokine levels. In the present study, we did not observe a 
statistically significant increase in serum LPS (one of many measures for intestinal 
barrier leakiness), suggesting that this model of alcohol feeding may not induce as robust 
 
 
 
 
  79 
intestinal barrier leakage as other models. Commercially available LPS quantification 
assays require extensive optimization as there are many inhibitors and activators within 
samples leading to significant noise273,274. Therefore, measuring alternative indicators of 
intestinal leakage (bacterial 16S rDNA in circulation, culturable bacteria from mesenteric 
lymph nodes, other bacterial surface biomarkers) could shed light on the state of the gut 
barrier. Additionally, further investigation into intestinal molecular changes (ex, tight 
junction protein expression), histologic examination of the intestinal barrier and into 
alterations in the cellular composition (immune cell within the lamina propria, support 
cells in intestinal crypts, etc.) in this model of alcohol administration, as has been 
explored in other models of chronic alcohol32,50, will be informative.  
Beyond the effects of alcohol on bacterial community changes, we also 
investigated the role of overall bacterial load on hallmarks of steatohepatitis showing that 
gut bacterial load reduction attenuated immune cell infiltration, steatotic accumulation 
and inflammation in the liver. Intestinal microbiota and bacterial products are involved in 
the pathogenesis of alcoholic liver disease21,22. Infiltration of immune cells, especially 
neutrophils, is an important component of the acute-on-chronic model110,275. However, 
the question of whether neutrophils are brought in to repair damage or whether their 
presence causes damage in the liver remains unclear. Here, we reduced the hepatic 
infiltration of neutrophils by treating with antibiotics without protecting the liver from 
damage (indicated by increased serum ALT and AST). This is partially corroborated by 
Bertola et al. who used an anti-neutrophil (anti-Ly6G) antibody and showed near 
complete elimination of neutrophil infiltration into the liver, but only partial protection 
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from transaminase increase110. A possible explanation for the continued elevation of ALT 
and AST, despite protecting the liver from infiltrating inflammatory cells such as 
neutrophils, comes from the nature of the feeding model. This acute-on-chronic model 
includes an oral gavage of high-dose ethanol after ten days of feeding. The metabolism of 
this large dose of alcohol in a short time may induce hepatocyte damage and 
transaminase release regardless of the presence or absence of other damage or pathogen 
associated signals. Suppression of circulating bacterial components (such as LPS) 
reduces the inflammatory signaling in the liver that would normally attract immune cells 
such as neutrophils to the site of liver injury.  
We describe the protective role of antibiotic-mediated reduction in bacterial load 
in alcohol-induced inflammatory signaling, steatotic changes and neutrophil infiltration in 
the liver. Reducing circulating bacterial products, such as LPS (Fig 2.3B), likely reduces 
signaling via TLR4 and subsequent inflammatory signaling70,71. Additionally, the 
reduction in circulating CCL2 protein in antibiotic-treated mice may contribute to the 
protection from alcohol-induced steatosis we report here, as we have previously shown 
the role of CCL2 in promoting lipid accumulation276. We describe a protective role of 
antibiotic treatment in reducing circulating CCL2, neutrophil infiltration and steatotic 
changes within the liver. This protection occurs without the protection of ALT and AST 
increases, indicative of hepatocyte damage, suggesting that this protection is related to a 
role of the antibiotics independent of primary protection of the main parenchymal cell in 
the liver. Antibiotics reduced the intestinal bacterial load as well as circulating LPS 
which activates multiple immune process. Further study is needed to confirm whether 
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liver steatosis and inflammatory signaling is truly independent of primary hepatocyte 
damage and could include the use of immune cell-specific knockouts to inhibit immune 
activation (such as TLR4, the main LPS receptor) or perhaps protecting hepatocytes from 
alcohol-induced damage by knocking out enzymes involved in alcohol metabolism. 
Identifying whether immune and steatotic changes persists in the liver despite the absence 
of alcohol metabolism (and the cellular damage associated with its byproducts) could 
shed light on this important question. 
To further investigate the effect of alcohol and bacterial reduction on steatosis, we 
measured mRNA levels of liver transcripts related to fat metabolism and lipid regulation. 
Interestingly, we found that ethanol reduced expression of fatty acid synthase (Fasn), 
uncoupling protein-1 (Ucp1), PR-domain zinc finger protein 16 (Prdm16), stearoyl-CoA 
desaturase 2 (Scd2). Antibiotic treatment also reduced expression of these genes 
compared to pair-fed mice without antibiotics. Gene suppression by antibiotics is 
consistent with other studies that have shown antibiotic treatment can have a negative 
impact on fat accumulation in the liver277. 
Adipose differentiation-related protein (Ardp) and lipocalin-2 (Lcn2) are both 
involved in storage and transport of accumulated lipids within the cell. Their increased 
expression (Lcn2 p=0.10) in alcohol-fed animals compared with pair-feds, irrespective of 
antibiotic treatment, mirrors the increased lipid store within cells observed on histology. 
Therefore, we have observed that genes regulating lipid production tend to be suppressed 
by antibiotics and alcohol in this feeding model, while genes associated with regulating 
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lipid stores (Adrp, Lcn2) are elevated presumably to compensate for the alcohol-induced 
fat accumulation. 
Many of the liver findings intriguingly contradict those observed in germ-free 
mice55 which displayed significantly greater liver injury, inflammation and steatosis 
when compared with conventional mice in a model of acute alcohol exposure. In that 
study, germ-free mice were given a single gavage of 3g/kg ethanol and sacrificed 9h later 
(compared to our treatment of ten days of 5% EtOH in liquid diet and a final gavage of 
5g/kg sacrificed 9h later). The lower alcohol dose of 3g/kg induced only modest changes 
in serum ALT, steatosis and inflammatory cytokine expression in alcohol- versus pair-fed 
conventional (bacteria-competent) mice. Additionally, while we successfully reduced gut 
bacterial load using antibiotic treatment, some intestinal microbes still persisted (Fig 
2.3E-F). It is possible that the remaining bacterial composition contained protective 
species (although we could not sequence these populations due to the low yield of 
bacterial DNA) or that the remaining bacteria may serve a homeostatic function in either 
intestinal metabolism or barrier maintenance54.  
In our study, we observe changes in the liver, including inflammatory cytokine 
expression, elevated markers of liver injury and immune cell infiltration in the alcohol-
fed mice, despite relatively stable communities of gut bacteria (i.e. no dramatic shifts in 
diversity) compared to long-term alcohol feeding49. Long-term alcohol feeding (6- to 8-
weeks) induces both shifts in alpha- and beta-diversity as well as changes at the phylum 
level and other taxa, including significant increases in the phylum Firmicutes and 
reduction in phylum Bacteroidetes49. This suggests that while some features of alcoholic 
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liver disease may be related to shifts in the gut bacterial composition seen over the long-
term, there are other features, such as inflammation signaling and immune cell infiltration 
and hepatocyte injury that may be independent of bacterial diversity changes.  
In the present study, we found evidence of microglial activation by acute-on-
chronic alcohol administration in mice. Activated microglia take on an amoeboid-like 
morphology with reduced process length and, typically, an increased soma size270. We 
found that average cell process length was decreased in alcohol-fed mice in addition to 
CNS proinflammatory cytokine expression increases, indicative of a neuroinflammatory 
state. Acute-on-chronic alcohol reduced cell process length in both the cortex and 
hippocampus and significantly increased the soma size in the CA3, a region of the 
hippocampus important for spatial learning and short-term memory.  
Similar to observations in the liver72, antibiotic treatment protected the CNS from 
proinflammatory gene expression and changes in the resident macrophage population 
induced by alcohol consumption. As already discussed, germ-free mice do not show the 
same protection from alcohol-induced liver damage that we describe using antibiotic 
decontamination55. While studies in germ-free mice focused on CNS inflammation are 
lacking, recent reports suggest that the microbiome plays a critical role in regulating 
microglial maturation and function278. Germ-free mice have dysregulated microglia with 
blunted immune reactivity, display immature phenotypes and are altered in distribution 
and numbers. Additionally, mice treated with long-term (four weeks) broad-spectrum 
antibiotics had microglia that displayed immature morphology. Replenishing germ-free 
mice with a complex microbiota or treatment with short-chain fatty acids served to 
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partially restore microglial morphology278. Our present study used a shorter course of 
antibiotic treatment (ten days versus four weeks) in addition to alcohol feeding and 
changes in microglia morphology (cell processes) were observed in alcohol-fed mice. 
Further studies using germ-free animals and alcohol feeding will be beneficial in 
understanding the contributions of the microbiome and microglia to neuroinflammation. 
Additionally, selectively replenishing germ-free mice with a microbiome rich in 
particular bacterial communities, such as Akkermansia and other “beneficial” species, 
accompanied by alcohol treatment, will shed important light on the connections between 
the microbiome, microglia and neuroinflammation. These future studies will be of 
additional interest because anti-inflammatory antibiotics such as the tetracyclines have 
been shown to reduce alcohol consumption and seizures following alcohol exposure in 
mice239,260. Whether or not these behavioral observations are due to the antibiotic effect 
on the microbiome, on microglia or elsewhere in the CNS deserves further study to 
explore yet unknown connections between the microbiome and alcohol drinking 
behavior. 
Our data are consistent with previous studies examining the role of TLR4 
signaling in alcohol-related organ pathology. While some have suggested that alcohol 
may interact directly with TLR4 or affect lipid membrane interactions required for proper 
TLR4 signal transduction187,279, TLR4 also recognizes endogenous (including 
HMGB1)168,169 and exogenous (PAMPs such as LPS)167 danger signals. Studies show that 
TLR4 knockout and knockdown mice are protected from numerous inflammation-related 
sequelae of alcohol exposure in the liver280 and in the brain170-172. Rather than focusing on 
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TLR4 and its signaling pathway, we used antibiotics to reduce bacterial LPS, one of the 
prominent ligands of TLR4, and reveal a similar reduction in tissue inflammation from 
the gut to the brain. Our study adds critical evidence to the understanding of the gut-brain 
axis that relates multifocal pathology in the body after chronic alcohol exposure. 
An important remaining question is whether gut bacteria or their products are 
primarily responsible for organ damage. A direct link between LPS and organ 
inflammation is possible: leakage of live or dead bacteria or bacterial-derived products 
into the systemic circulation has been documented in various alcohol administration 
settings24,26,31,32. These bacterial signals could be directly responsible for inducing 
inflammation in the gut, liver and in the brain, as well as the associated organ damage. 
Although LPS does not cross the blood-brain barrier at significant levels173, it could be 
interacting with juxta-cerebrovascular cells to transmit an immune signal across the 
barrier. Evidence of blood-brain barrier disruption in alcohol models and human patients 
provides another explanation for a possible direct mechanism of LPS-induced 
neuroinflammation174. LPS may also act by inducing peripheral inflammation and 
expression of cytokines that can easily cross the blood-brain barrier. Regardless of how 
LPS may be communicating with the CNS, peripheral LPS exposure induces 
neuroinflammation including astrogliosis, microglial activation and cytokine signaling252. 
Alternatively, gut-derived signals, such as LPS, bacterial metabolites or other 
undescribed intestinal signals, could lead to a systemic reaction. This reaction could 
include inflammatory cytokines or activated immune cells in the liver or in circulation 
that then induce organ-specific inflammation in the CNS and elsewhere in the body. 
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Developing models to study this question will be a critical area of further study to explain 
inter-organ communication after alcohol consumption. 
Interestingly, components of the inflammasome were affected both by antibiotic 
decontamination as well as alcohol consumption in the intestine and in the brain in our 
experiments. Unlike the effect on other proinflammatory cytokines, gut decontamination 
generally induced an increase in the expression of inflammasome components in the 
intestine and cortex, while acute-on-chronic alcohol had limited effects on expression. 
Recent studies have revealed that the inflammasome and gut microbiota interact in 
important ways, including inflammasome-dependent remodeling of the flora to protect 
from autoimmunity268. Inflammasome activation requires two signals to first induce 
expression of effector molecules like pro-Il-1b (typically through TLR4 signaling) and a 
second signal to activate the inflammasome cascade leading to pro-caspase-1 and pro-IL-
1b cleavage. Alcohol, which induced intestinal Il-1b expression (encoding uncleaved 
pro-IL-1b), has been previously shown to reduce certain bacterial phyla, including 
Verrucomicrobia72,281, which is also decreased in mice with overactive NLRP3 
inflammasome268. Restoration of Akkermansia, a bacterial genus within the 
Verrucomicrobia phylum, was shown to be protective in liver disease282, including 
alcohol-related pathology281, suggesting a strong connection between alcohol, the 
inflammasome and gut bacterial dysbiosis.  
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Conclusion 
This study supports the hypothesis that the gut microbiota are impacted by alcohol 
consumption and that the acute-on-chronic feeding model alters the microflora at 
multiple taxonomic levels. We conclude that gut microbes influence intestinal, liver and 
CNS inflammation, neutrophil infiltration and liver steatosis following alcohol 
consumption and these data further emphasize the gut-liver-brain axis, even in early 
alcohol-induced inflammation. 
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CHAPTER III 
 
Pharmacological inhibition of CCR2/5 signaling prevents and reverses alcohol-induced 
liver damage, steatosis and inflammation in mice 
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Abstract 
Kupffer cell (KC) and macrophage activation contributes to steatosis, 
inflammation and fibrosis in alcoholic liver disease (ALD).  We found increases in 
macrophages as well as T cells in the livers of human alcoholics, along with increased 
expression of Ccr2 and Ccr5 and their corresponding chemokines, CCL2 and CCL5.  We 
hypothesized that inhibition of CCL2 (MCP-1) signaling with the dual CCR2/5 inhibitor, 
Cenicriviroc (CVC), would attenuate ALD. In a mouse model of ALD, liver injury (ALT) 
and steatosis were prevented by CVC whether used as “prevention” throughout the 
alcohol feeding or as “treatment” started after the development of ALD.  Alcohol-
induced increases in liver fibrosis (Sirius Red, Collagen mRNA expression and 
hydroxyproline) were normalized by both “prevention” and “treatment” with CVC. We 
found that “prevention” and “treatment” with CVC reversed alcohol-related increases in 
liver cytokine mRNA expression, such as Tnfa, Il-1b, Il-6, Ccl2 as well as TNFa, IL-1b 
and IL-6 protein levels. Both CVC regimens prevented the increase in infiltrating 
macrophages (F4/80lo CD11bhi) in livers of alcohol-fed mice. CVC increased liver T cell 
numbers and attenuated Il-2 expression without an effect on CD69+ or CD25+ T cell 
expression. In vitro, CVC inhibited CCL2-induced increases in hepatocyte Fasn and 
Adrp while it augmented Acox-1, Pgc1a and Ucp-2 expression, suggesting mechanisms 
for attenuated hepatocyte steatosis after CVC treatment. Finally, we found that CCL2 and 
CCL5 sensitized hepatocytes to lipopolysaccharide-induced liver TNFa, ALT and LDH 
release and caspase-3 activation and that CVC prevented this injury. In summary, our 
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data provides preclinical evidence for CCR2/CCR5 inhibition with CVC as a potent 
intervention to ameliorate alcohol-induced steatohepatitis and liver damage. 
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Introduction 
Alcoholic liver disease (ALD) is an increasing health concern worldwide8. The 
clinical pathophysiology of ALD involves a progressive spectrum of steatosis, 
steatohepatitis, fibrosis, cirrhosis, and increased risk of hepatocellular carcinoma9. While 
simple fatty liver, induced by binge alcohol consumption, can be reversed after alcohol 
cessation, more severe forms of liver injury can develop in up to 35% of heavy alcohol 
drinkers10. There is no definitive treatment for progressive ALD, except for abstinence, 
and the current standard of care with prednisolone for acute alcoholic hepatitis has 
limited efficacy, many contraindications, and side effects20.  Thus, an urgent need to 
explore novel therapies for ALD is apparent.  
The pathomechanism of ALD has been attributed to direct effects of alcohol and 
its metabolites inducing macrophage infiltration, steatosis, and hepatocyte cell death 
through increased cytokine/chemokine receptor signaling and proinflammatory cytokine 
induction in the liver106. The C-C chemokine receptor types 2 and 5 (CCR2 and CCR5), 
which signal through G proteins and other intracellular molecules, and their respective 
ligands, C-C chemokine ligand types 2 (CCL2; also known as monocyte chemoattractant 
protein-1 [MCP-1]) and CCL5 (also known as regulated on activation, normal T cell 
expressed and secreted [RANTES]) are implicated in liver inflammation and macrophage 
recruitment to the liver89.  In response to animal models inducing hepatocyte injury, such 
as acetaminophen, carbon tetrachloride or bile duct ligation, resident liver macrophages 
(Kupffer cells) secrete CCL2 promoting monocyte recruitment and migration to the liver, 
where they mature into proinflammatory macrophages283.  CCR2 and CCR5 mediate the 
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intrahepatic immune-cell interactions that promote activation and migration of peripheral 
monocytes to the liver90,91. Activation of inflammatory cells and upregulation of several 
soluble inflammatory mediators, including the ligands of these key receptors, CCL2 and 
CCL5, are features of ALD92. In animal studies of ALD, mice with CCL2 deletion or 
pharmacological blocking of CCL2 showed protection93,94. Similarly, animal models 
lacking CCL5 display lower immune-cell activation and reduced liver fibrosis95. 
Therefore, CCR2 and CCR5 are promising targets for treatment of ALD. 
 Cenicriviroc (CVC) is a novel, oral, dual CCR2/CCR5 antagonist with nanomolar 
potency against both receptors, and a long plasma half-life (30–40h in humans)284. Phase 
2 studies 652-2-201 (NCT01092104) and 652-2-202 (NCT01338883), conducted in 
human immunodeficiency virus (HIV)-infected participants have validated CVC 
blockade of CCR2 and CCR5 with a reciprocal increase in CCL2284-286. In addition, 
marked reduction in a circulating biomarker of monocyte activation, soluble cluster of 
differentiation 14 (sCD14), was observed with CVC treatment in HIV-infected adults 
(study 652-2-202) and in adults with NASH and liver fibrosis (652-2-203; CENTAUR; 
NCT02217475) over up to 48-52 weeks of therapy285,287. Anti-inflammatory and anti-
fibrotic effects of CVC have been demonstrated in multiple animal models of acute liver 
injury and fibrosis225,288-290. A post hoc analysis of phase 2b clinical study 652-2-202 
(NCT01338883) revealed reductions in the fibrosis indices AST to Platelet Ratio Index 
(ARI) and Fibrosis-4 (FIB-4), which were significantly correlated with decreases in 
sCD14 in HIV-infected subjects treated with CVC at 48 weeks291. The efficacy, safety 
and pharmacokinetics of CVC in adults with NASH and liver fibrosis compared to 
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placebo have been evaluated in the 2-year CENTAUR study; results of the Year 1 
primary analysis showed that CVC was well tolerated and resulted in twice as many 
participants achieving ³1 stage improvement in fibrosis and no worsening of 
steatohepatitis versus placebo287,292. CVC is currently undergoing Phase 3 evaluation for 
the treatment of liver fibrosis in adults with NASH (AURORA; NCT03028740). 
Therefore, CVC is an attractive candidate for the treatment of ALD through antagonism 
of CCR2/CCR5 receptors.  
Here, we hypothesize that CCR2/5 blockade using CVC will inhibit macrophage 
infiltration, lower inflammation and reduce steatosis and thereby alleviate ALD. We 
employ the Lieber-DeCarli model of ALD and administer CVC throughout the alcohol 
regimen for 6 weeks (hereafter referred to as “prevention”) or for the final 3 weeks 
(“treatment”) of alcohol administration.  Our results show that CVC treatment 
significantly improves the hallmark phenotypes of ALD including hepatocyte damage, 
macrophage infiltration and inflammation in the liver. Our novel in vivo findings 
presented here suggest that CCR2/5 antagonism using CVC is a potential therapy for 
ALD. 
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Methods 
Human Alcoholic Liver Disease Samples  
Alcoholic liver disease (ALD) samples were obtained from The Liver Tissue Cell 
Distribution System (LTCDS, Department of Pediatrics, University of Minnesota, 
Minneapolis, MN) and included ten human liver samples from patients with end-stage 
alcoholic cirrhosis who received liver transplantation. Alcoholic cirrhosis was diagnosed 
by LTCDS and was based on a history of alcohol drinking and liver histology. Control 
human liver tissue was the non-involved surrounding tissue obtained from patients 
undergoing partial hepatectomy for liver cancer. The protocol for using these liver 
samples has been approved by the Liver Tissue Cell Distribution System of the 
University of Minnesota and the Institutional Review Board (IRB) of the University of 
Massachusetts Medical School. An informed consent in writing was obtained from each 
patient and the study protocol conformed to the ethical guidelines of the 1975 Declaration 
of Helsinki as reflected in a priori approval by the IRB. Peripheral blood mononuclear 
cells (PBMCs) were obtained from patients with alcoholic hepatitis at the University of 
Massachusetts or from healthy controls with no history of ALD as part of a study 
approved by the IRB of the University of Massachusetts Medical School.  
 
Alcohol Feeding and CVC Administration 
The study protocol was approved by the Institutional Animal Use and Care 
Committee of the University of Massachusetts Medical School. All the methods were 
carried out in accordance with the approved guidelines. Eight-week-old C57BL/6J mice 
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were divided into alcohol- and pair-fed (control) groups as well as two CVC alcohol-fed 
groups. Alcohol-fed mice received 5% alcohol in Lieber-DeCarli liquid diet ad libitum as 
previously described70. Pair-fed animals received a calorie-matched liquid diet. Some 
alcohol-fed mice received daily subcutaneous injections of 15mg/kg BW CVC for six 
weeks (“prevention” cohort) while others received the same dose daily for three weeks 
(beginning at week four through six of alcohol feeding; “treatment” cohort). 10% 
hydroxypropyl-b-cyclodextrin, 5% solutol HS15 and 85% sterile water was used as a 
vehicle to dissolve CVC into solution. At sacrifice, blood and liver tissues were collected 
for further assays. 
 
Isolation of Hepatocytes and Liver Mononuclear Cells 
Liver cell isolations were performed as described previously293. Mice received 
anesthesia with ketamine (100mg/kg BW) and xylazine (10mg/kg BW) and livers were 
perfused with HBSS followed by in vivo digestion with collagenase enzyme (900mg/L). 
Hepatocytes were separated by centrifugation for five minutes at 300rpm and the pellet 
was washed in HBSS containing 2% FBS and were plated on collagen-coated plates. The 
non-hepatocyte content was loaded on the top of the 40%-70% Percoll gradient and 
centrifuged for thirty minutes at 1800rpm. Hepatocytes The liver mononuclear cellular 
(LMNCs) fraction from the Percoll interface was washed and immediately stained for flow 
cytometry or lysed in Qiazol (Qiagen, Germantown, MD, USA). 
 
Flow Cytometry 
 
 
 
 
  96 
Isolated LMNCs were suspended at a concentration of 106 cells/ml in PBS and 
stained with Live/Dead Fixable Blue Dead Cell Stain Kit from Life Technologies (Grand 
Island, NY, USA) to exclude dead cells. Anti-mouse CD16/CD32 mAb from BD 
Pharmingen (San Jose, CA, USA) was used to block nonspecific Fc receptor binding and 
incubated for 20min at 4°C. LMNCs were then immunostained with anti-CD45-Pacific 
Blue, anti-CD11b-PE, and anti-F4/80-APC, anti-CD3-PE, anti-CD25-FITC or anti-CD69-
APC from Biolegend (San Diego, CA, USA). Hepatocytes were stained with anti-CCR2-
AF647 and anti-CCR5-PE from Biolegend and albumin (Abcam, Cambridge, MA, USA) 
with a donkey anti-rabbit Brilliant Violet 421 secondary from Biolegend. Live singlet 
CD45+ cells were gated and differentiated based on expression of CD11b and F4/80 or 
CD3, while albumin+ cells were selected after gating live single cells. As a negative control, 
cells were stained with isotype-matched control antibodies. Cells were washed with FACS 
staining buffer (2% FBS in PBS) and fixed with 1% paraformaldehyde prior to data 
acquisition. Data were acquired on a BD LSR II instrument (BD Biosciences, San Jose, 
CA, USA) and analyzed using FlowJo v10.1 software (Ashland, OR, USA). 
 
Biochemical Assays  
Human serum chemokines were measured by CCL2 and CCL5 ELISA kits (BD 
Biosciences, San Jose, CA, USA). Serum alanine aminotransferase (ALT) activity was 
determined using a kinetic method (D-TEK LLC, PA, USA). Intracellular cytokine levels 
were monitored in liver whole cell lysate using TNFa, MCP-1, IL-1β ELISA kits 
(Biolegend, San Diego, CA, USA).  Liver triglycerides were assayed in liver whole cell 
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lysates using L-Type TriGlyceride M kit (Wako Diagnostics, Richmond, VA, USA). 
Mouse serum soluble CD14 was measured by ELISA (R&D, Minneapolis, MN, USA). 
LDH assay (Abcam) and caspase-3 assay (R&D Systems) were completed according to the 
manufacturers’ recommendation. 
 
RNA Extraction and Real-Time PCR 
Total RNA was extracted using the Direct-zol RNA MiniPrep according to the 
manufacturer’s instructions (Zymo Research, Irvin, CA, USA). RNA was quantified using 
Nanodrop 2000 (Thermo Scientific, Wilmington, DE, USA). Complementary DNA 
(cDNA) synthesis was performed by reverse transcription of total RNA using the iScript 
Reverse Transcription Supermix (Bio-Rad Laboratories, Hercules, CA, USA). Real-time 
quantitative PCR was performed using the CFX96 real-time detection system (Bio-Rad). 
Primers were synthesized by IDT, Inc. (Coralville, IA, USA) and are shown in Table 1. 
Accumulation of PCR products was detected by monitoring the increase in fluorescence of 
double-stranded DNA-binding dye SYBR Green during amplification. Relative gene 
expression was calculated by the comparative cycle threshold (Ct) method and the 
expression of target genes was normalized to the house-keeping gene (18S rRNA) in each 
sample and the fold-change in the target gene expressed compared to pair-fed values, as 
previously described294. Melt-curve analysis was used to confirm the authenticity of the 
PCR products. 
Table 3.1 Real-time PCR primers. 
Gene Forward Sequence Reverse Sequence 
hCcr2 ACTGGTCCTTAGCCCCATCT CATCGGACTCCACCAAAACT 
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hCcr5 GGTTGGTGTTGCAGAAGGTT TGGTCTCCTTGCCCTAAATG 
hCd11b ACTGGTGAAGCCAATAACGCA TCCGTGATGACAACTAGGA 
TCTT 
hCd68 CTTCTCTCATTCCCCTATG 
GACA 
GAAGGACACATTGTACTCCA 
CC 
hCd14 ACGCCAGAACCTTGTGAGC GCATGGATCTCCACCTCTAC 
TG 
hCd3 TGCTGCTGGTTTACTACTGGA GGATGGGCTCATAGTCTGGG 
mCollagen GCTCCTCTTAGGGGCCACT CCACGTCTCACCATTGGGG 
mTnfa GAAGTTCCCAAATGGCCTCC GTGAGGGTCTGGGCCATAGA 
mIl-1b CTTTGAAGTTGACGGACCC TGAGTGATACTGCCTGCCTG 
mIl-6 ACAACCACGGCCTTCCCTA 
CTT 
CACGATTTCCCAGAGAACA 
TGTG 
mCcl2 CAGGTCCCTGTCATGCTTCT TCTGGACCCATTCCTTCTTG 
mCcr2 GTGTACATAGCAACAAGCCTC 
AAAG 
CCCCCACATAGGGATCATGA 
mCcr5 TGGGGTGGAGGAGCAGGGAG TAGGCCACAGCATCGGCCCT 
mFoxp3 GCAATAGTTCCTTCCCAGAG 
TTC 
ATAAGGGTGGCATAGGTGAA 
AG 
mIl-2 TGAGCAGGATGGAGAATTACA 
GG 
GTCCAAGTTCATCTTCTAGGC 
AC 
mIfng CGGCACAGTCATTGAAAGCCTA GTTGCTGATGGCCTGATTGTC 
mFasn GAGGTGGTGATAGCCGGTAT TGGGTAATCCATAGAGCCCAG 
mAcox-1 CCATCACGCAATAGTTCTGG 
CTC 
AAGCTCAGGCAGTTCACTCA 
GG 
mAdrp CTGTCTACCAAGCTCTGCTC CGATGCTTCTCTTCCACTCC 
mPgc1a AGACGGATTGCCCTCATTTGA TGTAGCTGAGCTGAGTGTTGG 
mUcp-2 AGTTCCGCCCTCGGTGTCGT ATTGTGTCCGGACCGCAGGA 
GA 
18S GTAACCCGTTGAACCCCATT CCATCCAATCGGTAGTAGCG 
The above forward and reverse sequences of primers were used in real-time PCR. The 18S 
primers recognize both the human and mouse genes. 
 
Histopathological Analysis 
Sections of formalin-fixed, paraffin-embedded livers were stained with 
hematoxylin and eosin (H&E) or Sirius Red. To assess steatosis, Oil Red O staining was 
performed on 12-14µm cryofrozen liver tissue sections. Immunohistochemistry staining 
was performed on formalin-fixed, paraffin-embedded livers using antibodies against 
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CD11b, CD14, CD68 and CD3 (Abcam). Images were acquired on a Nikon microscope. 
The quantification of the Oil Red O and Sirius Red staining was performed using ImageJ 
software. 
 
In vitro Experiments 
For in vitro sensitization experiments, mouse primary hepatocytes were isolated as 
described above, plated on collagen-coated plates and allowed to rest for at least four hours. 
The media was changed and cells were then stimulated with either 200ng/mL CCL2 (MCP-
1; PeproTech, Rocky Hill, NJ, USA) or 20ng/mL CCL5 (RANTES; PeproTech) for 24h. 
Some groups received either 10nM, 20nM or 100nM CVC. After changing the media, 
10ng/mL lipopolysaccharide (LPS) was added for 18h after which culture supernatants 
were collected for measurement of TNFa, ALT and lactate dehydrogenase (LDH). Cell 
lysates were prepared for caspase-3 assay. 
 
Statistical Analysis  
Statistical significance was determined using either two-tailed t-test or ordinary 
one-way ANOVA with Tukey’s multiple comparison post-test to compare the means of 
multiple groups. Data are shown as mean +/- SEM and were considered statistically 
significant at p<0.05. GraphPad Prism 6.02 (GraphPad Software Inc., La Jolla, CA, USA) 
was used for analysis. 
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Results:  
Patients with ALD have elevated expression of the CCR2/5 signaling axis and 
increased leukocyte infiltration in the liver 
To investigate the clinical significance of CCR2/5 in ALD, we first confirmed the 
presence of these receptors in livers of human patients with alcoholic cirrhosis. 
Messenger RNA expression of Ccr2 and Ccr5 as well as their ligands Ccl2-5 and Ccl8 
was significantly upregulated in livers of patients with alcoholic cirrhosis compared to 
control livers (Fig 3.1A). Peripheral blood mononuclear cells (PBMCs) from patients 
with alcoholic-hepatitis have increased expression of Ccl2 and Ccl3 and decreased Ccl5 
compared to healthy control PBMCs (Fig 3.1B). CCL2 (or MCP-1) and CCL5 (or 
RANTES) are chemokines that bind to their respective receptors, CCR2 and CCR5, and 
activate downstream signaling295. We evaluated the levels of the ligands of these 
receptors in serum samples obtained from patients with acute alcoholic hepatitis. Both 
serum CCL2 and CCL5 levels were significantly higher in patients with alcoholic 
hepatitis compared to healthy controls (Fig 3.1C). 
Macrophages play an important role in inflammation and progression of the liver 
injury in alcoholic liver disease (ALD) and cirrhosis283. Indeed, we found increased 
expression of macrophage markers in human liver samples (Fig 3.1D). The gene 
expression of characteristic macrophage markers including Cd11b, Cd68 and Cd14 were 
significantly upregulated in the alcoholic cirrhotic livers compared to controls (Fig 3.1D). 
Further, we observed increased macrophage infiltration in the human alcoholic livers 
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indicated by immunostaining for the macrophage markers CD11b, CD68 and CD14 (Fig 
3.1E).  
CCL5 plays a significant role in activation and migration of T cells, particularly in 
viral infection296. We found an increase in expression of Cd3 mRNA (Fig 3.1D) as well 
as an increase in the number of CD3+ T cells by immunohistochemistry in the livers of 
patients with alcoholic cirrhosis (Fig 3.1E). Together, our data demonstrate increases in 
macrophages and T cells in human alcoholic livers, elevation of CCL2 and CCL5 serum 
levels and increased expression of their receptors, CCR2/5, in human alcoholic liver 
disease. 
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Figure 3.1 CCR2 and CCR5 expression and immune cell infiltration to the liver is 
increased in human patients with alcoholic liver disease. A-B) Expression of CCR2 
and CCR5 receptor and ligand genes were measured by qPCR in livers of patients with 
alcoholic cirrhosis or healthy controls or from peripheral blood mononuclear cells 
(PBMCs) from patients with alcoholic hepatitis or healthy controls. C) CCL2, CCL3, 
CCL4 and CCL5, chemokine ligands of CCR2 and CCR5, were measured from the sera 
of healthy controls and alcoholic hepatitis (AH) patients by ELISA. D) Expression of 
macrophage markers Cd11b, Cd68 and Cd14 and T cell marker Cd3 were measured by 
qPCR in the livers of controls and patients with alcoholic cirrhosis. E) Macrophage 
markers CD11b, CD68 and CD14 and the T cells marker CD3 were stained by 
immunohistochemistry in liver tissue sections from controls and patients with alcoholic 
cirrhosis. * p<0.05 by student’s t-test  
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Inhibition of CCL2/CCL5 signaling with a dual CCR2/CCR5 antagonist alleviates 
chronic alcohol-induced liver injury in mice 
Having confirmed the elevation of Ccr2 and Ccr5 expression in human alcoholic 
liver, we tested the efficacy of Cenicriviroc (CVC), a dual CCR2/5 antagonist in a mouse 
model of alcoholic liver disease that is reliable for preclinical testing of potential 
interventions112,297. Administration of CVC for 6 weeks during alcohol administration in 
the “prevention” cohort showed significant protection from alcohol-induced ALT 
increases with significant attenuation at 2-4 weeks and normalization of ALT to the level 
of pair-fed controls at weeks 5-6 (Fig 3.2A).  Furthermore, when CVC was started at 
week 4 of the alcohol feeding in the “treatment” cohort, we found rapid normalization of 
ALT levels that remained at the level of pair-fed mice for the final 3 weeks of the alcohol 
feeding (Fig 3.2A).  
We found a significant improvement in liver pathology in both “prevention” and 
“treatment” administration of CVC in ALD in mice (Fig 3.2B). Liver steatosis, estimated 
by Oil Red O staining was significantly lower after both regimens of CVC 
administrations compared to alcohol-fed without CVC treatment (Fig 3.2C). Liver 
triglyceride measurement further confirmed the inhibitory effect of CVC on alcohol-
induced liver steatosis (Fig 3.2E). Chronic alcohol exposure leads to liver fibrosis in 
mice and often to cirrhosis in humans. Liver fibrosis was increased by alcohol feeding as 
assessed using Sirius Red staining (Fig 3.2D), Collagen mRNA expression in the liver 
(Fig 3.2F) and liver hydroxyproline (Fig 3.2G). We found a significant reduction in 
alcohol-induced liver fibrosis in CVC-treated mice both in the “prevention” and 
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“treatment” cohorts (Fig 3.2D-G). These results indicate that inhibition of CCR2/5 
signaling protected mice from alcohol-induced increase in parenchymal injury and 
steatosis, improved liver pathology and restricted fibrosis in mice. 
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Figure 3.2 Inhibition of CCR2/5 signaling alleviates chronic alcohol-induced liver 
injury. Mice were fed a liquid diet containing 5% ethanol (Alc) or pair-fed (PF) diet for 
6 weeks. Some mice were injected subcutaneously with the CCR2/5 inhibitor 
Cenicriviroc (CVC) daily for the entire 6 weeks or during the final 3 weeks (weeks 4-6) 
of ethanol feeding. Control mice were injected with vehicle. A) Serum ALT was 
measured weekly to track liver damage caused by chronic alcohol consumption. The 
Prevention Cohort received CVC daily beginning at the start of ethanol feeding while the 
Treatment Cohort began receiving injections at week 4. Data from PF + Vehicle and 
Alcohol + Vehicle are replotted on each graph to allow comparison with each 
administration group. n=3-4 mice/group for weeks 0-5 and 13-15 mice/group for week 6. 
* p<0.05 between Alcohol + Vehicle and Alcohol + CVC. B) Livers from pair-fed (PF), 
alcohol-fed or alcohol-fed plus CVC treated mice were stained with hematoxylin and 
eosin. C) Oil Red O staining was completed on mouse livers to visualize and quantify 
lipid accumulation. D) Sirius Red staining was completed to visualize and quantify 
fibrosis development. E) Liver triglycerides were measured. F) Liver expression of 
collagen mRNA was measured by qPCR. G) Liver hydroxyproline, a surrogate marker of 
collagen content, was measured using a colorimetric assay. * p<0.05 by one-way 
ANOVA. 
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CVC reduces macrophage infiltration to the liver in ALD 
Macrophages are the primary contributors to alcohol-induced inflammation in the 
liver283. Circulating monocytes respond to CCL2 chemoattraction via the receptor CCR2. 
We found that expression of Ccr2 mRNA by qPCR (Fig 3.3A) and F4/80+ cells, 
measured by immunohistochemistry (Fig 3.3B), were significantly increased in the livers 
after alcohol feeding compared to pair-fed controls. Furthermore, the alcohol-induced 
increase in Ccr2 mRNA and F4/80+ cell number were dramatically normalized to the 
level of pair-fed controls by CVC “prevention” or “treatment” (Fig 3.3A-B). 
To examine the state of resident and infiltrating macrophages in the liver 
following alcohol consumption, we analyzed the CD45+F4/80+CD11b+ population of 
liver mononuclear cells283 (Fig 3.3C). We detected no significant difference in the total 
liver CD45+F4/80+CD11b+ macrophage population (Fig 3.3D) and no changes in 
CD45+F4/80hiCD11blo liver resident Kupffer cells (Fig 3.3E). However, we observed a 
robust increase in the number of CD45+F4/80loCD11bhi infiltrating liver macrophages 
after alcohol feeding that was abrogated both in the “treatment” and “prevention” CVC 
treated mice (Fig 3.3F). Soluble CD14 (sCD14) serum protein level, an indicator of 
monocyte activation, was significantly increased after alcohol treatment and reduced after 
CVC administration in both administration cohorts (Fig. 3.3G). 
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Figure 3.3 CVC decreases the infiltration of peripheral macrophages into the liver.  
A) Liver mRNA expression of Ccr2, a target of CVC, was measured by qPCR. B) Liver 
sections were formalin fixed and stained by immunohistochemistry for macrophage 
surface marker F4/80 to identify hepatic macrophages. C-F) Flow cytometry was used to 
quantify total liver macrophages (D; F4/80+CD11b+), resident Kupffer cells (E; 
F4/80hiCD11blo) as well as infiltrating liver macrophages (F; F4/80loCD11bhi). Cells were 
gated based on size, singlets, dead cell exclusion using an amino-reactive dye and for 
CD45+ positivity (C). * p<0.05 by one-way ANOVA. 
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CVC reduces proinflammatory cytokine production and macrophage activation in 
ALD 
Proinflammatory cytokines produced by macrophages accelerate the progression 
of alcoholic liver disease298.  Administration of CVC significantly reduced liver mRNA 
expression of Tnfa, Il-1b, Il-6, Ccl2 (Fig 3.4A). The liver protein levels of TNFa, IL-1b 
and IL-6 were also significantly lowered by CVC, however, the tissue CCL2 protein 
levels did not change after CVC administration (Fig 3.4B), consistent with previous data 
in animal models suggesting that CCL2 mRNA expression in tissue did not change after 
CVC treatment288.  
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Figure 3.4 CVC inhibits pro-inflammatory cytokine expression induced by alcohol.  
A-B) Liver mRNA expression of pro-inflammatory cytokines Tnfa, Il-1b, Il-6 and Ccl2 
were measured by qPCR (A) and the corresponding liver proteins were measured by 
ELISA (B). * p<0.05 by one-way ANOVA. 
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CVC blocks activation of T cells in alcoholic liver disease 
CCL5 is induced in the liver upon alcohol consumption and CCR5 mediates the 
intracellular signaling cascade of CCL5. We next evaluated the effect of dual CCR2/5 
inhibitor CVC on T cells in the liver. We found a significant increase in Ccr5 mRNA in 
livers of mice with alcoholic liver disease (Fig 3.5A). CVC significantly lowered Ccr5 
expression in livers in both “prevention” and “treatment” cohorts (Fig 3.5A). 
Immunostaining for CD3 on mouse liver sections did not show significant differences 
after alcohol or CVC administration in either cohort (Fig 3.5B). FACS analysis of 
isolated liver leukocytes revealed that while alcohol consumption did not impact the 
proportion of CD3+ T cells in the liver, CVC administration surprisingly led to a 
significant increase in liver T cells (Fig 3.5C). Further flow cytometric analysis revealed 
that CD69+ activated T cells were not significantly altered by alcohol (Fig 3.5D), while 
CD25+ T cells were increased by alcohol consumption (Fig 3.5E)299. CVC in both 
administration methods tended to lead to reduced CD25 expression in T cells compared 
to alcohol alone (Fig 3.5E).  Consistent with the increase in T cell activation (CD25 
expression), Il-2 expression was increased by alcohol but attenuated by both CVC 
regimens (Fig 3.5F). Alcohol did not have an effect on expression of Foxp3, a key 
transcription factor of regulatory T cells300, or Ifng expression (Fig 3.5F). 
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Figure 3.5 CVC reduces the infiltration and activation of T cells into the liver 
following chronic alcohol. A) Liver mRNA expression of Ccr5, another target of CVC, 
was measured by qPCR. B) Liver sections were formalin fixed and stained by 
immunohistochemistry for T cell surface receptor CD3 to identify hepatic T cells. C-E) 
Flow cytometry was used to quantify total liver T cells (C; CD3+), activated CD69+ T 
cells (D) as well as CD25+ T cells (E). Cells were gated for lymphocytes, singlets, dead 
cell exclusion using an amino-reactive dye and for CD45+/CD3+ positivity. F) Liver 
mononuclear cells were isolated via tissue digestion followed by density gradient and 
mRNA expression of T cell-associated genes Il-2, Foxp3 and Ifng were measured by 
qPCR. * p<0.05 by one-way ANOVA.  
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CVC blocks alcohol-induced steatosis in primary hepatocytes 
Excess alcohol consumption leads to hepatic steatosis caused by the direct effects 
of alcohol and alcohol metabolites through modulation of hepatic fatty acid synthesis and 
reduction in fatty acid oxidation301,302 as well as through other mechanisms including 
CCL2 signaling. Consistent with previous reports that showed CCR2/5 expression on 
hepatocytes in hepatitis C virus-infected patients303,304, we confirmed by flow cytometry 
that primary hepatocytes in mice express CCR2/5 and their surface expression was 
upregulated after chronic alcohol exposure (Fig 3.6A). Next, we assessed the effect of 
CVC on fatty acid metabolism gene expression in primary hepatocytes in vitro. We found 
that CCL2-induced steatosis was attenuated by CVC at multiple levels: the fatty acid 
synthesis gene, Fasn, was down-regulated after CVC treatment in presence of CCL2 (Fig 
3.6B), while the FA oxidation genes such as Acox-1, Pgc1a were significantly 
upregulated after CVC treatment in vitro suggesting a direct effect on steatosis (Fig 
3.6B).  
 
CVC blocks alcohol-induced cell death in primary hepatocytes 
While the robust effect of CVC on inflammation and macrophage recruitment can 
be explained by inhibition of CCR2 receptor signaling, the mechanism by which CVC 
normalized alcohol-induced hepatocyte injury is less clear. Thus, we hypothesized that 
CCR2/CCR5 inhibition may have direct protective effects on hepatocytes in ALD. Given 
the dramatic improvement of ALT levels after CVC administration (Fig. 3.2A) we sought 
to test if CCL2 or CCL5 signaling can initiate a hepatocyte response and if CVC can 
 
 
 
 
  114 
protect against hepatocyte cell death.  We found that CCL2 or CCL5 treatment resulted in 
sensitization of primary hepatocytes to LPS and resulted in TNFa release (Fig 3.6C-D). 
CCL2 or CCL5 treatment of primary hepatocyte followed by lipopolysaccharide (LPS) 
treatment also led to an increase in ALT and lactate dehydrogenase (LDH) release (Fig 
3.6C-D).  Importantly, all of these effects of CCL2 or CCL5 were inhibited by CVC in a 
dose-dependent manner (Fig 3.6C-D). Treatment with CVC lowered LDH and Caspase-3 
activity and showed a significant reduction in TNFa production and ALT levels (Fig 
3.6C-D). These results indicate that both CCL2 and CCL5 sensitize hepatocytes to LPS-
induced injury and that CCR2/5 inhibition with CVC can prevent damage in primary 
mouse hepatocytes. 
  
 
 
 
 
  115 
 
Figure 3.6 CVC protects from induction of steatosis, inflammation and cell death in 
primary hepatocytes. A) Expression of receptor proteins CCR2 and CCR5 was 
measured on primary mouse hepatocytes from animals fed alcohol or a calorie-matched 
diet. Both were elevated by chronic alcohol consumption. B) To assess the influence of 
signaling through CCR2, primary hepatocytes were isolated and cultured in vitro with 
either recombinant CCL2 alone, CVC alone or CCL2 with CVC. mRNA expression of 
genes associated with fatty acid metabolism revealed the effects of CCL2 and CVC. C-D) 
Either CCL2 (C) or CCL5 (D), ligands of CCR2 and CCR5 respectively, were used in 
combination with varying doses of LPS and CVC to observe the induction of TNFa as 
well as indicators of cell death including alanine aminotransferase (ALT), lactate 
dehydrogenase release and caspase-3 activity. CVC protected hepatocytes from damage 
in a dose-dependent manner. * p<0.05 by student’s t-test or by one-way ANOVA.  
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Discussion 
Chronic inflammation, steatosis and hepatocyte injury are major components of 
the pathology and clinical manifestations of alcoholic liver disease106. A hallmark of 
ALD inflammation is an increase in the chemokines CCL2 and CCL5 (MCP-1 and 
RANTES, respectively) which are capable of recruiting peripheral macrophages and T 
cells89. The infiltration of circulating mononuclear cells (both macrophages and T cells) 
into the liver has been established as a feature of both animal and human alcoholic liver 
disease and is associated with disease severity283. Our present study demonstrates that 
monocyte recruitment in particular through alcohol-induced CCR2/5 signaling 
contributes significantly to the phenotype of alcoholic liver disease including hepatocyte 
injury, development of steatosis and significant cytokine upregulation (Fig 3.1-4). 
Hepatic protection was prominent using both a “prevention” dosing model, in which 
animals received daily CVC from the start of alcohol administration, as well as the 
“treatment” model where CVC began after ALD was already established (Fig 3.2A). 
Secretion of CCL2 leads to chemoattraction of macrophages by binding to the CCR2 
receptor, while CCL5 chemoattracts T cells through CCR589. Blockade of the CCR2/5 
receptors inhibits the characteristic alcohol-induced infiltration of peripheral 
macrophages as well as leukocyte activation markers (Fig 3.3-5). We found that CVC 
mitigates the metabolic shift in hepatocytes toward lipogenesis induced by CCL2 and 
reduces the damage induced by LPS, a gut-derived signal that causes significant liver 
inflammation and injury in alcoholic liver disease (Fig 3.6). 
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CCL2 is well known to be upregulated in hepatocytes as well as liver 
macrophages in alcoholic liver disease283. Activation of TLR4 by the interaction with one 
of its ligands, such as gut-derived LPS in the setting of chronic alcohol, induces CCL2 
expression which signals locally and chemoattracts peripheral cells305. The infiltration of 
peripheral macrophages leads to significant damage in alcoholic hepatitis by contributing 
to fibrosis and cirrhosis306,307. Circulating monocytes exhibit a proinflammatory 
phenotype in patients with alcoholic liver disease and consistent with this we found 
increased soluble CD14 levels after alcohol exposure that was attenuated by CVC 
administration. Peripheral monocytes also increase production of TNFa and other 
cytokines, as well as increase responsiveness to LPS308-310. Macrophage depletion has 
been shown to be effective at protecting from alcoholic liver disease in animal 
models112,311. Here, we provide evidence for effective pharmacologic inhibition of 
alcohol-induced infiltration of macrophages into the liver in a mouse model of ALD. 
Macrophage expression of CCR2 is not binary and some circulating lymphocytes may 
infiltrate tissue using non-CCR2 receptor mediated methods312. Our data suggests that 
blockade of CCR2/5 with CVC is sufficient to block alcohol-induced macrophage 
infiltration and support a CCR2-dependent mechanism for macrophage migration in 
chronic alcohol use. 
T cells have long been implicated in the pathogenesis of alcoholic liver disease in 
which key chemokines, including CCL5, are upregulated in the liver313,314. Here, we 
describe the upregulation of CCR5 in the livers of mice fed alcohol chronically. T cells 
were detected via both immunohistochemistry and flow cytometry in these livers, 
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however alcohol was not associated with an increase in T cell infiltration in this model. T 
cells of alcohol-fed mice have suppressed expression of CD62L (L-selectin), an 
important chemotactic protein315, which may contribute to a trend toward the decreased 
liver T cells we observed. CD69 and CD25 transmembrane proteins are found on 
activated T cells299,300. Interestingly, patients with alcoholic hepatitis have been found to 
have reduced numbers of circulating CD25+ T cells316. In our study, we found that 
alcohol increased the number of CD25+ T cells within the liver where they may be 
homing to serve a particular function. We did not detect an increase in expression of the 
Treg transcription factor, Foxp3, in the liver mononuclear cell fraction, suggesting that 
the detected increase in CD25+CD3+ cells represented activated T cells. CVC 
administration did not statistically affect CD25 expression but did reduce Il-2 expression 
in both administration models. These data suggest that inhibition of CCR2/5 may be able 
to reduce activated T cells, consistent with reports that CCR5 may be involved in T cell 
activation in other disease states such as viral infection296. 
 Interestingly, we have previously investigated the role of CCL2 and CCR2 in 
hepatocyte fatty acid oxidation93. Using CCL2 and CCR2 KO mice, our group showed 
that induction of genes related to lipid metabolism was absent in CCL2 KO mice and was 
independent of CCR2 based on data from CCR2 null animals. In the present study, using 
a CCR2/5 dual inhibitor, we show both that steatosis as well as fatty acid synthesis gene 
induction can be reduced while fatty acid oxidation can be induced by blockade of the 
receptors. While CCR5 blockade is a new and a potentially beneficial component added 
in the present study, previous results do suggest the critical role played by CCL2 in liver 
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lipid regulation. CCR2 null mice did not exhibit protection from alcohol-induced steatotic 
changes indicating that perhaps reduced (but not absent) CCR2 signaling can serve a 
protective function, similar to the protection seen in CCL2 KO animals93. 
The applicability of these findings in the pre-clinical mouse model to human 
alcoholic liver disease and acute alcoholic hepatitis awaits future investigations. Based on 
observations in human acute alcoholic liver disease, where monocyte and macrophage 
activation are a major element of the disease process, inhibition of macrophage activation 
would be a feasible approach. While the role of T cells is yet to be fully understood in 
alcoholic hepatitis and ALD, dysfunctional T cells and T cell exhaustion have been 
described317. Thus, dual CCR2/5 antagonism may have beneficial applications in the 
treatment of alcoholic liver disease.  
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Abstract 
 Chronic alcohol consumption is associated with neuroinflammation, neuronal 
damage and behavioral alterations including addiction. Alcohol-induced 
neuroinflammation is characterized by increased expression of proinflammatory 
cytokines (including TNFa, IL-1b and CCL2) and microglial activation. We 
hypothesized chronic alcohol consumption results in peripheral immune cell infiltration 
to the CNS. We further hypothesized that blockade of CCR2/5 signaling would inhibit 
alcohol-induced CNS infiltration of peripheral macrophages and would alter the 
neuroinflammatory state in the brain after chronic alcohol. Using CX3CR1eGFP/+ 
CCR2RFP/+ mice we found increased peripheral macrophage infiltration in the CNS, and 
particularly in the hippocampus, when mice were fed a chronic alcohol liquid diet 
compared to isocaloric pair-fed controls. Macrophage recruitment into tissue is mediated 
by CCL2 (MCP-1). Treatment with Cenicriviroc (CVC), a dual CCR2/5 inhibitor 
blocking CCL2 signaling, abrogated the alcohol-induced infiltration of peripheral 
macrophages. Chronic alcohol caused microglia to alter expression of surface activation 
markers and induced morphological changes consistent with an activated phenotype. 
Additionally, proinflammatory gene and protein expression was upregulated in various 
regions of the brain including the cortex, cerebellum and hippocampus and CVC 
treatment partially corrected these phenotypes. Finally, chronic alcohol significantly 
impacted synapses by inducing an increase in both excitatory (VGLUT1/HOMER1) and 
inhibitory (VGAT/Gephyrin) synapses in the hippocampus and these synapses were 
associated with increases in complement components C1q and C3, which are known to 
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signal synapses for pruning by microglia. Together these data indicate the role of 
peripherally-derived macrophages in alcohol-induced neuroinflammation and provide 
novel insights into the dysregulation of synapse maturation caused by chronic alcohol 
consumption. 
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Introduction 
Alcohol use disorder (AUD) impacts millions of people across the world, 
including at least 17 million US patients2. Nearly 100,000 patients die each year because 
of AUD2, which induces organ injury throughout the body, including in the liver and in 
the brain. In both humans and mice, alcohol intoxication leads to central nervous system 
(CNS) inflammation and neurodegeneration12-14. Recent studies using animal models 
have shown that inflammatory signaling not only contributes to neurodegeneration but 
also to alcohol addiction15-17, making targeting of neuroinflammation a critical approach 
in the treatment of AUD. 
Microglia, the resident macrophages of the CNS, become activated in the brain 
after alcohol use141,142. In addition to microglia, peripheral macrophages can be recruited 
into the CNS under pathologic conditions and may serve to amplify ongoing 
neuroinflammation200. Recent evidence suggests that breakdown of the blood brain 
barrier occurs in postmortem tissue of AUD patients and knockout of Toll-like receptor 4 
(TLR4), an important innate immune signaling receptor expressed by microglia and 
peripheral macrophages, protects from the ensuing alcohol-induced 
neuroinflammation174. While microglial activation has been studied in alcohol-induced 
neuroinflammation, the potential infiltration of peripherally recruited macrophages is yet 
to be evaluated. Both infiltrating macrophages (IMs) and microglia become activated in 
response to tissue damage and can release proinflammatory cytokines, which may 
contribute to neuroinflammation and blood-brain barrier breakdown201. 
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In addition to their role in immune responses to tissue damage, recent research has 
highlighted an important function of microglia in shaping synapses in the CNS. Microglia 
respond to neuronal signaling and can engulf inactive or unnecessary synapses during 
normal physiological pruning154,191. Synapses are marked for engulfment by members of 
the complement pathway which is a critical component of inflammation signaling in 
disease. Complement proteins C1q and C3 bind to synapses and are recognized by 
microglial complement receptors such as CR3157,159. Perturbations in the CNS 
microenvironment, such as expression of cytokines that may activate microglia and 
impact homeostatic synaptic signaling, can have significant impact on proper synapse 
regulation and can result in dysfunctional neurodevelopment manifested in dramatic 
behavioral phenotypes191-193. Indeed, binge alcohol models in rodents, which are known 
to activate microglia as well as various inflammatory pathways, have revealed altered 
synaptic development and pruning in the prefrontal cortex194,195. 
Peripheral macrophage chemotaxis through the receptor-ligand CCR2-CCL2 
signaling axis is important in macrophage recruitment to the CNS. Recent studies have 
found an increase in the expression of the CCR2 ligand, CCL2 (also called monocyte 
chemoattractant protein 1; MCP1), in the brain after chronic alcohol 
consumption142,162,170. Cenicriviroc (CVC) is a small molecule inhibitor recently 
developed to block signaling through CCR2, as well as the chemokine receptor CCR5 
that recognizes CCL5 and is involved in recruitment of monocytes and T cells224. CVC is 
currently under investigation in a Phase 3 trial to treat liver fibrosis in non-alcoholic 
steatohepatitis (NCT03028740), a disease that involves significant inflammation178. CVC 
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has been shown previously to inhibit macrophage recruitment and activation in liver 
disease225. 
We hypothesized that because CCL2 is highly expressed in human and mouse 
brains after chronic alcohol use, peripheral IM recruitment is important in alcohol-
induced neuroinflammation and that treatment with CVC to inhibit infiltration of 
peripheral macrophages would be neuroprotective. Here, we present evidence of region-
specific peripheral macrophage recruitment, associated with cytokine expression and 
microglial activation after a model of chronic alcohol in mice. Treatment with CVC 
reduced the number of IMs in the CNS, reduced cytokine expression and corrected 
microglial morphology. Additionally, we report that chronic alcohol alters the number of 
excitatory and inhibitory synapses in the hippocampus. 
These data provide important insights into the role of IMs in alcohol-induced 
neuroinflammation and offer a novel target for therapeutic treatment in this preclinical 
model of alcohol use disorder. 
 
  
 
 
 
 
  126 
Methods 
Mice 
The study protocol was approved by the Institutional Animal Use and Care Committee of 
the University of Massachusetts Medical School. All the methods were carried out in 
accordance with the approved guidelines. CX3CR1eGFP/eGFP mice were provided by Dr. 
Dorothy Schafer (Department of Neurobiology, University of Massachusetts Medical 
School). CCR2RFP/RFP mice were purchased from Jackson Labs. CX3CR1eGFP/wt 
CCR2RFP/wt mice were bred in-house. Wild-type mice were purchased from Jackson Labs 
and allowed to acclimate to our Animal Medicine facility for at least one week prior to 
experimental use. Eight-week-old female mice were used for alcohol feeding 
experiments. Eight-week-old C57BL/6J mice were divided into alcohol- and pair-fed 
(control) groups as well as two CVC alcohol-fed groups. Alcohol-fed mice received 5% 
alcohol in Lieber-DeCarli liquid diet ad libitum as previously described70. Pair-fed 
animals received a calorie-matched liquid diet. 
 
CVC Administration 
Some alcohol-fed mice received daily subcutaneous injections of 15mg/kg BW 
Cenicriviroc (CVC; provided by Tobira Therapeutics, Delaware, USA) for six weeks 
(“prevention” cohort) while others received the same dose daily for three weeks 
(beginning at week four through six of alcohol feeding; “treatment” cohort). 10% 
hydroxypropyl-b-cyclodextrin (Sigma, St. Louis, MO USA), 5% Kolliphor (solutol) 
HS15 (Sigma) and 85% sterile water was used as a vehicle to dissolve CVC into solution. 
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Pair-fed mice and alcohol-fed mice received daily injections of the vehicle without CVC 
for six weeks. 
 
Brain Immune Cell Isolation 
Mice were anesthetized and transcardially perfused with PBS/heparin (Hospira, Lake 
Forest, IL, USA) to clear blood cells from the vasculature. Brains were dissected out and 
meninges removed. The tissue was then homogenized with a Tenbroek homogenizer 
(Corning, Corning, NY, USA) and the cell suspension was then passed through a 70µm 
filter. This single cell suspension was then applied to a 70/50/35% Percoll Plus (GE 
Healthcare, Pittsburgh, PA, USA) density gradient and spun at 2,000 g for 20-30 min. 
Microglia and macrophages collected at the interphase were then washed with PBS 
before proceeding. 
 
Flow Cytometry 
Isolated immune cells were stained with Live/Dead Fixable Blue Dead Cell Stain Kit 
from Life Technologies (Grand Island, NY, USA) to exclude dead cells. Anti-mouse 
CD16/CD32 mAb from BD Biosciences (San Jose, CA, USA) was used to block 
nonspecific Fc receptor binding and incubated for 20min at 4°C. Cells were 
immunostained for 30min at 4°C with surface antibodies (Table 4.1), fixed and 
permeabilized with BD Biosciences Cytofix Cytoperm Plus according to manufacturer’s 
protocol and stained for intracellular CD68 for 30min at 4°C (Table 4.1). Data were 
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acquired on a BD Biosciences LSR II instrument and analyzed using FlowJo v10.1 
software (Ashland, OR, USA). 
 
Tissue Preparation and Confocal Microscopy 
Mice were anesthetized and cardiac perfused with PBS/heparin to clear blood cells from 
the vasculature. Brains were dissected out, meninges removed, fixed in 4% 
paraformaldehyde (Boston Bioproducts, Ashland, MA, USA) for 3-4h at room 
temperature then cryopreserved in 30% sucrose overnight at 4°C. Tissue was then placed 
in OCT Compound (Tissue Tek, Torrance, CA, USA) and frozen at -20°C. 12-14µm 
sagittal sections were cut using a Leica LM3050S cryostat (Buffalo Grove, IL, USA). 
Tissue sections were washed with PBS, blocked in 1% BSA (Fisher BioReagents, Fair 
Lawn, NJ, USA) and 1% normal goat serum (Invitrogen, Carlsbad, CA, USA) with 0.3% 
Triton X-100 (Sigma) at room temperature for 2h, stained overnight with the appropriate 
primary antibodies (Table 4.1) at 4°C, washed, stained with appropriate secondary 
antibodies (Table 4.1) for 1 hour at room temperature and mounted with Prolong Gold 
Antifade Reagent (Invitrogen). Images were acquired using either an LSM 700 scanning 
confocal microscope with Zeiss Imager.Z2 or a Zeiss Observer.Z1 confocal microscope 
equipped with Zen Blue acquisition software (Zeiss, Oberkochen, Germany).  
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Table 4.1 Flow cytometry and immunofluorescence antibodies. 
Antigen Color Clone Company Cat. No.   
CD11b APC M1/70 Biolegend 101212  
CD45 PE/Cy7 30-F11 eBioscience 25-0451-82  
CD68 PerCP/Cy5.5 FA-11 Biolegend 137010  
CD86 FITC     
MHC-II APC/Cy7 M5/114.15.2 Biolegend 107628  
CD206 PE C068C2 Biolegend 141706  
CD163 
(goat host) n/a K-18 Santa Cruz sc-18796  
Goat IgG Qdot 525 n/a Invitrogen Q22072  
      
Primary 
Antigen 
Primary 
Dilution Company Cat. No. 
Secondary 
and Fluor 
Secondary 
Dilution 
VGLUT1 1:250 
Millipore 
Sigma AB5905 anti-Gp-488 1:500 
HOMER1 1:250 
Synaptic 
Systems 160 003 anti-Rb-594 1:500 
VGAT 1:500 
Synaptic 
Systems 131 004 anti-Gp-488 1:500 
Gephyrin 1:500 
Synaptic 
Systems 1467 008 anti-Rb-594 1:500 
C1q 1:50 Hycult HM1044 anti-Rt-647 1:500 
C3 1:500 Abcam ab11862 anti-Rt-647 1:500 
IBA1 1:500 Wako  anti-Rb-488 1:500 
CD68 1:500 AbD Serotec MCA1957 anti-Rt-647 1:500 
Secondary antibodies from Life Technologies. 
 
Analysis of Microglia Morphology 
Microglia soma area and the perimeter length of microglial extensions were measured 
using Fiji v1.0. Soma were measured by drawing a circumferential outline along the edge 
of the cell body to the base of any cellular extensions. Perimeter length was measured by 
summing the lengths of all cellular extensions. 
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RNA Extraction and qPCR 
Brain tissue was dissected from mice perfused with PBS/heparin and the hippocampus, 
cerebellum and cortex tissue were stored in RNA Later. The cortex tissue was defined as 
the superficial tissue (from the surface to approximately 0.5mm deep) dissected 
approximately 2mm anterior, 2mm posterior and 3mm lateral with respect to bregma, a 
region that encompasses much of the motor and somatosensory cortex. RNA was 
extracted using the miRNeasy Kit (Qiagen, Germantown, MD, USA) with on-column 
DNAse digestion (Zymo Research, Irvine, CA). Concentration was determined using a 
Nanodrop 2000 (Thermo Scientific, Waltham, MA, USA) and 1µg RNA was used for 
cDNA reverse transcription (BioRad, Hercules, CA, USA). Quantitative real-time 
polymerase chain reaction (qPCR) was completed using SYBR Green polymerase 
(BioRad) and expression measured on a BioRad CFX96 Real Time System. qPCR 
primers are listed in Table 4.2 and expression was quantified by using the 2-DDCt method. 
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Table 4.2 Real-time PCR primers. 
 Forward Reverse 
Nanostring Hits 
C1qa CAAGGACTGAAGGGCGTGAA GGGGCTGGTCCCTGATATTG 
C1qb GGTGCCAACAGCATCTTCAC TTTGACCCCGTGATTACGCA 
Daxx CTATAGGCCAGGCGTTGACC GTTCGATTTTCCCGAAGGCG 
Gnas ATGGGTTTAACGGAGAGGGC ACCATCGCTGTTGCTCCTTG 
Hmgn1 CTCCTCGGTGACAGATCCGA AACCTTCCTCTTGGGCATCG 
Hspb1 CTGGCAAGCACGAAGAAAGG GCACCGAGAGATGTAGCCAT 
Il-23 TGGTTGTGACCCACAAGGAC CAGACCTTGGCGGATCCTTT 
Map3k9 TGGGCAGAAAGAGCTCACAT 
ACATCATCTGCCTCTTACCCT 
TC 
Mapk1 CAGTTTGTCCCCTTCCATTGAT ACTCCCACAATGCACACGAC 
Mef2a 
AGCACTTTGAAAGGAAGAGT 
CCA AGCTCCCCCACTGCACATTA 
Myd88 AGGCATCACCACCCTTGATG CGAAAAGTTCCGGCGTTTGT 
Plcb1 AGATCCTCGATGAGAAGCCC CTTCCGACAAGACTGAGGAGG 
Tgfb1 GTCACTGGAGTTGTACGGCA AGCCCTGTATTCCGTCTCCT 
Itgb2 TTCCTGGTGCCAGAAGCTGAA CCCCGTTGGTCGAACTCAG 
Ccl11 TGCAGGCAGTTTTCTCTGGA AGGCTCTCCCGACTAGCTTT 
   
Proinflammatory 
Tnfa GAAGTTCCCAAATGGCCTCC GTGAGGGTCTGGGCCATAGA 
Tlr4 TCAGAACTTCAGTGGCTGGA AGAGGTGGTGTAAGCCATGC 
Cox2 AACCGAGTCGTTCTGCCAAT CTAGGGAGGGGACTGCTCAT 
Ym1 CAGAAGCTCTCCAGAAGCAAT TGCCAGACCTGTGACAAGAAT 
Il-1b TCTTTGAAGTTGACGGACCC TGAGTGATACTGCCTGCCTG 
Il-17 CAGGGAGAGCTTCATCTGTGT GCTGAGCTTTGAGGGATGAT 
   
CCR2/5 Network 
Ccl2 CCACAACCACCTCAAGCACT AGGCATCACAGTCCGAGTCA 
Ccl3 ATATGGAGCTGACACCCCGA TCAACGATGAATTGGCGTGG 
Ccr2 
GTGTACATAGCAACAAGCCTC 
AAAG CCCCCACATAGGGATCATGA 
Ccr5 TGGGGTGGAGGAGCAGGGAG TAGGCCACAGCATCGGCCCT 
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Synapses 
Slc17a7 CCGGGCCTTGACCTTAGC CCTCGAGCCGCTGAATTAAT 
Slc17a6 TTGCTTGTGGTAGCAGTGATTTC 
AAATACCCAAAACTGACAGG 
TAAACA 
Homer1 CTTCACAGGAATCAGCAGGAG GTCCCATTGATACTTTCTGGTGT 
Vgat GCTTGGAAACTTGACCTTGAGG ACGCTGTAGATTCCAAGCACTG 
Gephyrin GACAGAGCAGTACGTGGAACTTCA GTCACCATCATAGCCGTCCAA 
   
Housekeeping 
Gapdh GGCAAATTCAACGGCACAGT GATGGGCTTCCCGTTGATGA 
18S GTAACCCGTTGAACCCCATT CCATCCAATCGGTAGTAGCG 
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Nanostring Gene Expression Analysis 
RNA was extracted as above. RNA and Nanostring reactions were prepared according to 
the manufacturer’s recommendation for the Mouse nCounter Inflammation Panel 
(Nanostring Technologies, Seattle, WA, USA). Data were analyzed using nSolver 
Analysis Software 3.0 (Nanostring Technologies). 
 
Statistical Analysis 
Statistical significance was determined using student t-test or ordinary one-way ANOVA 
with Tukey’s multiple comparison post-test to compare the means of multiple groups. 
Data are shown as mean +/- SEM and were considered statistically significant at p<0.05. 
GraphPad Prism 7.0c (GraphPad Software Inc., La Jolla, CA, USA) was used for 
analysis. 
  
 
 
 
 
  134 
Results 
Alcohol induces recruitment of peripheral macrophages into the CNS 
In order to investigate the role of peripheral infiltrating macrophages (IMs) in 
chronic alcohol, we used a common model318 of chronic alcohol consumption in mice 
(Fig 4.1A). We measured mRNA expression of the chemokine receptors Ccr2 and Ccr5 
and the macrophage chemokine Ccl2, a ligand for CCR2, in the CNS. Alcohol induced 
Ccl2, Ccr2 and Ccr5 expression in both the cerebellum and hippocampus, but not in the 
cortex (Fig 4.1B). To test if this upregulation of monocyte chemokines and receptors is 
associated with infiltration of macrophages, we next isolated CNS immune cells from the 
total brain and examined the cells using flow cytometry. Peripheral IMs, defined by flow 
cytometry as CD11b+CD45hi cells, and differentiated from CD11b+CD45lo microglia, 
were about twice as abundant in alcohol-fed compared to pair-fed mice (5.5 ± 2.1% 
versus 3.24 ± 0.7%, p = 0.02) (Fig 4.1C). These data suggested that peripheral immune 
cells indeed infiltrate into the CNS after alcohol feeding and, based on the differential 
expression of chemokine receptor and ligand, that they may be recruited to particular 
brain regions. 
To better understand the regional distribution of peripheral macrophages 
identified using flow cytometry from the total brain, we crossed CX3CR1eGFP/eGFP and 
CCR2RFP/RFP mice to yield CX3CR1eGFP/+ CCR2RFP/+ mice (Fig 4.1D), allowing for the 
differentiation of microglia (CX3CR1eGFP) and IMs (CCR2RFP). CCR2RFP macrophages 
were identifiable in the cortex, cerebellum and the hippocampus (Fig 4.1E). Although 
there was a general trend toward an increase in the number of peripheral CCR2RFP+ IMs 
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after chronic alcohol in all three brain regions, IMs were approximately twice as 
numerous in the hippocampus compared to pair-fed mice (Fig 4.1F). Interestingly, there 
was no change in the number of CX3CR1eGFP/+ microglia in any of the brain regions (Fig 
4.1G). 
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Figure 4.1 Alcohol induces infiltration of peripheral macrophages into the CNS. 
A) Brain immune cells from wild-type mice fed chronic alcohol (EtOH) or a pair-fed 
(PF) control diet were isolated and quantified by flow cytometry gating for live, single 
cells. Microglia (CD11b+CD45lo) were differentiated from peripheral macrophages 
(CD11b+CD45hi) based on surface marker staining. B) Quantification of infiltrating 
macrophages in pair- versus alcohol-fed mice. C-F) CX3CR1eGFP/+ CCR2RFP/+ mice were 
generated by crossing CX3CR1eGFP/eGFP CCR2+/+ and CX3CR1+/+ CCR2RFP/RFP mice to 
allow visualization of resident microglia (GFP+; green) and brain infiltrating 
macrophages (RFP+; red) in the cortex (D), cerebellum (E) and hippocampus (F) of mice 
fed chronic alcohol or a calorie-matched diet. Acquired 10X images were stitched 
together to provide the larger images shown. G-H) Quantification of resident GFP+ 
microglia and RFP+ brain infiltrating macrophages in the cortex, cerebellum and 
hippocampus. I) mRNA expression of Ccr2 and Ccr5 was measured from the 
hippocampus of PF and EtOH mice. Data are mean +/- SEM, n=4-7 mice/group. *p < 
0.05; n.s., not significant by student’s t-test. 
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Inhibition of CCR2/5 signaling with Cenicriviroc (CVC) reduces CNS macrophage 
infiltration 
 In order to investigate the role of IMs that infiltrate into the CNS after chronic 
alcohol, we used a small molecule inhibitor, Cenicriviroc (CVC), that blocks the 
chemokine receptors CCR2 and CCR5, receptors expressed on monocytes and 
macrophages, among other immune cells225,319. Some mice were fed chronic alcohol and 
were treated daily with CVC throughout alcohol exposure, while other mice fed chronic 
alcohol were only treated with CVC for the final three weeks, mimicking a clinical 
treatment paradigm where treatment often begins only after exposure has occurred (Fig 
4.2A). In both cases, CVC blocked alcohol-induced infiltration of CD11b+CD45hi IMs, 
reducing the number to the level of pair-fed mice (Fig 4.2B-C). Pair-fed and alcohol-fed 
mice received daily vehicle control injections. 
 
Treatment with CVC alters expression of activation markers in microglia but not in 
infiltrating macrophages 
Previously, we and others have shown that proinflammatory cytokine expression 
is increased in the brain after chronic alcohol exposure162,170,171. Because of the 
proinflammatory environment in the CNS induced by alcohol consumption, we 
hypothesized that microglia and macrophages may have altered expression of surface 
activation markers. Using flow cytometry of isolated CNS immune cells from the total 
brain, we observed that alcohol modestly altered expression of multiple investigated 
activation markers, including CD86, CD68, MHC-II, CD163 and CD206 (Fig 4.2D-E). 
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CD68 expression was downregulated in microglia following alcohol consumption, while 
the remainder of the activation markers were not significantly altered, although both 
CD86 and CD163 showed a trend toward increased expression in alcohol-fed mice. 
However, CVC treatment increased both CD86 and CD68 in both treatment paradigms 
and reduced expression of MHC-II and CD163 (Fig 4.2D). Although CD11b+CD45hi 
macrophages were increased in number by alcohol treatment and this increase was 
abrogated by CVC administration (Fig 4.2C), some CD11b+CD45hi were detected in all 
groups and we therefore measured expression of activation markers in these cells. 
Expression of these markers was not significantly changed on CNS IMs, although an 
increasing trend was observed for CD86 and a decreasing trend for CD163, both of which 
were trends also observed in microglia. CVC treatment did not significantly alter 
expression of these markers on CD11b+CD45hi macrophages (Fig 4.2E).  
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Figure 4.2 Inhibition of CCR2/5 signaling reduces CNS macrophage infiltration and 
alters expression of activation markers in resident microglia but not infiltrating 
macrophages. A) Mice received a pair-fed diet (PF) or chronic alcohol (EtOH) and some 
alcohol-fed mice received six weeks of daily preventive subcutaneous CVC injection 
(EtOH + 6wk CVC) or three weeks of daily CVC treatment (EtOH + 3wk CVC). PF and 
EtOH mice received daily vehicle control injections B) Representative flow cytometry 
plots of microglia (CD11b+ CD45lo) and peripheral macrophages (CD11b+ CD45hi). C) 
Quantification of infiltrating brain macrophages (CD11b+ CD45hi) in pair-fed, alcohol-
fed and treatment groups. D-E) Peripheral macrophage and resident microglia expression 
of various activation markers were measured by flow cytometry (CD86, CD68, MHC-II, 
CD163 and CD206). Data are mean +/- SEM, n=6-7 mice/group. *p < 0.05 by one-way 
ANOVA.  
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Alcohol induces morphologic changes in microglia that are partially restored by 
CCR2/5 inhibition 
 Activated microglia often assume an amoeboid morphology that is characterized 
by shortened cell processes and an enlarged soma. We used immunofluorescent staining 
of the microglial marker IBA1 to investigate if chronic alcohol induces morphological 
changes in line with an activated cell shape. We focused on hippocampal microglia 
specifically because the significant infiltration of peripheral CCR2RFP macrophages to 
this region (Fig 4.1F) suggested this as a site of active neuroinflammation. We found that 
chronic alcohol tended to increase the cell soma size of microglia (Fig 4.3B). Inhibiting 
CCR2/5 signaling with CVC significantly reduced the soma in chronic alcohol-fed mice 
with three weeks of CVC treatment. Chronic alcohol significantly reduced the process 
length of hippocampal microglia and CVC administration did not affect this morphology 
compared to chronic alcohol-fed mice (Fig 4.3C). These data indicate that chronic 
alcohol induces a more amoeboid morphology than in pair-fed control mice and CCR2/5 
inhibition modestly restores a normal cell body. 
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Figure 4.3 Alcohol-induced morphologic changes in microglia are partially restored 
by CCR2/5 inhibition. A) Representative images of hippocampal microglia (GFP+; 
green) displaying altered morphologies in pair-fed (A) versus alcohol-fed (B) mice. B) 
Quantification of average hippocampal microglia soma area (pixel2) and C) perimeter 
distance (pixel length) in mice fed control or alcohol diet or alcohol-fed mice treated with 
CCR2/5 inhibitor. Data are mean +/- SEM, n=3 mice/group and 3-10 sections/mouse. *p 
< 0.05 by one-way ANOVA.  
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Chronic alcohol induces inflammatory protein and gene expression changes 
 We measured protein levels of proinflammatory cytokines including TNFa, IL-1b 
and IL-6 in the hippocampus, where we had observed a significant increase in CCR2+ 
macrophages following chronic alcohol. We found that both TNFa and IL-1b (including 
both cleaved and uncleaved forms) were induced by chronic alcohol and that three-week 
treatment with CVC reduced these proteins as well as IL-6 in CVC-treated alcohol-fed 
mice (Fig 4.4A).  
To further probe the expression of proinflammatory cytokines and related immune 
genes, we used the Nanostring Inflammation Panel to screen mRNA levels of 254 
inflammation-related genes. In this screen, we found 17 immune-related genes that were 
significantly altered in the cerebellum (Fig 4.4B). We followed this screen with qPCR 
quantification of these gene targets as well as other selected proinflammatory targets and 
chemokine ligands and receptors associated with CCR2/5 signaling (Fig 4.4C). Including 
more samples as well as samples from mice treated with CVC, we found that gene 
expression was significantly altered in the hippocampus, cortex and cerebellum and that 
CVC treatment corrected some of these alterations (Fig 4.4C). Prominent upregulation in 
the CCR2/5 signaling pathway were observed in alcohol-fed mice in the hippocampus 
where we also observed the most infiltration of CCR2+ peripheral macrophages. Table 
4.3 provides the mean and standard deviation for each gene and group in the cortex, 
hippocampus and cerebellum as well as p-value comparisons between pair- and alcohol-
fed mice (PF v EtOH) as well as alcohol-fed and CVC-treated alcohol-fed mice (EtOH v 
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6wk CVC; EtOH v 3wk CVC). Significant differences are denoted with an * and are 
offset in the column (Table 4.3).  
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Figure 4.4 Chronic alcohol induces inflammatory gene expression changes in 
multiple brain regions. A) Proinflammatory cytokines TNF, IL-1 and IL-6 protein was 
measured from the hippocampus of pair- (PF) and alcohol-fed (EtOH) as well as alcohol-
fed mice treated with CVC for three weeks (3wk) by ELISA. B) Inflammatory gene 
expression of pair- and alcohol-fed mice was analyzed using Nanostring nCounter 
Immunology Panel and revealed 17 genes significantly altered in the cerebellum (green, 
expression increased; red, expression decreased). C) Gene expression changes of genes 
found by Nanostring to be altered as well as some common inflammatory markers and 
CCR2/5 axis genes were measured in the hippocampus, cortex and cerebellum by qPCR 
in a larger cohort of pair- and alcohol-fed mice as well as mice treated with 3 or 6 weeks 
CVC (purple, >3-fold increase in expression; cyan >3-fold decrease in expression 
compared to PF; complete gene expression profile data found in Table 4.3). Data are 
mean +/- SEM, A) n=4-6 mice/group; B) n=3 mice/group; C) n=5-6 mice/group. *p < 
0.05 by one-way ANOVA. 
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Table 4.3 Gene expression profile of the cortex, hippocampus and cerebellum. 
 
  
Gene expression was measured by qPCR. Data are mean or standard deviation (Stdev), 
n=5-6 mice/group. *p < 0.05 and significant p-values are offset from non-significant 
values.  
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Table 4.3 (cont.) Gene expression profile of the cortex, hippocampus and 
cerebellum. 
 
 
Gene expression was measured by qPCR. Data are mean or standard deviation (Stdev), 
n=5-6 mice/group. *p < 0.05 and significant p-values are offset from non-significant 
values.
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Table 4.3 (cont.) Gene expression profile of the cortex, hippocampus and 
cerebellum. 
 
 
Gene expression was measured by qPCR. Data are mean or standard deviation (Stdev), 
n=5-6 mice/group. *p < 0.05 and significant p-values are offset from non-significant 
values.  
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Alcohol increases excitatory VGLUT1 and HOMER1 synapses in the hippocampus 
 Having observed significant macrophage infiltration and proinflammatory 
cytokine expression in the hippocampus, we next asked if these immune-related changes 
may also be associated with changes in neural connectivity and synapses. First we looked 
at excitatory synapses by staining for the presynaptic glutamate transporter VGLUT1 and 
the postsynaptic density protein HOMER1 (Fig 4.5A). Chronic alcohol significantly 
upregulated both VGLUT1 (Fig 4.5B) and HOMER1 (Fig 4.5C) in the hippocampus (All 
HPC) as well as in various subregions of the hippocampus including the CA1, CA3 and 
the dentate gyrus (DG). We provide aggregated HPC data to allow for comparison with 
prior studies that did not differentiate hippocampal subregions. Because these proteins are 
expected to be expressed in close proximity when forming an excitatory synapse, we 
measured the colocalization of VGLUT1 and HOMER1 and found that alcohol also 
increased the total area of overlap (Fig 4.5D), indicating an increase in excitatory 
synapses.  
At the transcriptional level, chronic alcohol also induced the expression of 
Slc17a7, the gene encoding VGLUT1 (Fig 4.5F). Interestingly, CVC treatment for three 
weeks further induced Slc17a7 expression. Alcohol did not increase the expression of 
Slc7a6 which encodes VGLUT2, another excitatory presynaptic protein (Fig 4.5F). 
Similar to the histologic staining, chronic alcohol induced expression of Homer1 
compared to pair-fed animals (Fig 4.5G). CVC treatment did not change the expression 
of Homer1 with either treatment approach (Fig 4.5G). 
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Figure 4.5 Alcohol increases excitatory VGLUT1 and HOMER1 synapses in the 
hippocampus. A) Representative images of hippocampal sections stained for VGLUT1 
(green) and HOMER1 (magenta) from pair-fed (PF) and alcohol-fed (EtOH) mice. B) 
Quantification of relative VGLUT1 positive staining area in the hippocampal (HIPP) 
CA1, CA3 and DG regions and throughout the HIPP. C) Quantification of HOMER1 in 
various hippocampal regions. D) VGLUT1 and HOMER1 colocalization in the 
hippocampus. E-G) Relative mRNA expression of Slc17a7 and Slc17a6 (encoding 
VGLUT1 and VGLUT2 proteins) as well as Homer1 in the hippocampus. Data are mean 
+/- SEM, n=3-4 mice/group with 4-5 images per region per mouse in A-D); n=6-7 
mice/group in E-G). *p < 0.05; n.s., not significant by student’s t-test or by one-way 
ANOVA.   
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Inhibitory VGAT and Gephyrin synapses in the hippocampus are increased after 
chronic alcohol 
 Next, we investigated whether chronic alcohol influences inhibitory hippocampal 
synapses by staining for the presynaptic GABA transporter VGAT and the postsynaptic 
structural protein Gephyrin (Fig 4.6A). Chronic alcohol did not significantly alter the 
expression of VGAT in CA1 or CA3 although expression in the DG was significantly 
reduced after alcohol consumption (Fig 4.6B). Interestingly, Gephyrin expression was 
increased in CA1 and CA3 but not the DG (Fig 4.6C). VGAT and Gephyrin 
colocalization was unchanged in CA1, significantly increased in CA3 and trended toward 
decreased in DG (Fig 6D). Vgat mRNA expression was increased from the total 
hippocampus after chronic alcohol feeding, with no effect in mice treated with CVC (Fig 
4.6E). Gephyrin expression was not significantly changed by chronic alcohol, although 
CVC six-week treatment did decrease expression (Fig 4.6F). Taken together, these data 
suggest that unlike the robust changes induced by alcohol in excitatory synapse proteins, 
chronic alcohol has modest impact on inhibitory synapses in the hippocampus. 
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Figure 4.6 Alcohol increases inhibitory VGAT and Gephyrin synapses in the 
hippocampus. A) Representative images of hippocampal sections stained for VGAT 
(green) and Gephyrin (magenta) from pair-fed (PF) and alcohol-fed (EtOH) mice. B) 
Quantification of relative VGAT positive staining area in the hippocampal (HIPP) CA1, 
CA3 and DG regions and throughout the HIPP. C) Quantification of Gephyrin in various 
hippocampal regions. D) VGAT and Gephyrin colocalization in the hippocampus. E-F) 
Relative hippocampal mRNA expression of Vgat and Gepheryin. Data are mean +/- 
SEM, n=3-4 mice/group with 4-5 images per region per mouse in A-D); n=6-7 
mice/group in E-G). *p < 0.05; n.s., not significant by student’s t-test or by one-way 
ANOVA.   
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Complement component C1q colocalizes with VGLUT1 in the hippocampus of mice 
fed chronic alcohol 
 Complement signaling is classically described as an inflammatory cascade, but it 
has also been identified as an important component of synapse development and in 
particular pruning158,159. Because we observed macrophage infiltration, inflammatory 
cytokine and chemokine expression and upregulation of excitatory synapses in the 
hippocampus, we investigated the expression of the complement component C1q along 
with the excitatory synapse marker VGLUT1 (Fig 4.7A). C1q expression was increased 
in the DG (Fig 4.7B). Colocalization of C1q and VGLUT1 was significantly increased in 
the DG (Fig 4.7C). We also measured C1qa and C1qb, which encode two components of 
the C1q protein (Fig 4.7D). C1qa expression in the hippocampus was unchanged by 
chronic alcohol while C1qb was upregulated. Treatment with six-week CVC reduced 
C1qa expression and had no impact on C1qb expression. 
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Figure 4.7 Complement component C1q colocalizes with VGLUT1 in the 
hippocampus of mice fed chronic alcohol. A) Representative images of hippocampal 
sections stained for VGLUT1 (green) and C1q (magenta) from pair-fed (PF) and alcohol-
fed (EtOH) mice. B) Quantification of relative C1q positive staining area in the 
hippocampal (HIPP) CA1, CA3 and DG regions and throughout the HIPP. C) VGLUT1 
and C1q colocalization in the hippocampal CA1, CA3 and DG regions and throughout 
the HIPP. D) Relative hippocampal mRNA expression of C1qa and C1qb. Data are mean 
+/- SEM, n=3-4 mice/group with 4-5 images per region per mouse in A-D); n=6-7 
mice/group in E-G). *p < 0.05; n.s., not significant by student’s t-test or by one-way 
ANOVA.   
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Complement protein C3 is increased in the hippocampus following chronic alcohol 
consumption and colocalizes with VGLUT1 
 Another complement protein, C3, has also been shown to play an important role 
in synapse development and pruning157,159. Again, we stained for C3 and VGLUT1 (Fig 
4.8A) and observed significantly increased expression of C3 in CA1, CA3 and DG of the 
hippocampus (Fig 4.8B). C3 colocalization with VGLUT1 was also significantly 
increased in CA1, CA3 and DG (Fig 4.8C). This pronounced increase in C3 protein, 
coupled with the modest increase in C1q expression, coincides with an increase in many 
other neuroinflammatory genes and proteins, including pro-inflammatory cytokines. 
Interestingly, the colocalization of complement proteins and the synaptic protein 
VGLUT1 also suggests that complement is marking some synapses for pruning and, 
since both excitatory and inhibitory synapses were increased after chronic alcohol, that 
this pruning process may be disrupted. 
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Figure 4.8 Alcohol upregulates complement C3 that colocalizes with VGLUT1 in the 
hippocampus. A) Representative images of hippocampal sections stained for VGLUT1 
(green) and C3 (magenta) from pair-fed (PF) and alcohol-fed (EtOH) mice. B) 
Quantification of relative C3 positive staining area in the hippocampal (HIPP) CA1, CA3 
and DG regions and throughout the HIPP. C) VGLUT1 and C3 colocalization in the 
hippocampal CA1, CA3 and DG regions and throughout the HIPP. Data are mean +/- 
SEM, n=3-4 mice/group with 4-5 images per region per mouse in A-D); n=6-7 
mice/group in E-G). *p < 0.05 by student’s t-test.   
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CD68 expression is downregulated by chronic alcohol 
 CD68 is a lysosomal protein marker that is often used in association with 
measurements of phagocytosis in macrophages and particularly microglia157,320. We 
hypothesized that because both excitatory and inhibitory synapses were increased in 
density in the hippocampus, perhaps microglial levels of CD68 may also be altered. 
Microglial CD68 expression, measured by immunofluorescence was decreased in the 
hippocampus of alcohol-fed compared to pair-fed mice (Fig 4.9A-B). This observation 
was corroborated by flow cytometric analysis of isolated microglia in which we also 
observed a decrease in microglial CD68 positivity in alcohol-fed mice (Fig 4.9C). 
Interestingly, treatment with CVC did not affect microglial CD68 expression (measured 
as colocalization of CD68 and the microglial marker IBA1) except in the CA3 region of 
the hippocampus where CVC decreased CD68 expression (Fig 4.9B). However, flow 
cytometry measurements of CD68+ microglia revealed an effect of CVC treatment as 
both inhibitor treatment paradigms increased CD68 positivity (Fig 4.9C). Importantly, 
the flow cytometry is based on microglia from the total brain, whereas the 
immunofluorescence measurements were isolated only in the hippocampus. Taken 
together, these data suggest that alcohol significantly reduces microglial CD68 
expression and provides evidence of microglial alterations that may impact synapse 
density in the hippocampus after chronic alcohol exposure. 
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Figure 4.9 Alcohol downregulates microglial expression of CD68. A) Representative 
images of hippocampal sections stained for Iba1 (green), CD68 (red) and DAPI (blue) 
from pair-fed (PF), alcohol-fed (EtOH) and CVC-treated alcohol-fed mice. B) 
Quantification of Iba1 and CD68 colocalization, normalized to total Iba1+ area per image 
in the hippocampal CA1, CA3 and DG regions and throughout the HPF. C) Flow 
cytometry data showing the percent of microglia (defined as CD11b+ CD45lo) that are 
positive for CD68 expression. Data are mean +/- SEM, n=3-4 mice/group with 4-5 
images per region per mouse in A-D); n=6-7 mice/group in E-G). *p < 0.05; n.s., not 
significant by one-way ANOVA. 
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Discussion 
Previous research has described neuroinflammation associated with chronic 
alcohol consumption. We hypothesized that alcohol could induce macrophage infiltration 
into the brain and that this infiltration could drive the neuroinflammation observed after 
chronic alcohol. We therefore tested if blockade using a CCR2/5 dual inhibitor of the 
chemokine network associated with macrophage chemoattraction could reduce alcohol-
induced neuroinflammation. Here, we show that chronic alcohol induces region-specific 
infiltration of IMs into the CNS that is associated with cytokine expression and 
microglial activation. Inhibition of CCR2/5 signaling using the small molecule inhibitor 
CVC abrogated the infiltration of macrophages, reduced cytokine expression and 
partially normalized microglial morphology. We also provide evidence of an increase in 
the number of excitatory and inhibitory synapses in the hippocampus following chronic 
alcohol administration.  
Although the CNS was long considered an immune privileged compartment, an 
appreciation for peripheral immune infiltration in the setting of disease has been 
accepted. Only recently has infiltration of peripheral macrophages been described in the 
setting of alcohol-induced neuroinflammation171,174. Using a different alcohol model than 
previously studied in mice, we confirm this observation using flow cytometry of total 
immune cells in the brain, detecting an increase in CD11b+CD45hi macrophages. 
Peripheral macrophages have previously been distinguished from microglia 
(CD11b+CD45lo) and although expression of CD45 can shift during inflammation, gene 
expression studies suggest its expression level remains a distinguishing feature between 
the two cell types321. Additionally, we created CX3CR1eGFP/+ CCR2RFP/+ mice to allow 
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for visualization and localization of infiltrating CCR2+ macrophages. While we observed 
a trend toward increased macrophages in the cortex and cerebellum, the largest alcohol-
induced increase observed was in the hippocampus, a region of significant alcohol-related 
inflammation in both rodents and humans142,184,185. These data suggest that alcohol-
induced macrophage infiltration into the CNS may be region-specific and possibly linked 
to localized neural damage and immune signaling. 
Blockade of CCR2/5 signaling with CVC successfully limited the alcohol-
induced infiltration of peripheral macrophages into the CNS. Previously, CVC was 
shown to be effective at limiting macrophage chemotaxis to the liver in a model of 
fibrosis225. While successful inhibition of peripheral immune cell infiltration is consistent 
with blockade of a chemokine receptor, blocking CCL2 signaling has additional 
advantages. In the CNS of CCL2 knock out mice, production of proinflammatory 
cytokines TNFa and IL-1b was significantly reduced after peripheral injection of 
bacterial endotoxin (lipopolysaccharide; LPS)322. Interestingly, these proinflammatory 
cytokines were expressed even before peripheral cell infiltration occurred, suggesting 
that, at least in this model, neuroinflammatory gene expression preceded the response of 
the peripheral immune system. This has important implications for our present study, 
using the small molecule CVC, which may cross the blood-brain barrier and block CCL2 
signaling in CNS resident cells in addition to its ability to inhibit chemotaxis of 
peripheral immune cells. Reducing inflammatory signaling in the CNS, which in the case 
of LPS precedes immune cell infiltration, may contribute to the reduced expression of 
chemokines. Cell-specific knockout of CCR2 (such as using LysM-driven knockout in 
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peripheral macrophages or CX3CR1-driven knockout in microglia, for example) could 
help to elucidate the importance of peripheral blockade of CCR2 versus central signaling. 
An important caveat to our study is that we did not examine the effect of CVC in pair-fed 
animals. Although we would not expect to see significant influence in these mice, 
without activation of inflammatory signaling or immune cell attraction, this could be 
included in future studies to better understand how CCR2/5 blockade may affect baseline 
peripheral and organ-specific immunity.   
Additionally, recent evidence suggests that, in the developing brain, mice 
deficient in either CCL2 or CCR2 are protected from alcohol-induced neuroinflammation 
(including proinflammatory cytokine expression and microglial activation) and 
neurotoxicity when treated with an acute alcohol exposure at postnatal day four323. These 
results are in agreement with the present data, which importantly is from adult mice with 
chronic alcohol consumption, and provide further evidence for the importance of 
CCL2/CCR2 signaling in alcohol-induced neuroinflammation. Further experiments, 
including using CCL2 and CCR2 knockout adult mice under chronic alcohol conditions 
will also be informative.  
Interestingly, we observed the most pronounced alterations in surface activation 
markers between microglia of alcohol-fed mice and microglia from mice treated with 
CVC. A possible explanation for this is that in the absence of IMs, the remaining 
microglia are forced to assume a more activated phenotype and respond to the damage 
induced by alcohol. Interestingly, while we observed surface protein activation markers 
in microglia, we also observed an activated morphologic phenotype with increased soma 
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size and reduced microglial cell process length. For this analysis, we focused on 
microglia in the hippocampus, the site of significant peripheral macrophage infiltration 
(Fig 4.1F) and an increase in protein and mRNA expression of proinflammatory 
cytokines (Fig 4.4). Microglial morphology is one indicator of an inflammatory milieu, 
as these cells change their shape in response to immune activation, and our flow 
cytometry data suggested that microglia are significantly affected by alcohol and CVC 
administration (Fig 4.2). CVC treatment partially rescued microglial morphology. 
Compared with alcohol-fed untreated mice, the CVC treatment groups had slightly larger 
cell bodies but retained the shortened cell process phenotype of alcohol-fed mice. This 
mixed microglial phenotype, despite the absence of IM infiltration, likely represents the 
innate response of microglia to alcohol which is characterized by activation and 
production of proinflammatory cytokines and reactive oxygen species187,324,325. The 
imaging in Fig 4.3 suggests that microglial morphology was altered by chronic alcohol 
exposure although histologic examination of the complete microglial architecture is 
technically limited as some microglial processes may be disrupted by the histologic 
preparation. Therefore, we examine microglial morphologic changes in the context of 
other measures of a neuroinflammatory milieu including analysis of activation markers 
and proinflammatory gene expression. 
Previous research has sought to characterize gene expression changes caused by 
chronic alcohol in various parts of the brain. Gene expression analyses in human243,326-328 
and rodents329 reveal alterations in genes related to neurons and neurogenesis, axonal 
growth, myelin regulation, intracellular signaling, protein trafficking and other critical 
 
 
 
 
  163 
cell processes. Interestingly, neuroimmune genes were significantly increased the frontal 
cortex of human patients with alcoholism243. Using a targeted screen, we observed 
alterations in inflammation-related transcripts in the CNS after chronic alcohol in mice 
and expanded our focus to investigate the hippocampus, cortex and cerebellum. We 
observed upregulation of multiple proinflammatory genes similar to previous descriptions 
and some of these were altered by the treatment of CVC to block CCR2/5 signaling. As 
noted previously, some cytokine expression is increased prior to the infiltration of 
peripheral immune cells in other neuroinflammation models322, which may provide an 
explanation for why CVC treatment only altered expression of some inflammatory genes 
in the brain regions investigated. 
Our data suggest that infiltrating macrophages specifically target the hippocampus 
as a site of increased infiltration. The hippocampus is a critical center for learning and 
memory and has been implicated in the pathology associated with AUD for decades. 
Hippocampal volume loss is associated with alcohol consumption in a dose dependent 
manner. In a recently published study, researchers followed individuals for over three 
decades and show that increasing amounts of alcohol consumption are associated with 
greater risk of hippocampal atrophy13. Alcohol also influences key processes in memory 
formation and learning by suppressing long-term potentiation (LTP) of synaptic 
connections135-137 and altering proper maturation and maintenance of dendritic spines and 
synaptic connections within the hippocampus138,139. 
In this study, we observed that chronic alcohol induces expression of presynaptic 
excitatory protein VGLUT1, as well as postsynaptic marker for excitatory synapses 
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HOMER1, and that these proteins colocalize, suggesting an increase in excitatory 
synaptic connections in the hippocampus. This observation is partially corroborated by 
Montesinos et al. who recently observed induction of the excitatory postsynaptic protein 
PSD-95 in the prefrontal cortex in a mouse model of adolescent binge drinking195. In 
their study, TLR4 KO mice did not show an alcohol-related induction of PSD-95. PSD-
95, like HOMER1, is part of the postsynaptic density, a cluster of postsynaptic proteins 
important in structural scaffolding and likely other function at the postsynaptic 
terminal330,331. Additionally, Klenowski et al. have observed increased excitatory synaptic 
activity as well as an increase in dendritic spine densities following binge alcohol 
administration in rats194. Although the models (binge versus chronic) and brain regions 
(prefrontal cortex versus hippocampus) examined differ between these two studies and 
the data presented here, the common observation of increased excitatory synaptic proteins 
suggests that alcohol consumption leads to an alteration in synapse density regulation. 
While a firm date of adulthood has not been agreed upon by the scientific 
community, mouse adulthood is generally considered to begin after sexual maturity 
sometime around twelve weeks of age332. In our study, we began alcohol feeding in eight-
week-old female mice (approximately post-natal day 56) and sacrificed 47-50 days later 
(between fourteen- and fifteen-weeks-old). Prior to adulthood, in adolescence, significant 
synaptic pruning occurs in various brain regions that are also implicated in alcohol 
addiction, including the amygdala, parts of the striatum and the prefrontal cortex333-335. 
While pruning continues into adulthood and is an important part of memory formation336, 
disruption of the proper developmental synaptic pruning process by the introduction of 
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alcohol at an age so close to the end of adolescence could account for the increased 
excitatory (VGLUT1/HOMER1) and inhibitory (VGAT/Gephyrin) synapses reported 
here. Indeed, adolescent but not adult alcohol consumption is associated with altered 
neuronal firing337,338 and neuron viability339-341 in the hippocampus, which could impact 
plasticity and synapse maturation. 
Interestingly, we have observed an increase in colocalized pre- and postsynaptic 
proteins while at the same time there is an increase in complement protein colocalized 
with VGLUT1 in the hippocampus of alcohol fed mice. Current understanding of 
complement proteins and synapses largely draws from developmental pruning in which 
microglia engulf synapses that are tagged with complement protein157,158. However, in 
our study in older mice (alcohol exposure for six weeks began in mice aged six- to eight-
weeks old), developmental pruning is unlikely to be continuing. Additionally, we observe 
an increase rather than a decrease in synapses. However, mice in this study were 
sacrificed at one time point and it is possible that synapse numbers may decrease after 
further alcohol exposure or after alcohol withdrawal. Indeed, Montesinos et al. describe 
an increase in excitatory synapses using an adolescent binge drinking model195. However, 
Risher et al. observed that mice treated under a similar adolescent binge drinking 
paradigm, but allowed to live into adulthood in abstinence, had reduced synapse density 
suggesting that there is likely a time course involved in the dysregulation of synapses 
following alcohol exposure138,139. 
Increased complement expression in the hippocampus not only coincided with an 
increase in synapse density but also with an upregulation of many proinflammatory 
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cytokines. Complement proteins make up an important signaling cascade that becomes 
activated in the setting of inflammation, making the observed increase consistent with a 
proinflammatory state in the CNS following alcohol exposure. Interestingly, there is 
evidence that proinflammatory cytokines may have influence on synapse function, much 
like complement involvement in the regulation of synapse development. For example, 
TNFa has been shown to modulate glutamate receptors and decrease synaptic strength342-
344. Interestingly, while the resident source is likely from microglia, peripheral 
macrophages also express TNFa and may be involved in influencing synapses in addition 
to their possible role promoting neuroinflammation344,345. Further study, using either 
CVC-treated animals or genetic knockout (e.g., CCR2) mice in which peripheral 
macrophages are blocked from the CNS, will be critical to understanding the 
contributions of infiltrating macrophages on synaptic dysregulation (including through 
either cytokine release or direct involvement in synaptic engulfment similar to microglia) 
in alcohol-exposed animals. 
Microglia play a critical role in the synaptic pruning process157 and alterations in 
their normal function have been shown to disrupt proper developmental synaptic 
pruning346. In our study, alcohol consumption led to morphologic changes in microglia 
(Fig 4.3) and changes in surface marker expression (Fig 4.2). Thus, the effect of alcohol 
on microglia is significant and may lead to altered synaptic pruning functionality. Indeed, 
the lysosomal protein CD68 was downregulated in hippocampal microglia. Additionally, 
we noted increased cytokine protein expression in the hippocampus (Fig 4.4) and 
cytokines have been implicated in synapse dysregulation in hippocampus neurons in 
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vitro196. Alcohol consumption may be inducing microglial activation and cytokine 
production that adversely affects the responsiveness of microglia to synaptic pruning, 
thus creating an environment where complement-tagged synapses are not properly 
engulfed. 
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Conclusion 
In conclusion, we report here that chronic alcohol induces region-specific 
infiltration of IMs into the CNS and that inhibition of CCR2/5 signaling using the small 
molecule inhibitor CVC abrogated the infiltration of macrophages. Chronic alcohol also 
induced cytokine expression and microglial activation that was partially normalized by 
CCR2/5 inhibition. We also provide novel evidence of an increase in the number of 
excitatory and inhibitory synapses in the hippocampus following chronic alcohol 
administration. These data provide critical insights into the role of CCR2/5 signaling, IMs 
and microglia in alcohol-induced neuroinflammation and offer a novel target for 
therapeutic treatment of alcohol use disorder. 
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Abstract 
Alcohol use disorder is a significant societal and medical burden that is associated 
with both organ pathology and addiction. Excessive alcohol use results in 
neuroinflammation characterized by IL-1b increase in the brain and activation of the 
inflammasome, a multiprotein complex that is involved in IL-1b production. Recent 
studies suggest that inflammation could contribute to alcohol addiction.  Here, we 
targeted components of the NLRP3 inflammasome cascade, which senses and responds to 
immunologic stimuli, to determine if NLRP3 inhibition modulates alcohol consumption. 
C57BL/6J male and female mice were provided a two-bottle choice of alcohol at 
increasing concentrations (3, 6, 9 and 12%, four days each) or water and some were 
treated with daily injections of an NLRP3 inhibitor (MCC950), a caspase-1 inhibitor 
(VX765), IL-1 receptor antagonist (IL1ra; Anakinra), or vehicle injection. In untreated 
animals, female mice consumed more alcohol than males. Treatment with MCC950 and 
Anakinra significantly reduced alcohol consumption and preference in female mice at all 
alcohol concentrations (3, 6, 9 and 12%), while caspase-1 inhibition with VX765 reduced 
consumption in females only at lower alcohol concentrations (3 and 6%). Male mice were 
largely unaffected by inflammasome inhibitor treatment. These findings highlight gender 
differences in alcohol preference and demonstrate that inhibition of different steps in 
inflammasome signaling can reduce alcohol consumption in females. Inhibition of 
NLRP3 inflammasome activation and the inflammasome-IL-1b cascade opens novel 
insights into the development of new therapies to address alcohol use disorder in an era 
of targeted and precision medicine. 
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Introduction 
 Alcohol consumption is prevalent in our society with a quarter of American adults 
consuming four to five drinks in one sitting, qualifying for binge drinking behavior2. In 
the United States, 15 million adults and more than 500,000 adolescents have alcohol use 
disorder, which causes the death of 88,000 individuals per year2. Alcohol use disorder 
(AUD) is the third leading preventable cause of death in the US, behind tobacco and poor 
diet/physical activity2. Current therapies to treat AUD vary in their therapeutic 
mechanism of action and include naltrexone (an opioid antagonist), acomporosate (a 
modulator of neurotransmitter signaling) and disulfuram (an inhibitor of acetaldehyde 
dehydrogenase)19. However, millions of patients continue to suffer with AUD and 
methods to reduce alcohol consumption, whether through changes in behavior or 
pharmacologic therapies, can have a significant impact on relieving a preventable, but 
often untreated, health burden. 
Recent gene expression studies of AUD and the mechanisms involved in disease 
progression have highlighted the role of immune pathways, suggesting a new avenue of 
possible candidates for targeted treatment243. Studies in animal models showed that 
manipulation of various immune pathways could reduce alcohol consumption in mice16. 
The reverse has also been demonstrated where inducing systemic inflammation, via 
peripheral injection of the bacterial wall component, lipopolysaccharide (LPS), increased 
alcohol consumption in mice253. Interestingly, studies in human patients correlate alcohol 
craving severity with increased markers of systemic inflammation, including cytokines29.  
We and others have previous identified interleukin-1b (IL-1b) as an important 
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cytokine that is increased in the brain following a chronic alcohol feeding model in 
mice170,179,180 and treatment with IL-1 receptor antagonist (IL-1ra) ameliorates both 
alcohol-induced neuroinflammation162 as well as hallmarks of alcoholic liver disease112. 
IL-1b production is a result of activation of the intracellular NOD-like receptor family 
pyrin domain containing 3 (NLRP3) inflammasome complex175. The NLRP3 
inflammasome is a multiprotein complex including NLRP3 as the sensor, apoptosis-
associated speck-like protein (ASC) as the adaptor and caspase-1 (Casp1) as the 
enzymatic effector. Upon inflammasome activation, Casp1 becomes active and cleaves 
pro-IL-1b into its active form, IL-1b, which can signal to neighboring cells and 
beyond177,178. Preclinical studies have revealed signaling through the NLRP3 
inflammasome as a key component in alcohol-induced liver pathology in chronic alcohol 
mouse models70,111. We have also shown that mice lacking functional ASC, Casp1 and 
IL-1 receptor are protected from alcoholic liver disease112,113. 
Based on evidence that immune signaling can impact alcohol consumption as well 
as the importance of NLRP3 inflammasome in alcohol-induced pathology, we 
hypothesized that pharmacological targeting of the inflammasome could be an effective 
approach to modulate AUD. Multiple agents exist for targeting of NLRP3 inflammasome 
components347. MCC950 is a small molecule inhibitor that specifically targets and 
inhibits the inflammasome sensor NLRP3348. VX765 inhibits the effector protein of the 
inflammasome, Casp1, blocking its ability to enzymatically activate its cleavage targets, 
including pro-IL-1b and IL-18349,350. Anakinra is a recombinant IL-1 receptor antagonist 
(IL-1ra) capable of binding the IL-1 receptor (IL-1r) without inducing downstream 
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signaling. Thus, IL-1ra acts as a competitive inhibitor of endogenous IL-1r, thereby 
blocking the ability of IL-1b and/or IL-1r to carry out inflammation signaling and 
communication351,352. 
In this study, we aimed to test the novel hypothesis that inflammasome signaling 
is an important driver of alcohol consumption. Using the two-bottle choice paradigm with 
male and female mice, we describe the effects of three inflammasome cascade inhibitors 
(MCC950, VX765 and Anakinra) on alcohol consumption. These data will provide 
critical insight not only into the role of the inflammasome and inflammation in the 
behavior associated with alcohol consumption but may also offer rationale for the use of 
inflammasome inhibitors as adjuvants in clinical alcohol cessation therapy. 
  
 
 
 
 
  174 
Methods 
Mice 
All animals were cared for in strict accordance with the approved Institutional 
Animal Care and Use Committee protocol specific to the procedures described in this 
study at the University of Massachusetts Medical School (Protocol #A-1154-14; G.S.). 
Wild-type C57BL/6J 6- to 8-weeks-old male and female mice were purchased from 
Jackson Laboratories and were cohoused in the University of Massachusetts Medical 
School Animal Medicine Facility for one week prior to the start of the experiment at 
which time they were singly housed. Mice were maintained on a 12h light/dark cycle 
with lights on at 7:00 AM. Inhibitor injections and feeder changes occurred each day 
between 1:00 and 3:00 PM. 
 
Two-bottle choice test 
A two-bottle choice between alcohol or drinking water was used to measure 
alcohol consumption as previously described15. Briefly, we constructed glass graduated 
feeder tubes as described353. Feeders were placed in the cages 2.5cm from the left wall of 
the cage or 1cm from the right pellet food divider with 5cm between the two bottle 
feeders. Chow diet was provided ad libitum throughout the experiment. Singly housed 
mice received one-day acclimation to the new feeders containing water only. Thereafter, 
one feeder contained alcohol and the other normal drinking water. Mice consecutively 
received four days each of 3, 6, 9 and 12% alcohol in drinking water. Alcohol was made 
fresh daily to avoid concentration fluctuations due to evaporation. The side of the alcohol 
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and water feeders was altered each day to control for any side preference bias. Alcohol 
and water volume consumed was measured daily and a control cage without mice was 
included on each mouse rack to account for spillage of liquid throughout the 24-hour 
period. Alcohol consumption was calculated by converting the volume consumed 
(corrected for the spilled volume from the control cage) to g of alcohol and normalizing 
to the kg body weight of each mouse. Preference for alcohol was calculated by dividing 
the volume of alcohol consumed by the total liquid intake for that 24-hour period (water 
plus alcohol volume consumed). 
 
Non-Alcohol Tastants 
After receiving 12% alcohol, alcohol exposure and inhibitor injections were 
ceased and mice were allowed to rest for four weeks. Following this rest phase, all 
inhibitors were restarted and some mice received saccharin (0.033% and 0.066% w/v 
consecutively for four days at each concentration; Sigma, St. Louis, MO) while others 
received quinine (0.03mM and 0.06mM consecutively for four days at each 
concentration; Sigma, St. Louis, MO). The side of the tastant and water feeders was 
changed each day to control for a side preference bias. 
 
Inflammasome Inhibitor Administration 
Inhibitors of various inflammasome-related molecules were resuspended, 
aliquoted and frozen until use. MCC950 (Cayman Chemicals, Ann Arbor, MI) was 
resuspended with DMSO to a stock concentration of 50mg/mL and diluted to a working 
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concentration of 0.25 mg/mL in 0.9% saline. VX765 (ApexBio, Houston, TX) was 
resuspended with DMSO to a stock concentration of 100 mg/mL and diluted in saline to a 
working concentration of 1 mg/mL in 0.9% saline. Anakinra (KineretTM) was purchased 
in solution at a concentration of 100 mg/0.67 mL and diluted to a working concentration 
of 2.5 mg/mL. Inhibitors were given by intraperitoneal injection of the following doses: 
MCC950 5mg/kg body weight; VX765 20mg/kg body weight; Anakinra 25mg/kg body 
weight. 1% DMSO in 0.9% saline was used as a vehicle control injection. Some mice did 
not receive any injection.  
 
Chronic Alcohol Feeding 
All mice were fed Lieber-DeCarli (BioServ, Flemington, NJ) pair-fed diet during 
the first five days to become acclimated to the liquid diet. Some mice then received 
Lieber-DeCarli alcohol diet with maltose dextrin and increasing concentrations of alcohol 
from 1 to 5% over five days. Alcohol-fed mice were then maintained on 5% alcohol for 
four weeks. Pair-fed mice received a calorie-matched pair fed diet for the feeding 
duration. 
 
Liver Enzyme Assays 
Serum was separated from whole blood and frozen -80°C until the assay was 
completed. Serum alanine and aspartate transaminases (Teco Diagnostics, Anaheim, CA) 
were measured using a kinetic method as previously described72.  
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Blood Ethanol Concentration Measurements 
The amount of alcohol in the serum samples was measured using an Analox 
Alcohol Analyzer. 
 
Histology 
Liver sections were formalin fixed, paraffin embedded and stained with 
hematoxylin and eosin at the UMass Medical School DERC histology core. 
 
Statistical Analysis 
Statistical analysis was carried out using GraphPad Prism Version 7.0 using 
Student t-test. p < 0.05 was considered statistically significant.  
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Results 
Female mice consume more ad libitum alcohol than male mice 
In a preliminary study, we tested the alcohol consumption differences between 
female and male C57BL/6J mice. Mice were singly housed and provided two bottles in 
the cage containing either plain drinking water or alcohol at increasing concentrations (3, 
6, 9, 12%) in four-day intervals. Female mice consumed more alcohol than aged-matched 
male mice at each dose of alcohol ranging from 3 to 12% (Figure 5.1A). These results 
indicate significant gender differences in alcohol consumption in C57BL/6J mice. There 
was no statistical difference between females and males in the two-bottle choice (2-BC) 
test in serum alanine transaminases (ALT; 11.8 ± 4.3 vs. 14.7 ± 4.3 IU/mL, p = 0.27), 
aspartate transaminase (AST; 23.9 ± 5.9 vs. 23.1 ± 3.5 IU/mL, p = 0.80) or blood ethanol 
concentration (BEC; 2.35 ± 0.64 vs. 2.95 ± 1.9 mg/dL, p = 0.48). 
 
Two-bottle choice test of alcohol consumption does not induce obvious liver 
pathology  
There are multiple mouse alcohol feeding paradigms in laboratory use, including 
the chronic 5% alcohol feeding using the Lieber-DeCarli liquid diet for different lengths 
from ten days to four or more weeks318. These chronic alcohol-feeding models induce 
elevated liver transaminases, hepatic steatosis and inflammation112,354 and often female 
C57BL/6J mice are used in studies for liver disease. Because we did not observe any 
differences in ALT, AST or BEC between female and male mice, we present data in 
Figure 5.1B-D only for female mice in the two-bottle choice test and chronic feeding 
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model. A comparison between mice fed chronic 5% alcohol in the Lieber-DeCarli liquid 
diet and mice exposed to the two-bottle choice paradigm revealed that mice in the two-
bottle choice test had lower blood alcohol concentration than those in a chronic feeding 
(Figure 5.1B). Chronic 5% alcohol in liquid diet significantly elevated serum ALT and 
AST compared with two-bottle choice exposed mice (Figure 5.1C). H&E staining of 
livers from the two-bottle choice treated mice did not reveal evidence of inflammation or 
lipid accumulation as observed in livers from the chronic feeding paradigm (Figure 
5.1D). Although the lack of profound pathology may not be surprising in the two-bottle 
choice paradigm, it is useful to recognize the differences between this behavioral model 
and the chronic 5% Lieber-DeCarli paradigm. 
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Figure 5.1 Female mice drink more alcohol than males but 2-BC induces less liver 
damage and steatosis than chronic alcohol exposure. A) In a preliminary study, male 
and female mice were singly housed and provided ad libitum water or alcohol (EtOH) in 
drinking water at various concentrations of 3%, 6%, 9% and 12% for four days each 
(two-bottle choice test, 2-BC). Consumption was measured daily. B) Blood ethanol 
concentration was measured from mice treated with the two-bottle choice test (after the 
final day of 12%) or from mice fed a chronic liquid diet of 5% alcohol for four weeks 
(the Lieber-deCarli (LdC) chronic model). C) Serum concentration of liver enzymes 
alanine and aspartate aminotransferase (ALT and AST, respectively) were measured from 
mice from the two-bottle choice test and chronic LdC feeding model. D) Livers from 
mice in the two-bottle choice test or the chronic LdC feeding were stained with 
hematoxylin and eosin to observe lipid droplet accumulation and hepatocyte ballooning. 
n=3-6 mice/group. * p-value < 0.05 determined by student’s t-test; error bars depict 
SEM. 
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NLRP3 inflammasome inhibition with MCC950 reduces alcohol consumption in 
female mice 
Previously, we have shown the importance of the NLRP3 inflammasome and its 
role in alcoholic liver disease pathology70,113 as well as in neuroinflammation162. Here, we 
hypothesize that signaling through the inflammasome may contribute to alcohol 
consumption and addiction. Therefore, we treated mice with daily i.p. injections of the 
NLRP3 inhibitor, MCC950. Control mice were injected daily with an equal volume of 
the vehicle.  We found that female mice treated with MCC950 consistently consumed 
less alcohol per kg body weight (Fig 5.2A) and had significantly lower alcohol 
preference (Fig 5.2C) compared to vehicle-treated controls. However, male mice were 
unaffected by MCC950 treatment in total alcohol consumption and preference (Fig 5.2B, 
D). 
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Figure 5.2 Female but not male mice treated with NLRP3 inflammasome inhibitor 
MCC950 consume less alcohol. Mice were housed singly and received daily 
intraperitoneal injection of either the NLRP3 inflammasome inhibitor MCC950 (5mg/kg 
BW) or a control saline injection. Two-bottle choice of water or alcohol in drinking water 
at increasing concentrations (3%, 6%, 9% and 12%) for four days each was provided ad 
libitum. Consumption was measured and mice were provided fresh water and alcohol 
daily. A-B) Dose of alcohol consumed at each concentration was normalized to mouse 
body weight for male and female mice. C-D) Alcohol preference was determined as a 
ratio of the volume of alcohol consumed to the total liquid volume consumed per day in 
male and female mice. n=6 mice/group. * p-value < 0.05 determined by student’s t-test; 
error bars depict SEM. 
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VX765, a Caspase-1 inhibitor, mildly attenuates alcohol consumption 
To target the catalytic component of the NLRP3 inflammasome, Caspase-1, we 
used the inhibitor VX765. Daily VX765 treatment reduced alcohol consumption and 
alcohol preference in female mice when provided at 3 and 6%, but not at higher 
concentrations (Fig 5.3A, C). Alcohol consumption and preference at all four 
concentrations were unaffected in male mice treated with the Casp1 inhibitor, VX765 
(Fig 5.3B, D). 
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Figure 5.3 Caspase-1 inhibition with VX765 mildly reduces alcohol consumption. 
Mice were housed singly and received daily treatment with either a Caspase-1 inhibitor 
VX765 (20mg/kg BW) or a control saline injection. Two-bottle choice of water or 
alcohol in drinking water at various concentrations (3%, 6%, 9% and 12%) for four days 
each was provided ad libitum. Consumption was measured and mice were provided fresh 
water and alcohol daily. A-B) Dose of alcohol consumed at each concentration was 
normalized to mouse body weight for male and female mice. C-D) Alcohol preference 
was determined as a ratio of the volume of alcohol consumed to the total liquid volume 
consumed per day in male and female mice. NB: Saline/DMSO data replotted from 
Figure 5.2. n=6 mice/group. * p-value < 0.05 determined by student’s t-test; error bars 
depict SEM.  
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Treatment with Anakinra reduces alcohol consumption both in female and male 
mice 
Secretion of the effector molecules IL-1b and IL-18 is the ultimate step of 
inflammasome activation. We have previously highlighted the important role of IL-1b in 
alcohol-induced liver disease111,112 and neuroinflammation162.  Anakinra (recombinant 
IL-1ra) is currently in clinical trials for numerous diseases including severe acute 
alcoholic hepatitis (NCT01809132). We found that female mice treated with Anakinra 
consumed less alcohol and had lower alcohol preference than vehicle treated animals (Fig 
5.4A, C). Male mice also showed a modest trend toward reduced alcohol consumption at 
3, 6, and 12% and statistically lower consumption at 9%, but no change in preference 
(Fig 5.4B, D). These results indicate that inhibition of IL-1 receptor signaling with the 
IL-1ra, Anakinra, can attenuate alcohol consumption in both genders in mice. 
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Figure 5.4 Recombinant IL-1r antagonist Anakinra reduces alcohol consumption in 
both female and male mice. Mice were housed singly and received daily treatment with 
either a recombinant IL-1 receptor antagonist Anakinra (25mg/kg BW) or a control saline 
injection. Two-bottle choice of water or alcohol in drinking water at various 
concentrations (3%, 6%, 9% and 12%) for four days each was provided ad libitum. 
Consumption was measured and mice were provided fresh water and alcohol daily. A-B) 
Dose of alcohol consumed at each concentration was normalized to mouse body weight 
for male and female mice. C-D) Alcohol preference was determined as a ratio of the 
volume of alcohol consumed to the total liquid volume consumed per day in male and 
female mice. NB: Saline/DMSO data replotted from Figure 5.2. n=6 mice/group. * p-
value < 0.05 determined by student’s t-test; error bars depict SEM.  
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Consumption of sweet and bitter tastants is not reduced by inflammasome cascade 
inhibitor treatments 
In order to test if inhibitor treatment had an effect on consumption or preference 
based on taste or other factors, we provided two alternate non-alcoholic tastants in a 
follow up experiment. Female and male mice were rested after the conclusion of the last 
12% alcohol exposure for 30 days and were provided normal water only without any 
injections. Some mice were then provided a two-bottle choice of either water or a sweet 
tastant, saccharin (0.033% and 0.066%), in drinking water for four days at each 
concentration. The remaining mice were provided a bitter tastant, quinine (0.03 and 
0.06mM) for the same duration. Mice that had previously received daily inhibitor or 
vehicle injections again received the same injections throughout the tastant test. 
Although inhibitor treatments reduced alcohol consumption and preference, particularly 
in female mice, treatments did not reduce consumption of saccharin (Fig 5.5A-B) or 
quinine (Fig 5.5C-D) in either female or male mice compared with vehicle treatment. 
These results suggest that alcohol consumption is unlikely to be influenced by taste. 
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Figure 5.5 Consumption of non-alcoholic tastants (saccharin and quinine) does not 
indicate alterations in taste lead to reduced alcohol consumption in mice treated 
with inhibitors. A-B) Female and male mice were provided two-bottle choice between 
drinking water and saccharin in drinking water at two doses (0.033 and 0.066%) for four 
days each. C-D) A different cohort of female and male mice were provided two-bottle 
choice between drinking water and quinine in drinking water at two doses (0.03 and 
0.06mM) for four days each. In all cases (A-D), some mice received daily treatment with 
Anakinra (25mg/kg BW), MCC950 (5mg/kg BW), VX765 (20mg/kg BW) or a control 
injection. n=3 mice/group. * p-value < 0.05 determined by student’s t-test; error bars 
depict SEM. 
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Vehicle injection modestly effects alcohol consumption 
To investigate whether the stress of daily handling and injection impacted alcohol 
consumption, we compared mice injected daily with the vehicle to mice that were not 
injected and not regularly handled. Daily injection of vehicle modestly increased alcohol 
consumption in female mice at the lower concentrations of 3 and 6%, but not at higher 
concentrations (Fig 5.6A). Male mice drank slightly less alcohol at 3 and 6%, but not at 
higher concentrations (Fig 5.6B). This important observation suggests that, particularly in 
female mice who were most impacted by inflammasome inhibition, daily handling and 
injecting did not in and of itself reduce alcohol consumption. 
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Figure 5.6 Daily injection has modest effect on male and female mice alcohol 
consumption. Two-bottle choice of water or alcohol in drinking water at various 
concentrations (3%, 6%, 9% and 12%) for four days each was provided ad libitum. 
Consumption was measured and mice were provided fresh water and alcohol daily. Some 
mice were handled daily and received injection of vehicle while other mice were 
untreated. A-B) Dose of alcohol consumed at each concentration was normalized to 
mouse body weight for female and male mice. n=6 mice/group. * p-value < 0.05 
determined by student’s t-test; error bars depict SEM. NB: Vehicle data replotted from 
Figure 5.2. 
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Discussion 
The molecular regulatory pathways that promote alcohol consumption and 
preference are only partially understood.  While most studies focused on 
neuromodulators and neuronal functions, recent evidence suggests a potential role for 
inflammatory mediators in alcohol addiction16,253.  Based on previous work revealing the 
importance of the NLRP3 inflammasome in alcohol-related pathology as well as early 
evidence that inhibiting immune signaling can affect alcohol consumption, in this study 
we hypothesized that inhibiting the inflammasome would reduce alcohol consumption in 
mice. Using the two-bottle choice paradigm, we show that female mice consume 
significantly greater amounts of alcohol compared to male mice. This indicates a 
significant gender difference in alcohol preference. Unlike the chronic 5% alcohol in 
Lieber-DeCarli liquid diet model, our results reveal that although a two-bottle choice test 
is useful to study alcohol consumption and mouse behavior, it does not replicate the liver 
pathology associated with chronic alcohol consumption. We found that female, but not 
male, mice reduce their alcohol consumption and preference when treated with the 
NLRP3 inflammasome inhibitor MCC950, the caspase-1 inhibitor VX765, or with IL-1ra 
Anakinra. These findings emphasize the utility of the two-bottle test for behavioral 
assessments and provide novel insights into the role of the inflammasome pathway in 
alcohol use disorder and addiction. 
Multiple alcohol consumption models exist for rodent experiments and each 
provides utility depending on the questions being tested. For example, the chronic 5% 
alcohol in Lieber-DeCarli liquid diet model induces liver pathology including steatosis, 
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hepatocyte damage and mild inflammation297,318,355 as well as extrahepatic pathology 
including neuroinflammation170. Our previous research showed that mice deficient in 
either ASC, Casp1 or IL-1r were protected from liver pathology in the chronic alcohol 
feeding model112. We found that administration of Anakinra in the chronic alcohol 
feeding model effectively attenuated alcohol-induced liver disease112 and 
neuroinflammation in mice162. Here, we chose to use pharmacologic inhibitors with 
therapeutic potential to show that targeting this same pathway significantly reduces 
alcohol consumption in female mice. Future behavioral assays using mice deficient in 
inflammasome components, and particularly cell-specific deletion of inflammasome 
component signaling within the CNS and periphery, may yield supporting evidence for 
targeting this pathway in human patients with AUD and provide insight into the critical 
cellular sources of inflammasome signaling that contribute to alcohol drinking behavior. 
Interestingly, our previous studies focused on female mice in order to study liver 
disease because females have been shown to have greater sensitivity to alcohol and 
develop more severe alcohol-induced liver pathology than males356-358. Given the 
differential effect of the inflammasome inhibitors in female and male animals on alcohol 
consumption and preference, it will be interesting to examine the effect of genetic 
knockout of the inflammasome in chronic feeding models on liver damage and 
inflammation in male mice as well. While the gut-liver axis is well established in 
alcoholic liver disease and alcohol-related liver inflammation as a result of alcohol-
induced gut leakiness22, communication between the intestine, liver and brain, which may 
influence alcohol consumption, continues to be an active area of research105,249. Alcohol 
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consumption in the chronic Lieber-DeCarli 5% alcohol feeding model is often unaffected 
by genotype or treatment, likely due to the fact that this model delivers alcohol along 
with a liquid food diet so all calorie intake includes alcohol consumption. For this reason, 
the two-bottle choice provides an important model to measure behavioral changes that 
cannot be adequately assessed in other models of AUD. 
Targeting inflammatory pathways has previously been shown to modulate alcohol 
consumption. Blednov et al. showed that alcohol consumption and preference were 
reduced in mice lacking functional inflammation-related genes such as CD14 and IL-616. 
Harris et al.359 recently showed that TLR4 manipulation in mice and rats had only modest 
effects on alcohol consumption, however, female TLR4 knockout rats had reduced 
alcohol preference compared to wild-type animals. These observations are consistent 
with our finding that inhibition of the inflammatory cytokine circuit attenuates alcohol 
consumption. Interestingly, IL-1ra knockout mice exhibit reduced alcohol preference in 
female and male mice, with female mice showing a stronger alcohol-aversive behavior16. 
It is interesting that both IL-1ra knockout mice16 and mice treated with Anakinra in this 
present study (recombinant IL-1ra) would exhibit similar alcohol-aversive behavior. It is 
possible that the total body knockout of IL-1ra throughout development compared with 
the temporally-limited i.p. dosing of Anakinra could induce different behavioral 
outcomes. It may also be the case that systemic administration of concentrated Anakinra, 
which has been shown to cross the blood-brain barrier, has an effect different from that of 
knocking out physiologically normal IL-1ra expression360.  Indeed, Anakinra has 
previously been shown to be effective at reducing alcohol-induced sedation and 
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improving recovery from alcohol-induced motor impairment in mice361. Further study 
comparing IL-1ra knockout mice and pharmacologic treatment with recombinant IL-1ra 
will be necessary to further dissect these findings. 
The link between immune signaling and a behavioral response to alcohol 
exposure was highlighted in a study by Blednov et al.253 LPS, a potent TLR4 ligand 
naturally found on the surface of gram-negative bacteria, was injected in mice who were 
then provided access to alcohol. LPS injection produced a prolonged alcohol preference 
and mice deficient in CD14, an important component of the TLR4 receptor complex that 
recognizes LPS, were protected from this preference induction. In the same study, 
investigators examined firing rates of dopaminergic neurons in the ventral tegmental 
region of the brain, a key area in the reward pathway. LPS injection reduced firing rates 
in these neurons which could lead to an increased threshold for a rewarding dopamine 
response. These experiments tie together TLR4 immune signaling, neurochemical reward 
pathways and alcohol consumption253.  
Our present study adds insight into a parallel pathway, the NLRP3 
inflammasome, that also influences alcohol preference. Inhibition of NLRP3 
inflammasome activation prevents production of IL-1b that is a central amplifier of pro-
inflammatory responses and cytokine production362. Unlike other pro-inflammatory 
cytokines, TNFa, IL-6 or CCL2, that are induced by a single danger signal through NF-
kB activation, IL-1b production requires a secondary danger signal and inflammasome 
activation178. This unique regulatory feature of IL-1 highlights the importance of 
inflammasome activation in alcohol consumption and preference. Indeed, a recent study 
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showed that blockade of IL-1b signaling in the ventral tegmental area (VTA), a critical 
area in the mesolimbic reward circuitry, reduced dopamine release in response to cocaine 
exposure363, which may contribute to addiction and seeking more reward from a given 
drug. While the exact signaling mechanism involved has not been fully described, these 
data highlight an important role for IL-1b and immune signaling in addiction. 
 The different effects of inflammasome inhibition in females versus male mice 
were notable in our present study. However, sex difference related to alcohol-induced 
pathology are not unexpected, as ample evidence exist suggesting that males and females 
respond differently to alcohol exposure. Indeed, women have a stronger immune 
response and more prominent organ damage than males after alcohol 
consumption356,358,364. Neurotoxicity and immune activation is greater in female mice as 
well365. Given these sex differences, perhaps it is not surprising to observe differential 
behavior in male and female animals when treated with immune inhibitors. Knowledge of 
these differences may be critical to development of future therapeutics for alcohol use 
disorder and may be important in developing more personalized medicine approaches to 
treating addiction and disease. 
Our observations further highlight the potential significance of inflammation 
pathways in alcohol addiction and provide evidence for new therapeutic interventions to 
attenuate alcohol preference. It remains to be evaluated whether these gender differences 
and/or inflammasome pathways play a role in alcohol preference in humans. The need for 
more effective therapies to both curb alcohol consumption and treat alcoholic liver 
disease remains high. Medications that can both reduce consumption and alleviate some 
 
 
 
 
  196 
of the organ pathology associated with chronic intake would be a significant 
advancement for the field of alcohol treatment. Targeting the inflammasome may serve 
this purpose and further research will be needed to show the efficacy of blocking organ 
disease and reducing consumption.  
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Conclusion 
Here, we show that blocking the NLRP3 inflammasome at multiple points reduces 
alcohol consumption and preference in female but not in male mice. We also show that 
while the two-bottle choice test may be useful as a behavioral assay, it does not induce 
pathology typically associated with alcohol use disorder. Our novel findings add new 
insights into the role of the inflammasome and offer promising new targets for treating 
alcohol use disorder. 
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CHAPTER VI  
 
Discussion 
 
 
Introduction 
 The simplicity with which alcohol can be consumed and enjoyed, whether in 
social settings, communal meals or any of the varied occasions in which alcohol-
containing beverages are consumed, is hardly comparable to the complicated inter-organ 
process that occurs after alcohol flows into our bodies. The normal physiology involved 
with casual alcohol consumption involves an axis of organs including the intestine and 
microorganisms of the gut microbiome, the liver, the immune system and the central 
nervous system (CNS). Overconsumption of alcohol, such as occurs in alcohol use 
disorder (AUD), is associated with even more complicated inter-organ communication 
and pathophysiology that leads to organ dysfunction, adaptation and damage. Research 
suggests that some of the organ dysfunction and adaptation, particularly in the CNS, can 
reinforce aspects of alcohol consumption and lead to addiction, thus initiating a vicious 
cycle of alcohol consumption, continued dysfunction and adaptation, followed by more 
consumption. Efforts to better understand the physiology and pathophysiology of alcohol 
consumption and identify areas for therapeutic intervention are critical to helping the 
millions world-wide who suffer from AUD and its associated medical sequelae. 
The previous chapters provide novel evidence that alcohol consumption induces 
organ-specific immune activation and pathology between the intestine, liver, peripheral 
immune system and the central nervous system. After consumption, alcohol encounters 
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the microorganisms of the intestine and causes changes in the flora of the gut that is 
associated with proinflammatory signaling in the intestine itself. Bacterial content of the 
intestine significantly contributes to features of alcoholic hepatitis, including steatosis 
and inflammation, in the liver and neuroinflammation in the brain and reduction in the 
intestinal bacterial load with antibiotics protected the liver and CNS from these changes. 
Immune signaling and the peripheral immune system are critical players in alcohol-
induced organ pathology and, through blockade of CCR2/5 signaling, we have shown 
that peripheral macrophage infiltration into the liver and the CNS significantly contribute 
to this process. We demonstrate that chronic alcohol consumption leads to a 
dysregulation in excitatory and inhibitory synapses that is associated with upregulation of 
complement proteins and activated microglia in the CNS. Finally, we have established 
that immune signaling, through the NLRP3 inflammasome, has significant influence over 
behavior associated with alcohol seeking and that inhibiting inflammasome activation can 
reduce alcohol consumption in female mice. Taken together, these studies provide novel 
therapeutic approaches, including blockade of CCR2/5 chemotaxis and inhibition of the 
inflammasome, to protect from the complicated interactions between the gut, liver, 
peripheral immune system and the brain stimulated by alcohol consumption. 
 
The intestinal microbiome is critical in the development of alcohol-induced liver and 
CNS inflammation 
We analyzed the intestinal microbiome from the cecum of mice treated with a 
relatively short alcohol treatment (ten days) with one acute binge. This is a model that has 
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been useful because of its replication in mice of human alcoholic hepatitis, particularly 
steatosis, liver enzyme elevation and neutrophil-associated hepatic inflammation110,259. 
The intestinal microbiome has not previously been studied in this model and expanding 
our knowledge of alcohol-associated changes in the microorganism profile, with the 
advent of techniques for bacterial taxonomic analysis and the increasing recognition of 
the microbiome in disease, is important.  
We chose to suppress the intestinal microbiome in order to study the 
microbiome’s function. Others have instead sought to alter the microbiome profile, using 
prebiotics, probiotics or direct administration of particular bacteria, to study alcohol-
microbiome-liver interactions. One such study is particularly relevant to the data 
presented in Chapter II. Grander et al.281 observed that alcohol reduced Akkermansia in 
human patients with alcoholic hepatitis, similar to the findings presented here and 
observed by others45. Replenishing Akkermansia both prevented and ameliorated alcohol-
induced liver injury, steatosis and immune cell infiltration281. Future studies are likely to 
explore potential benefits of replenishing bacterial communities, such as Akkermansia272 
that are reduced in the alcohol-exposed microbiome, or the potential harmful effects of 
other bacteria (such as those that are increased in the alcohol-exposed intestinal 
microbiome) either in the presence of or independent from alcohol consumption in order 
to expand our understanding of microbiome function in ALD. While specific metabolites 
of particular bacteria (such as Akkermansia) have not been well-characterized or studied 
in vivo, evidence is already emerging that some general bacterial metabolites, including 
short-chain fatty acids, can be neuroactive and influence microglial development, 
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function and morphology278. The development of targeted anti- or pro-biotics that could 
promote or suppress bacterial communities specifically may be of significant benefit in 
the future, although the use of broad-spectrum antibiotics, like those used in Chapter II, 
would not be an appropriate approach to treating or protecting from ALD or alcohol-
induced neuroinflammation due to the significant risk of antibiotic resistance as well as 
the dangers associated with a depleted intestinal microbiome (i.e. filling that niche with 
clostridium difficile or other dangerous pathogenic microbes). Broadening the scope of 
future studies using probiotics or promoting a particular microorganism community, and 
including investigations into the CNS-related effects, will be critical.  
Treatment with antibiotics in this study significantly reduced culturable stool 
bacteria, 16S bacterial DNA and serum lipopolysaccharide (LPS), all indicating that the 
intestinal microbiome was significantly suppressed. Previous studies have also used 
antibiotics to examine the role of the gut microbiome in ALD and have observed 
protection from features of ALD similar to our results50,73. However, these studies used 
an antibiotic cocktails of nonabsorbable antibiotics whereas we used absorbable 
antibiotics, including ampicillin, metronidazole and vancomycin, along with neomycin 
which is non-absorbable50. It is possible that there were off-target effects of absorbable 
antibiotics. One such possible side effect could be the interaction of metronidazole with 
the liver and alcohol metabolism, as drinking alcohol is contraindicated in human patients 
taking metronidazole366. In our study, both alcohol-fed mice treated with metronidazole 
and those without antibiotic treatment had similarly elevated liver enzymes as those with 
antibiotic-treatment, suggesting the absence of any potential liver-related toxicity. 
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Additionally, we observed a general improvement in liver histology (steatosis, immune 
cell infiltration) and proinflammatory cytokine expression indicative of protection by 
antibiotic treatment and intestinal bacterial load suppression.  
Two alternative approaches to examine the effect of the gut microbiome on 
neuroinflammation would include the use of non-absorbable oral antibiotics or germ-free 
mice. Non-absorbable antibiotics would restrict the bacterial killing effect to the intestinal 
lumen and could eliminate off-target effects of the medications or extra-enteric 
antimicrobial activity. Some antibiotics, such as the tetracycline-derivative minocycline, 
has been used as an anti-inflammatory agent can suppress microglial reactivity to various 
stimuli145,239. While the antibiotics used in this study are not tetracycline derivatives, the 
possibility of absorption and systemic effects in the body has not been ruled out. Using 
non-absorbable antibiotics would limit such an “off-target” effect (i.e. not restricted to the 
reducing the intestinal microbiome). Additionally, the use of germ-free mice would 
remove the need for pharmacologic treatment altogether. However, this latter approach 
has its own limitations. Treatment of germ-free mice with alcohol has been shown to 
induce rather than reduce significant liver damage including liver enzyme elevation, 
histologic changes and significantly elevated levels of inflammatory markers55. The 
discrepancy between studies that use antibiotics50,73, including ours in Chapter II, and 
those using germ-free mice55 is likely accounted for by the role played by the microbiome 
in immune development throughout life59-61.  
Germ-free mice could, however, provide a number of interesting avenues to study 
the role of the microbiome in alcohol-induced steatohepatitis and neuroinflammation. 
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Microbiome transfers into germ-free animals followed by alcohol exposure could help 
differentiate the role of developmental exposure to commensal bacteria and the 
microbiome present at the time of alcohol exposure. Indeed, germ-free animals that 
receive gut microbiome transfer from human patients with ALD exhibit signs of 
steatohepatitis, even without exposure to alcohol69. To date, no study has explored the 
effects of alcohol on neuroinflammation in germ-free animals or in germ-free animals 
that receive intestinal microbiome transfer from alcohol-exposed individuals and further 
exploration using these or other approaches will critically expand our understanding of 
the gut microbiome’s influence on alcohol-induced CNS changes. 
 Chapter II provides evidence of protection from intestinal, hepatic and CNS 
inflammation in mice with suppressed gut microbiome after alcohol consumption. 
Although this approach provides insight into the overall role of the microbiome itself on 
multiple organs, it is limited by a lack of organ-specific blockade of microbiome 
signaling. Additionally, we and others29,80,88 have shown that systemic inflammation is 
induced by alcohol consumption. The presence of systemic inflammatory signals, 
initiated by leakage of bacterial products from the gut24,26,31,32, could be responsible for 
the communication between, for example, the liver and brain leading to 
neuroinflammation and CNS changes. Alternative approaches will be needed to address 
whether any one organ (intestine, liver, brain or others) is more important in initiating 
alcohol-induced inflammation or if each organ is affected in unique ways. One way to 
address this question would be to specifically target certain immune receptors, such as 
Toll-like receptors (TLRs), that are responsible for sensing various bacterial components. 
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For example, TLR2 recognizes gram-positive bacterial surface molecules and TLR4 is 
the main surface receptor on immune cells for recognition of gram-negative LPS167,367. 
Whether through Cre/Lox genetic targeting368, AAV delivered silencing369 or other 
mechanisms, knocking out or silencing TLRs in cell-specific immune compartments 
throughout the body (including in intestinal immune cells, circulating immune cells, liver 
Kupffer cells, CNS microglia and BBB juxta-vascular cells, etc.) would provide insight 
into the contribution of each organ and each cell-type to alcohol-induced dysfunction and 
inflammation. Previous research showing protection from ALD and neuroinflammation 
using TLR2 and TLR4 knockout mice has been mostly limited to whole-body 
knockouts170-172,280. Exploring cell-specific immune responses will be particularly 
satisfying to answer important questions surrounding CNS alterations by alcohol and 
could provide novel approaches for AUD and addiction therapy.  
 
Chronic alcohol induces liver damage and inflammation that is dependent on 
CCR2/5 signaling 
 Expression of the CCR2/5 signaling axis is upregulated in patients with ALD 
along with elevated macrophage and T cell markers in the liver. We therefore tested the 
hypothesis that signaling through CCR2/5, leading to leukocyte infiltration, is important 
in the development of chronic alcohol-induced liver damage, steatosis and inflammation. 
Use of the small molecule inhibitor Cenicriviroc (CVC) was hepatoprotective and 
reduced ALT increase, liver steatosis and fibrosis, infiltration of peripheral macrophages 
and proinflammatory expression, all of which had been induced in untreated alcohol-fed 
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mice. These findings are particularly promising as CVC is currently undergoing clinical 
trials and has the potential to be a beneficial therapeutic for patients with ALD. 
 Although inflammation is a protective physiologic response to acute insults, 
chronic inflammation has been implicated in multiple disease states and is associated 
with unhealthy dysfunction. In human patients with ALD, circulating monocytes are 
primed to respond with enhanced proinflammatory cytokine release upon immune 
challenge308-310. Mouse models of chronic ALD induce infiltration of peripherally derived 
monocytes into the liver94,305, as we have shown here. These infiltrated cells have 
subpopulations of infiltrating macrophages (IMs) that can be characterized as either 
tissue-protective and anti-inflammatory (high expression of phagocytosis-related genes, 
growth factors or tissue repair genes) or proinflammatory (elevated cytokines, 
chemokines and receptors). Interestingly, Wang et al. found significantly increased CCR2 
expression in proinflammatory Ly6Chi IMs compared to the tissue-protective Ly6Clo 
IMs305. Although we did not interrogate Ly6C expression in our model, it is possible that 
CVC (a CCR2 inhibitor) blocked the infiltration specifically of CCR2hi expressing 
Ly6Chi proinflammatory macrophages. Specifically targeting proinflammatory 
macrophage infiltration may prove to have additional benefits beyond CCR2/5 inhibition, 
which successfully protected the liver from alcohol-induced pathology. 
 Previous studies have attempted to elucidate the importance of macrophages in 
the liver, including both Kupffer cells as well as peripherally-derived macrophages. 
Using gadolinium chloride to deplete macrophages, Koop et al. showed significant 
protection from alcohol-induced steatosis, necrosis and inflammation311,370. Our lab 
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previously depleted macrophages using clodronate and replenished the bone-marrow 
niche with cells deficient in caspase-1112. Subsequent alcohol administration resulted in 
reduced liver damage compared to caspase-1 proficient animals, highlighting the 
importance of proinflammatory macrophage signaling in ALD. However, other forms of 
liver disease, including acetaminophen toxicity and fibrosis, are significantly worsened 
by elimination of macrophages, including Kupffer cells371-373. Targeted depletion of 
resident Kupffer cells followed by alcohol administration would provide an interesting 
additional test of the role of resident versus peripheral macrophage in ALD. 
 In addition to targeting macrophage chemotaxis, genetic interruption of 
CCL2/CCR2 signaling has also proven beneficial in mouse models of ALD. In particular, 
livers exhibited less steatosis in CCL2 KO mice compared with CCR2 deficient 
animals93. CVC reduced liver steatosis as well, providing further evidence of a link 
between CCL2 signaling and lipid accumulation in ALD. Experiments with isolated 
murine hepatocytes in vitro showed that CCL2 signaling can induce genes related to 
lipogenesis. These studies suggest that non-immune mechanism may, at least in part, be 
responsible for the reduction in liver steatosis. 
 
Alcohol-induced neuroinflammation is associated with peripheral monocyte 
infiltration through CCR2/5 signaling 
 Here, we studied the role CCR2/5 signaling using a small molecule inhibitor and 
show that treatment reduced alcohol-induced macrophage infiltration to the brain, 
expression of some proinflammatory genes and proteins and altered the microglial 
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morphology changes and protein expression profile. These data provide novel insight into 
the mechanism by which IMs are attracted to the CNS as well as their impact on resident 
microglia after chronic alcohol consumption.  
This pharmacologic approach does not differentiate cell-specific CCR2/5 
blockade because Kupffer cells, hepatocytes, microglia, neurons and other cell types, in 
addition to circulating immune cells, also express CCR2 and CCR5. An interesting 
follow up study would be to establish genetic models that specifically knockout 
chemokine receptors in various cell types to explore the role of chemokine/receptor 
signaling both in peripheral and resident immune cells and in parenchymal cells. Testing 
CCR2/5 deficiency specifically in peripheral immune cells would shed significant light 
on their infiltration and role in organ inflammation after alcohol consumption.  
  Another question explored in this study was the role of infiltrating 
immune cells in the CNS after alcohol consumption with blockade of these macrophages 
using CVC. Alcohol-induced infiltration of peripheral immune cells has long been 
studied in the liver, but is only recently being recognized in the CNS171,174 and will 
certainly require further exploration. Here, we report that infiltration of macrophages 
preferentially occurred in the hippocampus with a roughly two-fold increase in cells 
expressing CCR2RFP in the hippocampus. The hippocampus is important in memory and 
learning and alcohol has been shown to influence this area in particular to13,135-139. 
However, the role of infiltrating macrophages in this CNS region deserves further 
exploration and we have only begun to understand how these cells may contribute to 
local proinflammatory gene expression. Further study using CVC along with memory 
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tasks in alcohol-exposed mice will be an important follow up to the present study. 
Additionally, studying the important role played by resident macrophages such as 
Kupffer cells (discussed above) and microglia will also yield critical insight into innate 
immune signaling in AUD. 
 Recent identification of a CSF1R inhibitor PLX5622 has established a model for 
studying what happens in the CNS when microglia are removed (or at least dramatically 
reduced in number)374. Indeed, one study exists so far exploring how alcohol affects the 
microglia-deficient CNS. Walter et al. treated with PLX5622 followed by acute alcohol 
administration (6g/kg binge) and observed a reduction in proinflammatory cytokine 
expression including Tnfa and Ccl2 compared to non-PLX5622 treated mice161. There 
are many caveats that accompany the depletion of microglia, including whether any cell 
types (peripheral macrophages, immature microglia or other glia) fill the niche and alter 
their own behavior as well as whether the process of microglial depletion (clearance of 
debris, released cellular content) impacts the surrounding CNS, among others. These will 
most certainly be explored with the continued use of anti-microglial compounds such as 
CSF1R inhibitors. Regardless, further exploration using the CSF1R inhibitor or other 
methods to transiently deplete microglial in other models of AUD (including chronic 
alcohol models similar to those described here and elsewhere in animals), will help to 
answer important questions. These may include: what role do microglia play in 
proinflammatory cytokine and chemokine production after alcohol exposure? Do 
microglia serve a protective role or more harmful role and how does the time course of 
alcohol exposure (acute versus chronic) influence these functions? Are there “behavioral” 
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changes (addiction, memory impairment, social deficits) induced or reduced by alcohol in 
the absence of microglia? How are alcohol-induced synapse changes impacted in the 
absence of microglia? These and many more questions deserve further investigation to 
advance our understanding of the neurobiology underlying AUD. 
Inhibiting inflammation signaling can reduce alcohol consumption in rodents. As 
we show in Chapter V, blockade of inflammasome activation using pharmacologic 
methods in mice reduced alcohol consumption and preference in the two-bottle choice 
model. Others have studied both genetic and pharmacologic approaches to block various 
immune pathways and inhibit alcohol-seeking behaviors in animals15,16. Expanding our 
current understanding of the role of CCR2/5 signaling with these behavioral studies can 
be accomplished using CVC or similar targeted therapies. A possible experimental 
approach would include replicating the two-bottle choice or using other addiction models 
including the drinking in the dark model16, along with CVC administration. Blednov et al. 
observed that mice deficient in CCR2, CCL2 and CCL3 (both chemokine ligands for 
CCR2) consumed less alcohol in the two-bottle choice test and displayed stronger 
conditioned taste aversion15. Like our observations with inflammasome inhibitors 
(Chapter V), sex differences were observed in that study and only female CCL2 deficient 
mice consumed less alcohol; male mice behaved similarly to wild-type animals. 
However, these studies are in mice with total body receptor deficiencies since birth and a 
more clinically relevant approach using pharmacologic CCR2/5 inhibition is needed. 
Valenta et al. recently explored CNS infusion of CCL2 and showed that alcohol 
consumption was associated with CCL2 administration in a dose-dependent manner, 
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providing additional evidence for a connection between CCL2/CCR2 signaling and 
alcohol-related behavior213. 
 
Chronic alcohol alters excitatory and inhibitory hippocampal synapse density 
Chapter IV describes increases in the expression of hippocampal presynaptic 
excitatory protein VGLUT1 along with postsynaptic excitatory protein HOMER1 and an 
increase in colocalization of these proteins suggestive of increased synapses in alcohol-
fed mice compared with pair-fed controls. Additionally, expression of the inhibitory 
postsynaptic protein Gephyrin was increased in the CA1 and CA3 region of the 
hippocampus and colocalized inhibitory synapses (VGAT/Gephyrin) were increased in 
the CA3 in alcohol-fed mice. Coincidentally, complement proteins C1q and C3 were also 
elevated in the hippocampus alongside the increases in excitatory and inhibitory 
synapses.  
Synapse pruning occurs throughout the brain during development and involves 
microglia responding to complement-tagged synapses marked for engulfment and 
degradation157-159. Therefore, our observations of increased complement expression along 
with increased synapses is somewhat surprising based on our current understanding of 
complement-dependent synapse pruning. However, complement proteins are also 
involved in inflammatory signaling. In our model of alcohol consumption, we observe 
significant upregulation by alcohol of inflammatory genes and proteins in the CNS and 
particularly in the hippocampus. We also observe morphological and surface marker 
changes in microglia consistent with an activation phenotype. Therefore, although 
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synaptic pruning by microglia occurs via complement signaling in homeostatic 
development, dysregulation of microglia, complement expression and even neuronal 
synapse activity occur after chronic alcohol exposure. This dysregulation could impact 
the normal physiological process of pruning and may lead to altered synaptic engulfment, 
despite an increase in complement protein colocalization with synapses. Additionally, 
complement expression may be primarily caused by the proinflammatory milieu 
associated with alcohol-induced neuroinflammation and therefore not serve a synaptic-
regulatory purpose but rather an inflammatory role. This may point toward changes in 
microglial responsiveness to synapse regulation, perhaps due to a preoccupation with 
other inflammatory signaling in the CNS caused by alcohol consumption, and certainly 
deserves further investigation.  
Using a model of intermittent binge alcohol administration in adolescent rats, 
Risher and colleagues139 have provided some insight into mechanisms that may be 
involved in alcohol-related synaptic dysregulation. In these studies, the authors describe 
an initial decrease in colocalization of excitatory synaptic markers VGLUT1 and PSD95 
in the hippocampus after four alcohol binges (administered by intragastric gavage). 
However, after six more gavages (ten days after the early time point), VGLUT1/PSD95 
colocalization was increased in alcohol-exposed rats compared to control animals and 
these changes were associated with correlated levels of thrombospondin proteins, 
previously shown to be important in synaptogenesis and maintenance375,376. Interestingly, 
in a separate study138, rats who were treated with intermittent adolescent alcohol binges 
followed by four weeks of abstinence showed decreased excitatory synapses 
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(VGLUT1/PSD95 and VGLUT1/SAP102 colocalization) in the CA1 of the hippocampus. 
The researchers noted that the dendritic spines in adult rats who had been treated with 
adolescent alcohol were of a more immature morphology (long and thin filopodia) 
compared with control rat dendrites (stubby and mushroom morphology)138. 
Additionally, binge alcohol administration in rats has been shown to increase dendritic 
spine densities coinciding with excitatory synaptic activity in the prefrontal cortex194. 
Taken together, these two studies suggest that, at least in a model of adolescent binge 
exposure, alcohol acutely decreases hippocampal excitatory synapses which then rebound 
during chronic exposure, only to decrease again following abstinence.  
While the time course of synaptic density changes may be dynamic (even 
convoluted) when factoring in abstinence and various binge-drinking models, Montesinos 
et al.195 also used a model of adolescent alcohol exposure and observed an upregulation 
of synapses (in the prefrontal cortex) when mice were sacrificed immediately after 
alcohol exposure, similar to the findings we present in Chapter IV. Further research will 
be needed in chronic models of alcohol and at different life stages to better determine the 
time course of synaptic dysregulation and involved mechanisms. However, these studies, 
as well as the data presented here, make clear that alcohol exposure influences synaptic 
densities in a dynamic way that may underlie such behavioral manifestations as addiction 
and cognitive dysfunction in patients with AUD. 
Excitotoxicity is a mechanism of neuronal damage and degeneration caused by 
the excitatory neurotransmission. Following chronic alcohol use, a hyperexcitable state 
exists (caused by adaptive neurotransmitter receptor expression, including glutamate and 
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GABA receptors) in the CNS that can predispose patients with AUD to seizures if 
alcohol (which normally depresses excitation in the CNS) is removed377,378. We and 
others now report increased expression of excitatory synapses in the CNS in animal 
models of alcohol consumption, despite the association of chronic alcohol. The increase 
in synapses we observe may be related to the timing of our experiments, as we only look 
at one time point. As discussed above, the increase in excitatory synapses, coupled with 
the neuroadaptive changes in neurotransmitter receptor expression in chronic alcohol, 
may lead to eventual excitotoxity and neurodegeneration. However, the association of 
excitotoxicity with neuronal damage caused by alcohol remains an area of active 
debate379 and further research into the cause and effect will be needed to resolve this 
outstanding question.  
Important questions remain related to changes in synaptic density following 
chronic alcohol. These include whether the observed changes are a product of 
dysregulated synaptogenesis, dysregulated pruning processes or dysregulated neuronal 
activity. Indeed microglia have been shown to be involved in both developmental 
synaptogenesis380 as well as pruning157, although at a more advanced age their role in 
synaptic regulation is less clear. We and others have presented evidence of activation and 
inflammatory changes in microglia following alcohol142,171,187,188. This alcohol-induced 
immune activation may interrupt normal pruning processes in microglia and lead to more 
(or even fewer) synapses, depending on the model and time point. However, the change 
in synaptic numbers may also be intrinsic to neuronal activity and synaptogenesis. 
Further work will be necessary to distinguish these possible mechanisms, including 
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consideration of other glia, such as astrocytes, that may also play a critical role in 
alcohol-related synaptogenesis and synapse regulation375. As previously discussed, 
looking at various time points beyond six-week treatment of alcohol (including following 
a period of abstinence) will be important in understanding if the increase in synapses we 
describe here persist or if the effect of alcohol on hippocampal synapses is more 
dynamic.  
 
Inhibition of the NLRP3 inflammasome cascade reduces alcohol consumption in 
female mice  
 In an effort to apply our observations that alcohol induces systemic, hepatic and 
CNS inflammation to a therapeutic model, we used anti-inflammatory NLRP3 
inflammasome inhibitors in a mouse model to measure alcohol consumption and 
preference. We found that female mice consumed significantly less alcohol and exhibited 
less alcohol preference when treated with inflammasome inhibitors compared to control 
mice with limited effect in male mice. These findings are consistent with other studies 
that have used genetic and pharmacologic approaches to influence addiction 
behavior15,16,245,359 and establish the inflammasome as a novel target for further research 
and potential AUD treatment. 
 In order to validate our findings in the two-bottle choice test, it would be 
interesting to apply other behavioral assays, such as drinking in the dark or conditioned 
place preference/aversion, to alcohol-consuming mice treated with inflammasome 
inhibition. We observed behavior consistent with resistance to alcohol-seeking, a 
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component of addiction that can be influenced by both an aversion to negative effects of 
alcohol consumption and the positive influence of reward-pathway activation11. Indeed 
previous research has demonstrated that the response to alcohol of CNS dopamine 
regulation differs between females and males381. Whereas female rats had increased 
dopamine release in the nucleus accumbens and striatum (part of the mesolimbic 
dopamine reward pathway), male rats had attenuated release in response to low levels of 
alcohol and reduced dopamine levels when exposed to high alcohol levels381. Therefore, 
studying reward-associated dopaminergic signaling within the mesolimbic cortical 
system in alcohol-treated mice with or without inflammasome inhibitors or genetic 
knockout of inflammasome components would yield important insight regarding how 
immune signaling influences addictive behavior.  
Because inflammasome-related behavior could be influenced by alcohol-induced 
signals that originate and act within the CNS or could derive from peripheral signals that 
communicate to the CNS, future studies may investigate cell-type specific alteration of 
the inflammasome pathway, for example, in peripheral immune cells (Kupffer cells, 
monocytes, etc.) or CNS inflammasome-expressing cells (microglia or astrocytes). In 
fact, with such modest alcohol consumed in the two-bottle choice test used in our study 
(limited elevation of BEC, no ALT/AST change observed), there is unlikely to be 
significant liver or CNS inflammation like that observed in our other chronic studies. 
This could suggest that signaling through the inflammasome at levels below our detection 
ability or within a very small population of cells is important for alcohol-seeking 
behavior. Longer-term models of two-bottle choice offer intermittent alcohol with 
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alcohol-free days in between. Studies after thirty days of alcohol (sixty days total) have 
revealed significant changes in microglia and astrocyte gene expression with significantly 
upregulated microglial immune signaling189,190 and may be an interesting alternative 
model to investigate with inflammasome inhibition in order to achieve more significant 
inflammation. 
Rather than inhibiting inflammasome signaling in an effort to ameliorate alcohol 
addiction, treating mice to activate the inflammasome or mimic its activation could also 
shed important light on the inflammasome in alcohol addictive behavior. This could be 
accomplished both with peripheral and central injection of proinflammatory molecules 
(such as LPS) or IL-1b, the active end-product of NLRP3 inflammasome activation. A 
similar paradigm with intracranial CCL2 injection was recently used and showed 
increased alcohol consumption when the chemokine was injected and this effect lasted 
for weeks after CCL2 infusion was terminated213. Similar studies, including targets of the 
inflammasome signaling pathway, are warranted to explore what immune pathways are 
involved in the CNS biochemistry leading to alcohol consumption. 
 
Conclusion 
 The data presented here span the body, much like ingested alcohol does after 
absorption. We sought to investigate the role of inter-organ cross-talk and common 
pathways of immune activation in the intestine, liver, peripheral circulation and the 
central nervous system. We describe changes in the gut microbiome that may contribute 
to organ dysfunction in the liver and brain associated with alcohol consumption. We 
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present novel evidence for therapeutic interventions, such as targeting the gut 
microbiome, CCR2/5 signaling and inflammasome signaling, that are beneficial in our 
various models of alcohol consumption and could prove more broadly applicable in 
human populations with alcohol use disorder. The data presented here are a testament to 
the complicated path alcohol takes in our bodies and the complex interactions among the 
gut-liver-immune-brain axis induced by alcohol. 
To future explorations of interactions between alcohol and these systems, cheers! 
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